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ABSTRACT 
 
IDENTIFICATION OF A MESENCHYMAL PROGENITOR CELL HIERARCHY IN 
ADIPOSE TISSUE 
Alexander P. Sakers 
Patrick Seale, Ph.D. 
Adipose tissue plays a critical role in defending against metabolic disease by 
sequestering excess calories and preventing their harmful deposition in ectopic locations. 
Healthy expansion of adipose occurs via hyperplastic growth, the differentiation of 
adipocyte progenitor cells (APCs) into new fat cells. The capacity for hyperplastic 
expansion depends on the fundamental properties of APCs. Prior studies of APCs used 
narrow identification methods and did not fully characterize the identity and nature of 
APCs. We used single-cell RNA sequencing to identify distinct types of progenitor cells 
in murine and human adipose tissue. Functional assessments of these cell types in vitro 
and in vivo define a mesenchymal cell hierarchy involved in adipocyte formation. We 
identified several distinct mesenchymal cell types in murine and human adipose. 
Dipeptidyl peptidase–4–expressing (DPP4+) cells are highly proliferative and 
multipotent progenitors that are relatively resistant to differentiation into adipocytes. 
Intercellular adhesion molecule–1–expressing (ICAM1+) cells are committed 
preadipocytes that express Pparg and are poised to differentiate into mature adipocytes 
with minimal stimulation. CD142+ cells represent a distinct adipogenic population in 
murine subcutaneous adipose that shares many properties with ICAM1+ preadipocytes. 
Computational cell trajectory analyses and in vivo transplantation studies showed that 
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DPP4+ progenitors give rise to both ICAM1+ and CD142+ preadipocytes before 
differentiation into mature adipocytes. DPP4+ cells depend on transforming growth 
factor–b signaling to maintain their progenitor identity. Obesity and insulin resistance 
lead to a depletion of DPP4+ progenitors and a reduction in the adipogenic differentiation 
competency of APCs in visceral white adipose tissue. Single-cell analysis of human 
subcutaneous adipose tissue revealed distinct DPP4+ and ICAM1+ populations that 
displayed functional properties similar to those of the analogous mouse populations. 
Histological examination of murine subcutaneous adipose tissue showed that ICAM1+ 
preadipocytes are intercalated between mature adipocytes. The DPP4+ progenitor cells 
are localized in a previously uncharacterized fibrous niche which surrounds adipose 
depots, which we term the reticular interstitium. Overall, our studies define the 
developmental hierarchy of adipose progenitors, describe a new anatomic niche, and lay 
the groundwork for future therapies targeting one or more of these APC populations.  
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PREFACE 
Much of the work presented in this thesis was generated in collaboration with 
another member of the Seale laboratory, David Merrick MD, PhD. David Merrick, 
studying neonatal fat, and I, investigating adult fat, converged on similar lines of inquiry 
and decided to combine our efforts. Most of the experiments were conceived, performed, 
and analyzed collaboratively, with each of us participating in some component of nearly 
every experiment. Data visualizations, interpretations, and manuscript writing were 
performed jointly by me, David Merrick, and Patrick Seale. For the sake of clarity and 
proper attribution I have highlighted our relative contributions below: 
Chapter 1 contains only my individual work. 
In Chapter 2, generation of the adult mouse scRNA seq data, adipogenesis and 
proliferation assays, and bulk RNA sequencing data were performed by me. David 
Merrick performed the osteogenesis assays, transplantation studies, and generated 
visualizations for the single cell data. Large portions of the text in this chapter derive 
from our co-authored manuscript; notably, I have made significant additions for 
thoroughness and clarity. 
In Chapter 3, the diet induced obesity model was characterized jointly by David 
Merrick and me; he performed the GTT and flow sorting of cells, while I performed the 
adipogenesis and proliferation assays. Likewise, both David and I performed FACS for 
progenitor cells from the EWAT, AxWAT, and BAT. I performed all of the in vitro 
assays. David generated the visualizations for the FACS data. The bulk RNA sequencing 
and FACS analysis of the effects of cold exposure on progenitor cell populations was my 
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individual effort. Most of the text in this section is my individual work. Portions of the 
results section, describing the diet induced obesity model and the analysis of EWAT, 
AxWAT, and BAT, are derived from our co-authored manuscript. 
In Chapter 4, the development of the FACS sorting strategy for humans and in 
vitro characterization of human cells were performed by me. David Merrick analyzed and 
created the visualizations of the human single cell data. Some portion of the text in the 
results section of this chapter derive from our co-authored manuscript. 
 In Chapter 5, some of the text in the summary and in the section comparing our 
results to those of other groups is adapted from our co-authored manuscript. 
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Chapter 1: Introduction  
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1.1 Adipose Tissue: White, Beige, and Brown 
 Adipose tissue, or more colloquially fat tissue, is defined by the presence of 
specialized lipid storing cells called adipocytes (Rosen & Spiegelman, 2014). Mammals 
have three distinct types of adipose tissue – white, beige, and brown – each of which 
serves myriad roles in the regulation of systemic energy metabolism (Cannon & 
Nedergaard, 2004; Peirce, Carobbio, & Vidal-Puig, 2014). White adipose tissue (WAT) 
is a lipid storage and endocrine organ, while beige and brown adipose tissue are 
specialized thermoregulatory organs capable of expending nutritional energy to generate 
heat (Cannon & Nedergaard, 2004; Lidell et al., 2013; Rosenwald & Wolfrum, 2014). 
Due to the epidemic of obesity, a condition characterized by excessive body fat, there is 
immense interest in the mechanisms of adipose tissue development, function, and 
dysfunction (González-Muniesa et al., 2017; Rosen & Spiegelman, 2014). Targeting 
adipose to promote metabolically healthy storage of excess nutrients or to enhance energy 
expenditure represents a promising therapeutic approach (Ghaben & Scherer, 2019; 
Wernstedt Asterholm et al., 2014; Yoneshiro et al., 2013). 
 
White adipose tissue  
 White adipose tissue is the most abundant form of fat in humans and mice, and is 
found in almost every area of the body (Zwick, Guerrero-Juarez, Horsley, & Plikus, 
2018). The defining feature of white adipose tissue is the presence of white adipocytes, 
which have a single large lipid droplet, relatively few mitochondria, and a nucleus 
situated at the periphery of the cell. White adipocytes are found in places as superficial as 
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the dermis, where they function in wound healing and hair follicle cycling, to places as 
deep the ovaries, where they provide mechanical cushioning (Chambon et al., 2017; 
Zwick et al., 2018). The vast majority of white adipose tissue is located subcutaneously 
and functions as a dynamic store of nutritional energy to solve a fundamental problem 
that all living organisms encounter: the fact that access to food is sporadic (Ottaviani, 
Malagoli, & Franceschi, 2011; Pond, 2012).  
In normal physiology, WAT functions as a buffer against the oscillations in 
calorie availability over time. During times of nutritional excess, it stores chemical 
energy in the form of lipid droplets (Czech, 2017). During times of nutritional 
deprivation, it releases this energy to the rest of the organism by exporting lipid in the 
form of free fatty acids (lipolysis) (Morigny, Houssier, Mouisel, & Langin, 2016). These 
two processes ensure that other body tissues always have access to an adequate but not 
excessive level of nutrients. Although only vertebrates have adipose tissue, the capacity 
to safely store and efficiently release chemical energy is so important that all eukaryotes 
have evolved a mechanism to handle lipid droplets (Festuccia & Laplante, 2005; 
Ottaviani et al., 2011). 
The major signal for nutrient uptake into adipocytes is elevated circulating levels 
of the hormone insulin (Rorsman & Braun, 2013). Insulin is secreted by pancreatic β-
cells in response to increased levels of glucose and fatty acids, a proxy for nutrient 
abundance (Rorsman & Braun, 2013). Insulin binds to the insulin receptor, a receptor 
tyrosine kinase, on the extracellular membrane of adipocytes and other insulin responsive 
tissues (De Meyts, 2000). Through a complex signal transduction cascade, the binding of 
insulin activates AKT (protein kinase B) via phosphorylation (Kohn, Takeuchi, & Roth, 
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1996). Activated AKT stimulates uptake of glucose via the translocation of GLUT4 to the 
cell surface, and also suppresses lipolysis and stimulates de novo lipogenesis (Boucher J, 
Kleinridders A, 2014; Shepherd et al., 1993). Insulin signaling is critical for the de novo 
differentiation and maintenance of adipocytes (Nakae et al., 2003; Sakaguchi et al., 2017; 
Shearin, Monks, Seale, & Birnbaum, 2016). Numerous studies have shown that genetic 
deletion of the insulin receptor or downstream effectors such as GLUT4 or the various 
AKT isoforms in adipose tissue can cause insulin resistance and varying degrees of 
lipodystrophy (Abel et al., 2001; Bae, Cho, Mu, & Birnbaum, 2003; Shearin et al., 2016). 
Lipolysis is the process of hydrolyzing triacylglycerols, the primary constituent of 
adipocyte lipid droplets, into their component parts of glycerol and free fatty acids 
(Morigny et al., 2016). Lipolysis in adipocytes is primarily induced by signaling through 
β-adrenergic receptors; these G-protein coupled receptors signal through heterotrimeric 
Gs to activate adenylyl cyclase (Collins, 2012). Activated adenylyl cyclase raises 
intracellular levels of cyclic adenosine monophosphate (cAMP) which in turn activates 
the protein kinase a (PKA) and p38/MAPK signaling pathway (Collins, 2012). Activated 
PKA phosphorylates several components of the lipolytic machinery to enable lipolysis; 
these include activating phosphorylation on hormone sensitive lipase (HSL) and 
inhibitory phosphorylation on the lipid droplet protein perilipin (Collins, 2012; Tansey, 
Sztalryd, Hlavin, Kimmel, & Londos, 2004). Combined, these actions lead to release of 
free fatty acids and glycerol from WAT into the circulation for use by other organs. 
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Endocrine functions of white adipose tissue 
White adipose tissue is recognized as an endocrine organ as it secretes numerous 
hormones and other factors, collectively termed adipokines (Musi & Guardado-Mendoza, 
2014; Ouchi, Parker, Lugus, & Walsh, 2011). Adipokines serve numerous functions, but 
in general signal about the state of WAT to the central nervous system and other tissues 
(Musi & Guardado-Mendoza, 2014). Hundreds of adipokines have been described with 
roles in insulin sensitization ( ex. adiponectin), insulin resistance (ex. resistin, RBP4, 
lipocalin), inflammation (ex. TNF, IL-6, IL-18), and communication of nutrient levels 
(ex. leptin) (Ouchi et al., 2011). The most well-studied adipokine is leptin. Leptin is 
secreted by adipocytes and signals in the hypothalamus to communicate information to 
the brain about the current mass of adipose tissue (Zhang Y et al., 1994). High levels of 
leptin indicate that the adipose tissue is replete with nutrients while low levels signal a 
deficiency. Consistent with this role, rare loss of function mutations in leptin (in mice, 
ob/ob) or the leptin receptor (in mice, db/db) drive some of the most severe forms 
monogenic obesity (Clément et al., 1998; Ozata, Ozdemir, & Licinio, 1999).  
 
Thermogenic brown and beige adipose tissue 
Brown and beige adipocytes represent a relatively small proportion of total 
adipose tissue but exert an outsized metabolic impact due to their ability to engage in 
thermogenesis. Thermogenic adipocytes have the capacity for uncoupled respiration, a 
process in which nutrients are metabolized for the purpose of generating heat 
(Nedergaard et al., 2001). These tissues help mammals defend their body temperature in 
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cold environments (Cannon & Nedergaard, 2004). The discovery that adult humans have 
functional thermogenic fat promoted a surge of interest in brown and beige adipose tissue 
(Cypess et al., 2009; Ouellet et al., 2011). Since these tissues are specialized to burn 
excess energy, augmenting their activity holds promise as a potential anti-obesity therapy 
(Chondronikola et al., 2014, 2016; Yoneshiro et al., 2013).  
Brown and beige adipocytes display functional similarities due to shared gene 
expression patterns and regulatory circuits. Both are characterized by small multilocular 
lipid droplets, high mitochondrial density, and the expression of Uncoupling Protein 1 
(UCP1) (Cannon & Nedergaard, 2004; Jespersen et al., 2013). UCP1 disengages nutrient 
catabolism from ATP synthesis by dissipating the proton gradient in the inner 
mitochondrial membrane. Through this inefficiency, UCP1 enables brown/beige 
adipocytes to metabolize nutrients to generate heat (Nedergaard et al., 2001).  
Although brown and beige adipocytes show functional similarities, they develop 
from distinct developmental lineages. Brown adipocytes develop during embryogenesis 
from a shared lineage with muscle and are found in dedicated, relatively homogeneous 
depots of brown adipose tissue (BAT) (Seale et al., 2008, 2007). Beige adipocytes 
develop in response to cold or beta-adrenergic stimulation within white adipose depots 
(Young, Arch, & Ashwell, 1984). Several studies suggest that the thermogenic 
adipocytes found in adult humans are more similar to mouse beige adipocytes than to 
classical mouse brown adipocytes (Jespersen et al., 2013; Lidell et al., 2013; Sharp et al., 
2012). Therefore, it is critical to determine the regulatory circuits controlling and the 
cellular origins of beige adipose tissue. The precursor populations responsible for the 
development of beige adipose tissue will be discussed in later in this introduction. 
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1.2 Adipocyte Differentiation 
 Adipocyte differentiation is the process by which mesenchymal progenitor cells 
commit to the adipocyte lineage (commitment) and acquire the morphological and 
transcriptional features of mature adipocytes (terminal differentiation) (Cristancho & 
Lazar, 2011). Much of what we know about these processes comes from in vitro models 
of adipogenesis using primary cells or the highly adipogenic immortalized fibroblast 
3T3-L1 cell line. The most commonly used primary cell model involves isolating cells 
from the stromal vascular fraction (SVF) of adipose tissue. SVF is isolated by 
enzymatically digesting adipose into a single cell suspension followed by centrifugation 
to separate mature adipocytes (which float) from the SVF (the pelleted cells). The SVF is 
a complicated mixture of cells, many of which contain in vitro adipogenic potential 
(Bjorntorp et al., 1978). 
  A full understanding of adipocyte commitment has been hampered by the lack of 
in vivo marks for cells restricted to the adipocyte lineage (i.e. committed preadipocytes). 
Despite this, work has indicated that the commitment process likely involves the 
integration of several pro and anti adipogenic growth factor signals. Anti adipogenic 
signals include: cannonical and non-cannonical WNT pathways (especially WNT5, 
WNT6, WNT10a, and WNT10b) (Cawthorn et al., 2012; Cristancho & Lazar, 2011), 
transforming growth factor beta (TGFβ) (Ignotz & Massagut, 1985), and hedgehog 
signaling (Suh et al., 2006). Pro adipogenic signals include: Bone Morphogenic Protein 
(BMP) signaling (especially BMP2 and BMP4) (Cristancho & Lazar, 2011; Q.-Q. Tang, 
Otto, & Lane, 2004) and extracellular matrix composition (Cristancho & Lazar, 2011).  
The process of terminal differentiation involves the coordinated action of several 
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transcription factors, most notably Peroxisome Proliferator Activated Receptor-γ 
(PPARγ) and CCAAT/ enhancer binding proteins (C/EBP) family members, C/EBPα, 
C/EBPβ, and C/EBPδ (Chawla & Lazar, 1994; Tontonoz, Hu, & Spiegelman, 1994). The 
standard in vitro adipogenic cocktail includes glucocorticoids, insulin, and 3-isobutyl-1-
methylxanthine (which raises intracellular levels of cAMP). Upon treatment with this 
cocktail, there is a transient induction of C/EBPβ and C/EBPδ, which induce the 
expression of C/EBPα and PPARγ. C/EBPα and PPARγ engage in a feed forward loop, 
inducing the expression of each other, and driving the transcription of mature adipocyte 
identity genes (Cristancho & Lazar, 2011). Notably PPARγ is always necessary for 
adipogenesis and in many systems is sufficient (Cristancho & Lazar, 2011). Thus, PPARγ 
is often called the master regulator of adipogenesis. Overall, the process of adipocyte 
differentiation takes about 8 days in culture but may be shorter in vivo (Q. A. Wang, Tao, 
Gupta, & Scherer, 2013).  
 
1.3 Adipose Tissue Expansion: Where and How? 
White adipose tissue exhibits a remarkable ability to expand and contract. In 
humans, body fat percentages can range dramatically: from normal levels of 10-20% in 
men and 15-30% in women, to lows of below 5% in patients with cachexia, and highs of 
70% in people with severe obesity (Imboden, Swartz, Finch, Harber, & Kaminsky, 2017; 
L. B. Salans, Cushman, & Weismann, 1973). No other tissue in the body exhibits such 
extreme flexibility (J. H. Stern & Scherer, 2015). Notably, not all adipose tissue 
expansion is created equal. The site of expansion, whether in visceral or subcutaneous 
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depots, and the method, whether hyperplastic or hypertrophic, have profound impacts on 
metabolic health (Ghaben & Scherer, 2019; Samuel & Shulman, 2016). The following 
sections will more closely explore the topic of metabolic health and the concept of 
healthy versus unhealthy growth of adipose tissue. 
Metabolic health: obesity and insulin resistance 
 By 2025 it is estimated that nearly 20% of all adults globally will be obese (Di 
Cesare et al., 2016). Obesity is defined as body weight out of proportion to height and is 
typically measured as [kg/m2] using a scale called body mass index (BMI). A score of 
over 25 indicates overweight while a score over 30 indicates obesity (Karpe & Pinnick, 
2015). At the most basic level, obesity is a disorder of energy balance. A chronic excess 
of calorie intake relative to calorie expenditure leads to weight gain, predominantly in the 
form of adipose tissue (González-Muniesa et al., 2017). The rapidly increasing 
prevalence of obesity presents a significant challenge to healthcare systems due to its 
causal role in the development of type II diabetes, cardiovascular disease, and other 
illnesses (Bhaskaran, dos-Santos-Silva, Leon, Douglas, & Smeeth, 2018; Blüher, 2019; 
Di Angelantonio et al., 2016).  
Obesity is associated with a number of comorbid metabolic pathologies, which 
together are often called “the metabolic syndrome” (Lanktree & Hegele, 2017). They are: 
high blood glucose, high blood triglycerides, low HDL cholesterol, hypertension, and 
central (abdominal) obesity. These findings correlate strongly with the related 
phenomenon of insulin resistance, a condition in which cells and tissues show reduced 
responsiveness to insulin. (Samuel & Shulman, 2012). At the cellular level, insulin 
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resistance involves reduced signaling through the Insulin Receptor-PI3K-AKT pathway 
(Odegaard & Chawla, 2013). In adipocytes, it manifests as reduced uptake of glucose per 
unit of insulin and as a failure to suppress lipolysis (Koren et al., 2015). Systemically, 
insulin resistance is characterized by higher blood glucose and insulin levels. In animal 
models, insulin resistance is often assessed by demonstrating reduced blood glucose 
clearance in response to a bolus of glucose or insulin. 
The presence of insulin resistance or the metabolic syndrome is a risk factor for 
the development of metabolic disease (Vancampfort et al., 2016). Indeed, people with the 
metabolic syndrome have double the risk for developing cardiovascular disease and five 
times the risk for developing type II diabetes over a 5-10 year period (Lanktree & Hegele, 
2017). Because of these tight associations with disease, the term “metabolic health”, is 
often used as a shorthand to denote the absence of insulin resistance or the metabolic 
syndrome.  
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Figure 1.1: Metabolic consequences of adipose tissue expansion. 
Adipose tissue may expand in one of two ways, by hypertrophy or by hyperplasia, and in 
one of two anatomic locations, subcutaneous or visceral. Expansion through hypertrophy, 
growth in the size of preexisting fat cells, is associated with tissue dysfunction and 
predisposition to metabolic disease. Expansion via hyperplasia, growth in the number of 
fat cells through de novo differentiation of progenitors, is associated with protection from 
metabolic disease. Similarly, expansion in visceral compartments is metabolically 
detrimental but expansion in subcutaneous compartments is protective. The balance of 
which form and location of expansion predominates may depend on properties intrinsic to 
the tissue resident adipocyte precursors. 
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Where: subcutaneous versus visceral adipose tissue expansion 
The most commonly employed distinction between modes of adipose tissue 
expansion is based on whether the excess fat is located in subcutaneous or visceral 
anatomical compartments (Figure 1.1). This categorization has gained widespread use 
due to the strong association of increased visceral adipose tissue mass with the 
development of the metabolic disease (Tchernof & Després, 2013). In contrast, 
subcutaneous adipose tissue expansion, while not beneficial per se, is viewed as 
protective in the setting of obesity (Karastergiou & Fried, 2013).  
Visceral adipose tissue depots are those within the peritoneal cavity. In humans, 
visceral fat is found in the omental, mesenteric, epicardial, and (in females) gonadal 
depots. Subcutaneous depots are located more superficially, just beneath the skin. 
Subcutaneous adipose tissue represents 80% or more of total fat mass and is present as a 
continuous sheet in nearly all areas of the body (Karastergiou & Fried, 2013; M. J. Lee, 
Wu, & Fried, 2013). The largest concentrations of subcutaneous fat are found in the 
abdominal, gluteofemoral, and intramuscular depots (Chusyd, Wang, Huffman, & Nagy, 
2016). 
Mice have somewhat analogous visceral (mesenteric, perirenal, and gonadal) and 
subcutaneous (inguinal and axillary) depots. Commonly, the inguinal depot is used to 
model human subcutaneous fat and the gonadal depot (epididymal in male mice, 
paraovarian in female mice) is used to model visceral fat (Chusyd et al., 2016). While 
these models are imperfect (one notable example: murine gonadal fat drains into the 
systemic circulation while human visceral fat drains into the portal circulation) they have 
been useful in the field of adipose tissue biology, with results often translating from mice 
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to humans (Chusyd et al., 2016; Fried, Lee, & Karastergiou, 2015). 
Numerous studies have examined the effects of visceral versus subcutaneous 
adiposity on overall health (Karastergiou & Fried, 2013; Tchernof & Després, 2013; 
Wormser et al., 2011). They typically employ imaging for direct measurement or clinical 
proxies for visceral obesity such as the waist to hip ratio (a measure of “central 
adiposity”). Almost universally, increased visceral or central adiposity is associated with 
a higher risk of developing cardiovascular disease or diabetes (M. J. Lee et al., 2013). In 
contrast, at any given level of adiposity, those with a more subcutaneous or peripheral fat 
distribution are relatively protected from metabolic disease. 
Differences in the distribution of adipose tissue are often used to explain the 
existence of “metabolically healthy obese” and “metabolically unhealthy normal-weight” 
individuals (Cherqaoui et al., 2012; N. B. Ruderman, Schneider, & Berchtold, 1981; N. 
Ruderman, Chisholm, Pi-Sunyer, & Schneider, 1998). In general, the metabolically 
healthy obese have unexpectedly low levels of visceral adiposity for their body weight; 
the situation is reversed in those who are metabolically unhealthy but normal weight. 
Overall, the distribution of adipose tissue appears to be a key determinant of metabolic 
health at normal weight and in obesity. Therefore, deciphering how to promote 
subcutaneous and diminish visceral adipose tissue expansion may represent an effective 
therapy for metabolic disease.  
How: hypertrophic versus hyperplastic adipose tissue expansion 
In addition to the location of adipose tissue growth, the mechanism by which the 
tissue expands exerts a strong influence on metabolic health. Adipose tissue can expand 
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in one of two ways: by hypertrophy or by hyperplasia (Figure 1.1) (J. Hirsch & Han, 
1969). Hypertrophic growth occurs via the expansion in size of preexisting fat cells while 
hyperplastic growth is driven by an increase in the number of fat cells via the 
differentiation of adipocyte progenitors (Hepler & Gupta, 2017). Hypertrophic growth is 
associated with adipose tissue inflammation, fibrosis, hypoxia, and poor metabolic health 
(Hepler & Gupta, 2017). In contrast, hyperplastic growth avoids these pathologic changes 
and is generally metabolically favorable.  
Much of the evidence for the divergent consequences of hyperplastic versus 
hypertrophic expansion comes from association studies performed in humans. Very early 
work performed in the 1960’s and 1970’s examined the size and number of adipocytes in 
lean and obese subjects (Bjorntorp, 1974; Jules Hirsch & Batchelor, 1976; Lester B. 
Salans, Knittle, & Hirsch, 1968). A common method employed biopsies of subcutaneous 
adipose tissue from numerous sites (often the triceps, abdomen, and buttocks) followed 
by determination of the average adipocyte mass (μg lipid/cell) and measurement of total 
body fat mass. Dividing the total fat mass by the average adipocyte mass led to estimates 
of the total adipocyte number (Bjorntorp, 1974).  
These studies revealed several important findings. First, obese subjects on average 
have both more adipocytes and larger adipocytes than normal weight controls (Bjorntorp, 
1974; L. B. Salans et al., 1973). Adipocyte size appears to increase up to the point of 
moderate obesity, after which subsequent increases in fat mass are mediated by increases 
in adipocyte number (Per Björntorp & Sjöström, 1971; Hirsch, J, Knittle, 1970). Notably, 
there is substantial interindividual variation; at any given fat mass, people can exhibit a 
more hypertrophic or more hyperplastic adipose tissue phenotype (Bjorntorp, 1974). 
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Second, hypertrophic adipose tissue is associated with poor metabolic health, 
including increased fasting insulin, decreased insulin sensitivity, and elevated blood 
glucose levels (Per Björntorp & Sjöström, 1971; L. B. Salans et al., 1973; Lester B. 
Salans et al., 1968). Indeed, several studies have indicated that fat cell size correlates 
positively with markers of insulin resistance, while (when controlling for total fat mass) 
fat cell number shows a negative correlation (P. Björntorp et al., 1972; Per Björntorp & 
Sjöström, 1971; M. P. Stern, Olefsky, Farquhar, & Reaven, 1973). 
Third, longitudinal and cross sectional studies suggested that the total number of 
adipocytes increases throughout childhood before stabilizing in adulthood (Knittle, 
Timmers, Ginsberg-Fellner, Brown, & Katz, 1979; Spalding et al., 2008). This third point 
is worth examining further as these results have caused considerable confusion within 
both the scientific community and the general population. There are two seemingly 
inconsistent observations: 1) cross sectional studies imply adipocyte number is relatively 
stable in adulthood and 2) these same studies show that obese adults generally have more 
adipocytes than lean adults (on the order of twice as many) (Hirsch, J, Knittle, 1970; 
Spalding et al., 2008). This leads to the question: when do obese adults make their extra 
adipocytes? 
One possibility is that, compared to lean adults, obese adults produced more 
adipocytes in childhood, thus establishing a higher “set point” for their total number of 
adipocytes. Consistent with this, longitudinal studies have shown that obese children 
produce significantly more adipocytes during childhood than lean children (Knittle et al., 
1979). Normal weight children experience two developmental periods (from age 0-2 and 
from age 13-18 years) characterized by rapid increases in adipocyte number; in contrast, 
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obese children show ever increasing adipocyte numbers from age 0-18 (Knittle et al., 
1979). By the time they reach adulthood, those who were obese as children have about 
twice as many fat cells as their normal weight counterparts. 
Upon closer consideration however, these observations cannot explain the 
increased adipocyte number seen in adult obesity. While many obese children become 
obese adults, most obese adults were not obese as children (Freedman et al., 2005; 
González-Muniesa et al., 2017). Thus, we are still left to ask when this expansion in fat 
cell number occurred. Adults are capable of producing new adipocytes during the normal 
process of adipose tissue turnover (Spalding et al., 2008). Therefore, it seems more likely 
that independent of the age of onset, there is increased adipogenesis during the 
development obesity. To prove this, a longitudinal study quantifying adipocyte numbers 
in the transition from leanness to obesity during adulthood would be needed. To date, 
such a study has not been performed. 
The converse experiment, tracking adipocyte numbers during weight loss, has 
been performed (J. Hirsch & Han, 1969). Weight loss induced by dietary changes or 
bariatric surgery leads to a reduction in adipocyte size but a maintenance of adipocyte 
number (P Björntorp et al., 1975; Häger, Sjörström, Arvidsson, Björntorp, & Smith, 
1978; Kral, Bjorntorp, Schersten, & Sjostrom, 1977). Based on these studies, a model 
emerges in which adult humans likely have the capacity for hyperplastic adipose tissue 
expansion, albeit at a diminished level compared to children. Moreover, hyperplastic 
adipose tissue expansion may function as a one-way rachet; once new adipocytes are 
formed, a new set point for adipocyte number is established and maintained throughout 
the lifetime of the individual. Finally, there appears to be an upper limit on adipocyte 
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size, which is reached in extreme obesity, after which increases in fat tissue volume can 
only be achieved by increasing adipocyte number. 
 
1.4 Adipose Tissue Expandability 
There is considerable evidence that intervening in the natural history of obesity to 
promote hyperplastic rather than hypertrophic adipose tissue expansion would be 
metabolically beneficial. Support for this idea is derived from: 1) molecular analyses of 
hyperplastic versus hypertrophic adipose tissue and 2) pharmacological and genetic 
models of impaired or enhanced adipocyte hyperplasia. 
Hypertrophic adipose tissue is dysfunctional 
Hypertrophic expansion of adipose tissue is a risk factor, independent of body 
mass index, for the development of the metabolic syndrome (Gustafson, Hammarstedt, 
Hedjazifar, & Smith, 2013; Hardy et al., 2011). Molecular analyses of large versus small 
adipocytes from within the same individual provide moderate evidence for why this is the 
case. Some studies have shown that large adipocytes demonstrate higher rates of 
lipolysis, enhanced recruitment of immune cells, and increased production of 
inflammatory cytokines (Jernås et al., 2006; Laurencikiene et al., 2011; Xiao et al., 2016). 
In addition, small adipocytes may secrete higher levels of the insulin sensitizing hormone 
adiponectin (Meyer, Ciaraldi, Henry, Wittgrove, & Phillips, 2013). These observations 
must be interpreted with the caveat that many of these determinations were not made on a 
“per unit of adipocyte mass” basis. Therefore, it is unclear whether an equal mass of 
small non-hypertrophic adipocytes would behave equivalently; this is an open question 
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for the field. 
Stronger evidence comes from the analysis of WAT from insulin resistant 
patients. The WAT of obese insulin resistant patients is characterized by the presence of 
larger adipocytes and more fibrosis, hypoxia, and inflammation (Gustafson, Hedjazifar, 
Gogg, Hammarstedt, & Smith, 2015; Hepler & Gupta, 2017; Kai Sun, Kusminski, & 
Scherer, 2011). At a tissue level, this dysfunctional fat produces lower levels of insulin 
sensitizing adipokines such as adiponectin and is correlated with higher levels of ectopic 
lipid deposition in the muscle and liver (Klöting & Blüher, 2014). Interestingly, the WAT 
of non-obese patients with insulin resistance or diabetes is also characterized by large 
hypertrophic adipocytes suggesting a link between adipocyte hypertrophy (rather than 
total fat mass) and metabolic dysfunction (Acosta et al., 2016). 
 The initiating event in the maladaptive remodeling of adipose tissue is unknown. 
The prevailing model posits that a failure of angiogenesis, senescent or defective 
adipocyte precursors, and inflammation cause adipose tissue to expand via adipocyte 
hypertrophy rather than hyperplasia (Hepler & Gupta, 2017; Hepler, Vishvanath, & 
Gupta, 2017). These hypertrophic adipocytes become hypoxic and contribute to further 
tissue dysfunction by: 1) secreting high levels of inflammatory cytokines, 2) dying via 
necrosis and spilling lipid in an uncontrolled manner into the tissue, and 3) producing 
inappropriate amounts of collagen leading to tissue fibrosis. These processes are 
continuous and mutually reinforcing, making it difficult to disentangle cause and effect. 
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Pharmacologic and genetic manipulation of adipose tissue expandability 
 Several informative genetic and pharmacological studies have suggested that it is 
not hypertrophic adipocytes per se that drive adipose tissue and systemic metabolic 
dysfunction, but rather a failure of adipose tissue “expandability”. In this model, 
hypertrophic adipocytes are a symptom more than a cause of dysfunctional adipose 
tissue. The model posits that once adipose tissue becomes “full” and can no longer take 
up excess nutrients, ectopic lipid begins to accumulate in peripheral organs leading to 
metabolic decline. 
The first line of evidence for this model comes from two genetic models of 
healthy obesity, one characterized by extreme adipose tissue hyperplasia and the other by 
extreme hypertrophy. Leptin deficient (ob/ob) mice, a model of extreme obesity, exhibit 
glucose intolerance, hyperphagia, and adipose characterized by large hypertrophic 
adipocytes and inflammatory macrophage infiltration (Khan et al., 2009). The metabolic 
dysfunction of ob/ob mice can be ameliorated by concomitant overexpression of the 
insulin sensitizing hormone adiponectin (AdiponectinTG) or by knockout of collagen 6 
(col6KO) (Khan et al., 2009; Kim et al., 2007). Both models are characterized by 
increased adipose tissue mass which is believed to normalize insulin sensitivity by 
preventing ectopic lipid deposition in other tissues. The adipose tissue of ob/ob 
AdiponectinTG mice exhibits extreme hyperplasia and contains many small adipocytes. 
Interestingly, the adipose of ob/ob col6KO mice contains enormous highly hypertrophic 
adipocytes. 
If hypertrophic adipocytes are truly harmful, why do ob/ob col6KO mice have 
less severe metabolic disease than control ob/ob mice? Collagen 6 is selectively produced 
20 
 
by adipocytes compared to other cell types (Divoux et al., 2010b). It surrounds fat cells 
and is responsible for the pericellular fibrosis that restrains adipocytes from expanding 
past a certain size. Mice lacking collagen 6 therefore have a more permissive 
extracellular matrix, allowing for unrestricted expansion. Thus, it appears that 
hypertrophic adipocytes are not deleterious because they are large, but rather because 
they are prevented by the ECM from getting even larger. 
Further evidence comes from experiments with thiazolidinediones (TZDs) which 
demonstrate that augmenting the expansion capacity of adipose tissue is beneficial in 
metabolic disease. TZDs are pharmacological ligands for PPARγ, the master regulator of 
adipogenesis (Chawla & Lazar, 1994; Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., 
Wilkison, W.O., Willson, T.M., and Kliewer, 1995; Tontonoz et al., 1994). Activation of 
PPARγ leads to enhanced adipocyte differentiation (hyperplasia) and, in some depots, to 
enhanced expansion capacity (hypertrophy) (De Souza et al., 2001; Haliakon et al., 1997; 
W. Tang, Zeve, Seo, Jo, & Graff, 2011). Although PPARγ is expressed in other cell 
types, notably macrophages, muscle, and liver, the utility of TZDs as anti-diabetic drugs 
is primarily believed to come from their ability to promote adipose tissue insulin 
sensitivity and healthy expansion (Gavrilova et al., 2003; Hevener et al., 2003; Moore et 
al., 2001; Yki-Järvinen, 2004). 
 Adipose tissue expansion capacity is strongly related to metabolic health. 
Enhancing de novo adipocyte differentiation by overexpression of PPARγ in a subset of 
progenitor cells in visceral adipose tissue improves insulin sensitivity in mice fed a high 
fat diet (HFD); deletion of PPARγ in these cells demonstrates the opposite effect (Shao, 
Vishvanath, et al., 2018). A similar result was observed with adipocyte specific deletion 
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of phosphate and tensin homologue (PTEN) using the following model: AdipoQrtTA-TRE-Cre 
Pten fl/fl. PTEN is a negative regulator of adipogenesis (Morley, Xia, & Scherer, 2015). 
On HFD, these mice display enhanced nutrient partitioning into the subcutaneous adipose 
tissue and correspondingly enhanced insulin sensitivity. Outside of large effect size 
genetic models, genome wide association studies in humans have linked common genetic 
variants to reduced subcutaneous adipocyte storage capacity and to the risk of developing 
insulin resistance (Chu et al., 2017; Gulati et al., 2017). 
Finally, with age, adipose tissue loses some of its capacity for hyperplastic 
expansion (Caso et al., 2013; Gustafson et al., 2013; Lopez-Otin, Blasco, Partridge, 
Serrano, & Kroemer, 2013). This phenomenon may be due to cell-autonomous changes 
in the adipocyte progenitors or due to the inhibitory effects of senescent cells and the 
senescent associated secretory phenotype (SASP) (Palmer & Kirkland, 2016). Several 
age associated defects in adipocyte progenitor cells have been reported, including 
reduced expression of sirtuins, reduced expression of pro adipogenic transcription factors 
such as C/EBP family members, and impaired proliferative capacity (Caso et al., 2013; 
Karagiannides et al., 2001; Khanh et al., 2018). Furthermore, senescent progenitor cells 
accumulate in the adipose tissue of aged mice and humans (Baker et al., 2016; Gustafson, 
Nerstedt, & Smith, 2019). Clearance of senescent cells from the fat of old mice improves 
adipogenesis in vivo (Xu et al., 2015). Likewise, suppression of the SASP in cultures of 
human preadipocytes enhances adipogenic differentiation (Gustafson et al., 2019). 
Combined, the effects of precursor autonomous changes and senescent cells lead to a 
failure of adipogenesis in response to physiological stimuli such as HFD and cold 
exposure (Khanh et al., 2018; W. Wang et al., 2019). Overall, the reduction in the 
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expandability of adipose tissue with age may be a key driver of age associated metabolic 
decline. 
 
1.5 Depot Specific Mechanisms of Adipose Tissue Expansion 
 Several studies have examined the manner by which different adipose depots 
expand during obesity in mice. The general strategy for detecting adipogenesis is as 
follows: 1) Label all pre-existing mature adipocytes based on their expression of 
adiponectin (AdipoQrtTA-TRE-Cre or AdiponectinCreER), plus a Cre inducible reporter like 
Rosa26LacZ or Rosa26mT/mG). 2) Treat mice with high fat diet and examine the proportion 
of labeled (old) versus unlabeled (new) adipocytes (Jeffery, Church, Holtrup, Colman, & 
Rodeheffer, 2015; Q. A. Wang et al., 2013). In mice, expansion of the visceral (gonadal) 
adipose depots occurs through high levels of de novo adipocyte differentiation and 
progenitor cell proliferation. In contrast, expansion of subcutaneous (inguinal) fat is 
mediated primarily by hypertrophy, with little progenitor cell proliferation or 
differentiation (Jeffery et al., 2015; Q. A. Wang et al., 2013). 
Differences in progenitor cell behavior in response to dietary challenge are likely 
mediated by the variations in the depot specific microenvironment (Jeffery et al., 2016). 
When subcutaneous adipocyte progenitors are transplanted into visceral depots, they 
proliferate and differentiate similarly to the endogenous visceral progenitors in mice fed a 
high fat diet. Conversely, when visceral progenitors are transplanted into subcutaneous 
adipose tissue, they fail to differentiate or proliferate in response to HFD (Jeffery et al., 
2016). These results indicate that adipocyte progenitor cells are highly plastic and contain 
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the ability to proliferate or differentiate in response to the proper signals. This opens the 
exciting possibility of manipulating the signaling environment of subcutaneous adipocyte 
progenitors to promote de novo differentiation and healthy hyperplastic adipose tissue 
expansion in the setting of obesity. 
 
1.6 Adipose Tissue Turnover 
 Adipose tissue is in a constant state of low level turnover, with mature adipocytes 
dying and being replaced by new adipocytes (Rigamonti, Brennand, Lau, & Cowan, 
2011; Spalding et al., 2008). Several studies have attempted to estimate the rate of this 
turnover in mice and humans, with estimates varying widely. Overall these results range 
from a low of about 8.5% per year to a high of 60-100% per year in humans (Neese et al., 
2002; Spalding et al., 2008; Strawford, Antelo, Christiansen, & Hellerstein, 2003). In 
mice the estimates suggest a much higher turnover rate of approximately 1.5% to 4.5% 
per day (Rigamonti et al., 2011). 
The most widely cited study employed 14C measurements of adipocytes, taking 
advantage of the spike in atmospheric 14C that occurred due to nuclear tests in the 1960’s 
(Spalding et al., 2008). This group found that about 8.5% adipocytes turn over per year in 
both lean and obese subjects. They note that obese people have similar rates of turnover 
when normalizing to the number of adipocytes, but higher absolute levels of turnover due 
to their increased number of adipocytes (Bjorntorp, 1974; Jules Hirsch & Batchelor, 
1976; Knittle et al., 1979). Another study developed methods to track the proliferation of 
cells and turnover of substrates in slow turnover tissues using 2H2O long term labeling 
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(Neese et al., 2002; Strawford et al., 2003). This work suggested much more rapid 
turnover, suggesting that 0.16-0.29% adipocytes are replaced per day (58-105%/year). 
Interestingly, this study fractionated the tissue and found that the stromal-vascular 
compartment, where adipocyte progenitors are located, showed a turnover rate of 4.5% of 
cells/day.  
 In mice, the overall rates of turnover are higher than in humans. One study, using 
2H2O long term labeling found daily rates of 5% turnover in the stromal vascular fraction 
and 1-1.5% turnover in the adipocyte fraction (Neese et al., 2002). Follow up studies 
using Ki67, BrDU, and dilution of the stable histone H2BGFP, largely support these 
conclusions finding ~5% of cells in the stromal vascular fraction are replicating at any 
time and that 1-5% of adipocytes are replaced each day (Rigamonti et al., 2011). 
Consistent with the human models of obesity, they also find that ob/ob mice show higher 
rates of proliferation and adipocyte turnover. 
 The turnover of adipose tissue requires the coordinated action of multiple cell 
types within the tissue. Overall there must be: 1) efficient clearing of dying adipocytes, 2) 
a pool of progenitor cells capable of replacing lost adipocytes, 3) a mechanism to keep 
the production of new adipocytes and the death of old ones at approximately similar 
rates. 
Dying adipocytes must be cleared away in an orderly manner to avoid the harmful 
effects of releasing free lipid into the tissue (Kai Sun et al., 2011; Y. Lee et al., 2014; 
Rosen & Spiegelman, 2014). This clearing away process is dependent upon adipose 
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tissue macrophages, which engulf dying adipocytes and are detected within the tissue as 
crown-like structures (Hill et al., 2018; Murano et al., 2008; Nelson et al., 2018). 
Emerging evidence suggests that macrophages may even recruit adipocyte progenitor 
cells to the site of dying adipocytes, through a CD44 – Osteopontin chemotactic axis (Y. 
Lee, Kim, Kwon, Maddipati, & Granneman, 2015; Y. Lee, Petkova, & Granneman, 
2013). After recruitment, macrophages may then promote adipogenesis by producing 
activating ligands for PPARγ, the master regulator of adipogenesis (Y. Lee et al., 2015, 
2014). Notably, the endogenous ligand for PPARγ has not yet been identified in-vivo 
(Rosen & Spiegelman, 2014). Therefore, these results should be interpreted the caveat 
that the macrophage derived PARγ ligands they report, 9- and 13- 
hydroxyoctadecadienoic acid, may not be playing a role in vivo. Overall, these studies 
suggest that clearance of dying adipocytes within the tissue is a regulated process 
mediated by tissue resident macrophages. Numerous questions surrounding this process 
remain unclear including: 1) why do adipocytes die, 2) what signals control this process, 
3) why is turnover necessary, and 4) are there different mechanisms of turnover, some of 
which are adaptive and some of which are maladaptive? 
 
1.7 Precursor Origins of Adipocytes 
 The need for a pool of progenitor cells to maintain adipose tissue can be inferred 
from three observations. 1) Adipocytes are post mitotic and therefore cannot replace 
themselves (R. Berry, Jeffery, & Rodeheffer, 2013; Hepler, Vishvanath, et al., 2017; 
Rosen & Spiegelman, 2014). 2) The number of adipocytes within an individual is 
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relatively stable after puberty (i.e. adipocyte number does not decline throughout the 
lifetime of the organism) (Jules Hirsch & Batchelor, 1976; Knittle et al., 1979; Spalding 
et al., 2008). 3) Adipocytes die and are replaced at a low but appreciable rate (Rigamonti 
et al., 2011; Spalding et al., 2008; Q. A. Wang et al., 2013). Therefore, there has been 
immense interest in determining the identity, characteristics, and subtypes of adipocyte 
progenitor cells. The progress towards answering these questions is summarized here.  
 As recently as the 1980’s there was considerable speculation about the identity of 
the cells responsible for maintaining adipose tissue. Different groups posited that 
adipocyte precursors could be derived from cell types as diverse as endothelial cells, 
perivascular cells, smooth muscle cells, macrophages, adipose tissue fibroblasts, and 
circulating bone marrow progenitors (Hausman, Campion, & Martin, 1980; Hepler, 
Vishvanath, et al., 2017). Work in the 1970’s had shown that cells in the stomal-vascular 
fraction of rat adipose tissue contained cells capable of differentiating into mature 
adipocytes but the identity of these adipogenic cells remained unclear (Bjorntorp et al., 
1978).  
 Numerous technological and scientific advances by 2008 enabled a wave of more 
sophisticated studies probing the identity of adipocyte progenitors. First, the master 
regulator of adipocyte differentiation, PPARγ was discovered and a body of research 
emerged extensively characterizing the 3T3-L1 model of in vitro adipogenesis (Chawla 
& Lazar, 1994; Cristancho & Lazar, 2011; Farmer, 2006; Tontonoz et al., 1994). This 
work determined the core features of adipocyte differentiation and defined the gene 
expression signatures which characterize adipocytes. Second, technological advances in 
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lineage tracing, fluorescence activated cell sorting (FACS), immunofluorescence, and 
gene expression analysis (qPCR and RNA-sequencing) enabled more rigorous 
classification of the potentially adipogenic subpopulations found in adipose tissue. 
 In 2008 two foundational studies were published regarding the identity and 
anatomic localization of adipocyte progenitor cells. The first employed lineage tracing 
with a Pparg reporter mouse in the subcutaneous and retroperitoneal white adipose tissue 
of young (p0-p30) mice; they showed that there are Pparg expressing cells located along 
the walls of the adipose tissue vasculature (W. Tang et al., 2008). These cells co-express 
the mural (vessel wall) cell marker Pdgfrb and do not contain lipid, suggesting they are 
indeed potential adipocyte progenitors rather than small mature adipocytes. Lineage 
tracing revealed that PdgfrbCre but not the smooth muscle cell specific Sm22Cre traced to 
both the Pparg+ mural cells and to adipocytes. They therefore concluded that white fat 
progenitors reside in a perivascular location and that they are distinct from smooth 
muscle cells (W. Tang et al., 2008). 
 A second study in 2008 used candidate cell surface markers which were selected 
based on their expression in other stem cell compartments, notably the skin and 
mammary glands (Rodeheffer, 2008). They found a subset of cells in the stromal vascular 
fraction of adipose tissue which were negative for hematopoietic and endothelial cell 
markers (CD45 and CD31, hereafter celled Lin-), and positive for the markers CD29, 
CD34, Sca-1, and CD24. These Lin-:CD29+:CD34+:Sca1+:CD24+ cells were capable of 
producing adipocytes in vitro and in vivo in transplantation studies into lipodystrophic A-
Zip mice (Rodeheffer, 2008). 
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 These two initial studies were followed by numerous publications, each reporting 
their own markers for adipocyte precursors. Thus, there is considerable confusion in the 
field as to how these different cellular populations isolated from adipose tissue relate to 
one another. The following section will summarize the most common markers employed 
in the literature to date. A simplified model of the location and identity of adipocyte 
progenitor cells is presented in Figure 1.2. The major markers can be broken into two 
categories: cell surface markers and lineage determining markers. Cell surface markers 
include: PDGFRα, PDGFRβ, PREF1, and Lin-:CD29+:CD34+:Sca1+:CD24+. Lineage 
determining markers include: Pparg, Zfp423, and Wt1. 
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Figure 1.2: Preadipocytes reside in the perivascular space. 
A multitude of cell types are found within adipose tissue, including fibroblasts, 
preadipocytes, adipocytes, immune cells, and vascular (endothelial and smooth muscle) 
cells. The prevailing model of adipogenesis suggests that cells committed to the 
adipocyte lineage are located within a perivascular niche. 
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PDGFRα 
Platelet derived growth factor alpha (PDGFRα) was identified in 2010 by two 
separate labs as a marker of cells with adipogenic capacity in regenerating muscle (Joe et 
al., 2010; Uezumi, Fukada, Yamamoto, Takeda, & Tsuchida, 2010). During glycerol 
induced muscle injury, there is a wave of adipogenesis from a cellular subpopulation 
called fibro-adipogenic progenitors (FAPs); notably, these cells are distinct from the 
muscle stem cells (Joe et al., 2010). In addition to PDGFRα, FAPs express both CD34 
and Sca-1, similar to the population of adipocyte progenitors identified by Rodeheffer et 
al in 2008 (Rodeheffer, 2008). 
Based on these similarities, Lee et al examined whether PDGFRα is a marker of 
adipocyte progenitor cells in visceral and subcutaneous white adipose depots (Y. Lee, 
Petkova, Mottillo, & Granneman, 2012). They employed two models of adipogenesis: 
β3-agonist stimulation to induce the formation of beige fat and high fat diet (HFD) to 
induce the formation of white fat. Brdu and Edu labeling studies of the visceral 
(epididymal) white adipose tissue revealed that in both models of adipogenesis, the 
proliferating cells were indeed PDGFRα+:CD34+:Sca1+ when examined by flow 
cytometry and immunofluorescence. PDGFRα+ cells are fibroblast like with multiple 
elongated processes touching components of the ECM and vasculature; although many 
are proximal to the vasculature, they are not explicitly perivascular, in contrast to the 
location of PDGFRβ cells (Y. H. Lee, Petkova, Mottillo, & Granneman, 2012; W. Tang 
et al., 2008). Lineage tracing with PdgfraCreER confirmed the contribution of these cells to 
white and beige fat under conditions of high fat diet and β3-adrenergic stimulation 
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respectively (Y. H. Lee et al., 2012). A separate group employed a PdgfraCre lineage 
reporter and showed tracing of PDGFRα+ cells to adipocytes during development and 
under normal unstimulated conditions (R. Berry & Rodeheffer, 2013). 
Multiple subsets of PDGFRα+ adipocyte progenitors have since been reported. 
CD44+/PDGFRα+ cells are recruited by macrophages to the sites dying adipocytes in the 
visceral white adipose tissue under conditions of HFD, β3 adrenergic stimulation, and 
physical injury (Y. Lee et al., 2015, 2013). These cells are highly proliferative and are 
presumed to be differentiating preadipocytes, primed to replace the dying fat cells. 
CD9High/PDGFRα+ cells are enriched in the visceral adipose tissue in mouse models of 
obesity. Compared to CD9Low/PDGFRα+ cells, CD9High/PDGFRα+ progenitors are less 
adipogenic and exhibit a pro-fibrotic myofibroblast phenotype (Marcelin et al., 2017). 
Indeed these cells may be responsible for the maladaptive remodeling of the adipose 
tissue ECM observed in obesity (Divoux et al., 2010b; Sun, Tordjman, Clément, & 
Scherer, 2013). Our lab has reported that a subset of PDGFRα+ cells with high 
expression of EBF2 are primed to become thermogenic beige adipocytes, while those 
with low expression are primed to become white adipocytes (W. Wang et al., 2014). This 
distinction is somewhat unsurprising as EBF2 is a transcription factor responsible for 
determining and maintaining the thermogenic program in adipocytes (Rajakumari et al., 
2013; Shapira et al., 2017; Stine et al., 2016). 
Overall PDGFRα has rapidly become an accepted general marker for adipocyte 
progenitor cells. It is clear however that considerable heterogeneity exists within this 
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larger population. Therefore, future work will be needed to determine how the various 
already identified and yet unidentified subsets relate to each other. 
PDGFRβ 
 Platelet derived growth factor beta (PDGFRβ) was among the first markers used 
in the identification of adipocyte progenitors (W. Tang et al., 2008). PDGFRβ cells are 
typically described vascular “mural cells” which reside along the outer walls of blood 
vessels (Hong et al., 2015; Vishvanath et al., 2016). Lineage tracing experiments have 
shown that cells marked by expression of Pdgfrb (PdgfrbrtTA-Tre-Cre, Rosa26mT/mG) 
generate new white adipocytes in the epididymal adipose tissue depot on high fat diet. 
Indeed in one study, after 8 weeks of HFD, 10% of adipocytes within the tissue were 
derived from newly differentiated Pdgfrb+ progenitors (Vishvanath et al., 2016). De novo 
adipocyte differentiation from these cells is important for protection from metabolic 
disease. Genetic deletion of Pparg in Pdgfrb+ progenitors leads reduced adipogenesis on 
HFD and worsened insulin sensitivity; overexpression of Pparg has the opposite effect 
(Shao, Vishvanath, et al., 2018). 
Furthermore, Pdgfrb+ progenitors (PdgfrbrtTA-Tre-Cre, Rosa26mT/mG) can generate 
beige adipocytes after prolonged (2 weeks) but not short bouts of cold exposure in the 
inguinal adipose tissue (Vishvanath et al., 2016). This is in contrast to Pdgfra+ 
progenitors (PdgfraCreER Rosa26mT/mG), which generate new beige adipocytes within days 
(Y. H. Lee et al., 2012; Q. A. Wang et al., 2013). Interestingly, several groups report the 
existence of cells which co-express PDGFRα and PDGFRβ in the gonadal and inguinal 
fat of mice (Hong et al., 2015; Shao, Vishvanath, et al., 2018; Vishvanath et al., 2016). 
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However, another report however fails to find any PDGFRα+ cells which are also 
positive for PDGFRβ in these depots (Y. H. Lee et al., 2012). Therefore, the overlap 
between the function and identity of PDGFRα+ and PDGFRβ+ cells remains an open 
question for the field. 
Lin-:CD29+:CD34+:Sca1+:CD24+  
 Variations on the “Lin-:CD29+:CD34+:SCA1+:CD24+” FACS sorting strategy to 
isolate adipocyte progenitors have been widely reported in the literature(R. Berry et al., 
2013; Hong et al., 2015). The most common change is to omit CD24 and/or CD29 from 
the isolation strategy. For example, Lin-:CD34+ cells in human adipose tissue have been 
described as adipogenic and residing in a perivascular location (Traktuev et al., 2008; 
Zimmerlin et al., 2010). Another group has shown that Lin-:Sca1+:CD34+ cells derived 
from mouse adipose tissue are capable of adipogenesis upon transplantation (Joe, Lin, 
Even, Vogl, & Rossi, 2009). 
Nearly all Lin-:CD29+:CD34+:Sca1+ cells are also PDGFRα+ (R. Berry & 
Rodeheffer, 2013). The addition of CD24 to this sorting strategy enables separation of 
these cells into two pools with different biological activities. Compared CD24+ cells, 
CD24- cells are less proliferative and show higher expression of adipocyte identity genes 
such as Pparg, Lpl, AdipoQ, and Fabp4 (R. Berry & Rodeheffer, 2013). Transplantation 
studies and more descriptive analyses indicate that CD24+ cells directly produce CD24- 
cells during the course of adipogenesis in both visceral and subcutaneous depots (R. 
Berry & Rodeheffer, 2013; Jeffery et al., 2015, 2016).  
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PREF1 
 Preadipocyte factor 1 (Pref1), also known as Dlk1, is an epidermal growth factor 
(EGF) like protein that inhibits adipocyte differentiation in a paracrine manner (Hudak & 
Sul, 2013). PREF1 is a transmembrane protein whose expression decreases throughout 
the course of differentiation in the 3T3-L1 model of in vitro adipogenesis (Smas, Chen, & 
Sul, 1997; Smas & Sul, 1993). It is cleaved by TNFα converting enzyme to release a 
soluble form into the extracellular space. The soluble active form suppresses 
adipogenesis via upregulation of SOX9 which suppresses transcription of C/EBPs, a 
family of transcription factors which are critical for adipogenesis (Hudak & Sul, 2013). 
 Pref1 has the components of an ideal marker for adipocyte progenitor cells as it 
inhibits adipogenesis and is lost during differentiation. It has primarily been described as 
a marker of very early adipocyte progenitors during embryonic development (Hudak et 
al., 2014a). Lineage tracing using a Pref1 reporter mouse indicates that Pref1+ cells 
appear as early as E10.5 during mouse development and go on to develop into adipocytes 
in the inguinal fat. Pref1+ are also detected in the visceral adipose tissue which develops 
later. Finally, ablation of Pref1+ cells using diphtheria toxin leads to lipodystrophy, 
indicating that these cells are part of the adipocyte cellular lineage. 
PPARγ 
 PPARγ is required for adipogenesis therefore early studies attempted to identify 
adipocyte progenitor cells based on their expression of this key transcription factor (W. 
Tang et al., 2008). Cells expressing Pparg are found along the adipose tissue vasculature 
and co-express PDGFRβ (W. Tang et al., 2008). The fact that Pparg is a transcription 
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factor (and therefore intracellular) and highly expressed in adipocytes have limited its 
utility as a lineage tracing reporter. 
Nevertheless, one interesting study used a Pparg lineage tracing reporter 
(PpargtTA-Tre-Cre R26RLacZ) during early development to demonstrate that distinct 
progenitor cells are responsible for adipose tissue development versus maintenance 
(Jiang, Berry, Tang, & Graff, 2014). Using this doxycycline suppressible system, Pparg+ 
(LacZ+) cells are detectable in the inguinal WAT as early as E10.5. However, 
suppression of the reporter at this early stage leads to an unlabeled fat pad at birth. 
Deletion of Pparg in Pparg+ cells (PpargtTA-Tre-Cre/fl ) at E10.5 leads to normal adipose 
tissue at birth, but a progressive lipodystrophy with ageing. Combined these results 
indicate that two separate pools of progenitors regulate the initial development of adipose 
tissue (organogenesis) and maintenance of adipose tissue in adulthood (Jiang et al., 
2014). 
ZFP423 
 Zinc finger protein (ZFP) 423 is a transcription factor that is enriched in 
fibroblasts from adipose tissue compared to fibroblasts from non adipogenic tissues 
(Gupta et al., 2010). It has been reported as a marker of “committed preadipocytes” based 
on one study employing a Zfp423-GFP reporter mouse. Subsequent work has indicated 
that there is substantial overlap between Zfp423-GFP+ cells and PDGFRβ+ cells (Gupta 
et al., 2012; Vishvanath et al., 2016). 
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WT1 
 Wilms Tumor 1 (WT1) is a transcription factor with key roles in the development 
of the heart and kidneys (Chau et al., 2014). Gene expression and lineage tracing reporter 
lines (Wt1GFP and Wt1Cre Rosa26mT/mG) indicate that Wt1 is a selective marker of visceral 
but not subcutaneous adipocyte progenitor cells (Chau et al., 2014; Hepler, Shao, et al., 
2017). 
Other Markers 
 Various other markers have been reported to define different subsets of 
adipogenic progenitor cells each with different activities. Several groups have shown 
lineage tracing to adipocytes with smooth muscle markers such as smooth muscle actin 
(SMA) under normal conditions and myosin heavy chain 11 (Myh11) under conditions of 
prolonged cold exposure (D. C. Berry, Jiang, & Graff, 2016; W. Tang et al., 2011). As a 
final example, CD38 is reported to mark committed preadipocytes (similar to the 
distinction between CD24+ and CD24- cells discussed above) (Carrière et al., 2017). 
Other Origins 
 Some studies have suggested alternative origins for adipocytes such as from bone 
marrow progenitors or endothelial cells (Jr, Majka, Grazia, Gill, & Klemm, 2006; Majka 
et al., 2010; Tran et al., 2012). More carefully controlled work has determined that 
adipocytes do not derive from these lineages under normal conditions (R. Berry & 
Rodeheffer, 2013). The notable exception is that studies of human bone marrow 
transplant recipients have shown that approximately 10% of their subcutaneous 
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adipocytes are derived from donor rather than host cells (Gavin et al., 2016; Rydén et al., 
2015). 
Beige Adipocytes 
 Beige adipocytes have been variously reported to arise from the de novo 
differentiation of progenitor cells or transdifferentiation/phenotype conversion of mature 
white adipocytes (Rosenwald, Perdikari, Rülicke, & Wolfrum, 2013; Q. A. Wang et al., 
2013). Proposed markers for beige adipocyte progenitors include many of the same ones 
discussed for white fat progenitors: PDGFRα (Y. H. Lee et al., 2012; W. Wang et al., 
2019, 2014), PDGFRβ (Vishvanath et al., 2016), SMA+ (D. C. Berry et al., 2016), 
MYH11+ (D. C. Berry et al., 2016; J. Z. Long et al., 2014). There is considerable 
disagreement in the field as different groups have reported widely varying levels of 
contribution from each of these progenitor cell types to the beige adipocyte population.  
 One potential explanation for this disagreement may be that the mechanism by 
which an organism produces beige adipocytes is path dependent. After a bout of cold 
exposure followed by a return to warm temperatures, beige adipocytes slowly convert to 
a white adipocyte phenotype (Roh et al., 2018; Rosenwald et al., 2013). They lose Ucp1 
expression, mitochondrial density, and remodel their lipid droplets from a multilocular to 
a unilocular architecture over the course of approximately 4 weeks (Roh et al., 2018). 
After this rewarming induced phenotype conversion, the gene expression patterns of 
previously beige adipocytes are nearly indistinguishable from bona fide white adipocytes 
(never beige). However, these cells are able to rapidly reactivate the thermogenic 
program upon a second episode of cold exposure (Rosenwald et al., 2013). Increased 
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levels of the histone mark H3K4me1, commonly associated with active or primed 
enhancers, in previously beige adipocytes is reported to mediate the epigenetic memory 
of cold exposure (Local et al., 2018; Roh et al., 2018). Consistent with this, previously 
beige adipocytes have higher levels of H3K4me1 at the sites of thermogenic genes like 
Ucp1 and Cpt1b (the mitochondrial fatty acid transporter and rate limiting step in fatty 
acid oxidation) (Roh et al., 2018). 
 The balance of de-novo differentiation versus reactivation of previously beige 
adipocytes is likely dependent how many previously beige adipocytes are within the 
tissue. In a mouse with an extensive history of cold exposure, reactivation will likely 
predominate; in a cold naïve mouse, most beige adipocytes are expected to derive from 
de novo adipogenesis. Notably, room temperature, which can vary widely between mouse 
housing facilities, is cold enough to induce thermogenesis in mice (Fischer, Cannon, & 
Nedergaard, 2018). This suggests that mice housed at thermoneutrality versus at room 
temperature before cold exposure may recruit different pools of progenitors for beige 
adipogenesis. Likewise, the age of mice and length of cold exposure likely modulate 
which progenitor populations respond to cold stimulus (D. C. Berry et al., 2017; 
Vishvanath et al., 2016; W. Wang et al., 2019). Overall, more carefully controlled studies 
in which the complete cold exposure history of the mouse is known, are needed to better 
understand the precursor origins of beige adipocytes.  
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1.8 Outlook 
 The previous sections have outlined the central role of adipose tissue in the 
context of normal physiology and highlighted its capacity to either protect from or 
contribute to obesity associated metabolic decline. While much is already known, key 
questions about the fundamental biology of adipose tissue remain. Currently, there is a 
major effort in the field to advance two strategies for the treatment of metabolic disease: 
1) Promoting hyperplastic subcutaneous adipose tissue expansion in the setting of obesity 
and 2) Increasing beige adipogenesis to augment energy expenditure. However, the 
ability to develop these strategies is hampered by a lack of agreement about the identity 
and subtypes of adipocyte progenitors within adipose tissue. My thesis work aimed to 
establish consensus in the field by answering the following questions: 
First, what are the biologically meaningful subdivisions of adipocyte progenitor 
cells and where are these cells located in vivo? Previous studies have used candidate cell 
surface marker genes and lineage tracing approaches to classify cells isolated from the 
stromal vascular fraction of adipose tissue. While informative, these approaches were not 
comprehensive and may not have captured the most biologically meaningful subdivisions 
of progenitor cells (Figure 1.3). Therefore, we employed newly available single cell RNA 
sequencing (scRNA-Seq) technology to comprehensively profile the stromal vascular 
cells from mouse and human adipose tissue in an unbiased manner. These analyses were 
followed by computational lineage prediction methods, cell sorting, in vitro assays, and 
transplantation studies to define the location of and relationships between newly 
identified subtypes of adipocyte progenitor cells.  
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 Second, how do these progenitor cell populations change in response to common 
adipogenic stimuli such as diet induced obesity? We use flow cytometry and in vitro 
assays to provide evidence that progenitor cell exhaustion, specifically in the visceral 
adipose tissue, may be a feature of obesity.  
Third, are there distinct markers for cells committed to the white rather than the 
beige adipogenic lineage? Previous studies have been limited by a lack of precise control 
over the thermal history of their mouse models. This work employed a novel model of 
cold naïve mice to examine the progenitor cell responses to cold exposure but failed to 
find evidence for the existence of a specialized beige preadipocyte.  
 Overall, the work presented herein defines the lineage hierarchy of adipocyte 
progenitor cells, describes a novel anatomic niche for their location, and provides clarity 
for the field about the identity of adipocyte progenitors moving forward. 
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Figure 1.3: Expected cellular composition of subcutaneous white adipose tissue. 
The stromal vascular fraction of subcutaneous white adipose adipose tissue is expected to contain 
numerous mesenchymal populations which can be identified based on their expression of one or 
more common mesenchymal markers. Early progenitor cells are expected to express genes 
associated with niche maintenance. Committed preadipocytes are expected to express genes 
associated with adipocyte identity. 
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Chapter 2: Identification of a Mesenchymal Progenitor Cell Hierarchy 
in Adipose Tissue 
 
This chapter is adapted from: Merrick, David., Sakers, Alexander., Irgebay, Zhazira., 
Okada, Chihiro., Calvert, Catherine., Morley, Michael P., Percec, Ivona., Seale, Patrick. 
Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science (80-. 
). 364, eaav2501 (2019). (Merrick et al., 2019) 
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2.1 Abstract 
Metabolic health depends on the capacity of adipose tissue progenitor cells to 
undergo de novo adipogenesis. However, the cellular hierarchy and mechanisms 
governing adipocyte progenitor differentiation are incompletely understood. Here, we 
identify a lineage hierarchy consisting of distinct mesenchymal cell types present in 
mouse adipose tissue. Cells marked by DPP4 expression are highly proliferative, 
multipotent progenitors that, during murine subcutaneous adipose development, give rise 
to ICAM1+ committed pre-adipocytes and a related adipogenic cell population marked 
by Clec11a and F3/CD142 expression. Transforming growth factor-β maintains DPP4+ 
cell identity and inhibits adipogenic commitment of DPP4+ and CD142+ cells. 
Intriguingly, DPP4+ progenitors reside in the reticular interstitium, a recently discovered 
fluid-filled space within and between tissues, including adipose depots. Taken together, 
this study defines the adipose lineage hierarchy and identifies a new anatomical niche for 
multipotent mesenchymal progenitors. 
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2.2 Introduction 
White adipose tissue (WAT) stores excess nutritional energy in the form of 
triglycerides, which can be released for use in other tissues during periods of energy 
demand, such as during fasting and physical activity. The capacity for adipocytes to store 
chemical energy in lipid droplets protects other organs against the toxic effects of ectopic 
lipid deposition. Adipose tissue expands by increases in fat cell size (hypertrophy) and/or 
number (hyperplasia). Hyperplastic growth, mediated by the differentiation of progenitor 
cells (i.e. adipogenesis), is critical for proper adipose tissue function (Carobbio, 
Pellegrinelli, & Vidal-Puig, 2017; Gustafson et al., 2013; Sun et al., 2013). Defects in this 
process cause adipose fibrosis and inflammation, contributing to systemic insulin 
resistance (Gyllenhammer, Alderete, Toledo-Corral, Weigensberg, & Goran, 2016). 
Conversely, enhancing adipogenesis prevents maladaptive adipocyte hypertrophy, 
reduces ectopic lipid accumulation and ameliorates metabolic disease (Khan et al., 2009; 
Pasarica et al., 2009; Senol-Cosar et al., 2016; Shao, Vishvanath, et al., 2018; W. Tang et 
al., 2011). 
Adipose progenitor cells have been isolated based on their expression of common 
progenitor/mesenchymal cell surface markers, including PDGFRα, PDGFRβ, CD29, 
CD34, SCA1/LY-6A and CD24 (Hepler, Vishvanath, et al., 2017; Y. Lee et al., 2012; 
Rodeheffer, 2008). PREF1 (DLK1) and the adipose lineage marker PPARγ are reported 
to mark adipogenic cells that are closely associated with blood vessels in adipose tissue 
(Hudak et al., 2014a). Finally, mural and smooth muscle-related cells that express Acta2 
(smooth muscle actin), Myh11 or Pdgfrβ contribute to adipocyte formation under certain 
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conditions (D. C. Berry et al., 2016; Vishvanath et al., 2016). However, the overlap, 
heterogeneity and developmental inter-relationships between these and other described 
populations are incompletely understood. 
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2.3 Results 
Profiling and lineage trajectory analysis of adipocyte progenitor cells 
We applied single cell RNA sequencing to identify and profile progenitor cells in 
an unbiased manner from the developing subcutaneous inguinal WAT (iWAT) of 12-day-
old mice (p12). At this stage, adipocytes are rapidly developing from progenitor cells, 
allowing us to capture the continuum of cell states spanning differentiation. We 
hypothesized that we would observe numerous cell types, from less developed more 
“stem-like” cells, through committed preadipocytes, to even some small adipocytes 
(Figure 1.3). 
Mature lipid-laden adipocytes, which in mice range from 20-150 µM in diameter, 
are fragile and highly buoyant (Hagberg et al., 2018; Majka et al., 2014). Since these 
were likely to be incompatible with the microfluidics channels of the 10x genomics 
chromium device used for scRNA sequencing, they were depleted from the stromal 
vascular cells (SVCs) by low-speed centrifugation. This technique separates the digested 
adipose tissue into two fractions: the floating layer containing mature adipocytes and the 
pelleted stromal vascular layer containing all other cell types in the tissue. SVCs were 
then depleted of dead cells (DAPI+) and of CD45+ leukocytes using fluorescence 
activated cell sorting (FACS) and analyzed via single cell RNA sequencing (Figure 
2.1.A). Unsupervised clustering analysis of the gene expression profiles using Seurat 3.0 
identified 10 distinct cell types (Figure 2.1.B-C). 
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Figure 2.1: Single cell RNA seq reveals the heterogeneity of subcutaneous adipocyte 
progenitors. 
(A) FACS gating strategy for isolation of stromal-vascular cells used in single-cell RNASeq 
analysis Debris, most leukocytes and doublets were excluded based on forward and side scatter 
profiles. Live cells were selected by the absence of DAPI staining. CD45(-) cells were sorted to 
exclude leukocytes from the downstream analysis. Control cells (unstained with antibody) were 
included to define the gating strategy. (B) Unsupervised clustering of 11,423 cells (mean number 
of genes per cell = 1977) from the subcutaneous WAT of p12 pooled male and female C57BL/6J 
mouse pups reveals 10 distinct cell groups represented on a tSNE map (relevant marker genes are 
listed in parentheses). (C) Individual gene tSNE and violin plots showing the expression levels 
and distribution of representative marker genes. The y axis is the log-scale normalized read count. 
Adapted with permission from (Merrick & Sakers, 2019). 
 
49 
 
We wanted to focus our analysis on cells which may be part of the adipocyte 
lineage and therefore explored the data to identify clusters of cells expressing genes that 
were previously reported to mark adipocyte progenitors (Figure 1.3). Canonical 
mesenchymal progenitor markers Cd34, Pdgfra, Pdgfrb, Ly6a (Sca1) and Thy1 (Cd90), 
were predominantly expressed in groups #1-3 (Figures 2.2 and 2.3). Since adipocyte 
progenitors have been previously identified as containing one or more of these marks, we 
next examined the distinctions between these three clusters of cells, hypothesizing that at 
least one of these subgroups would represent preadipocytes, i.e. cells committed to the 
adipocyte lineage. 
Group 1 cells (blue), which we named “interstitial progenitors”, were 
characterized by the expression of Dipeptidyl peptidase 4 (Dpp4), Wnt2, Bmp7 and Pi16 
and by the lack of expression of adipocyte marker genes (Figures 2.1.C, 2.2, and 2.3). 
Group 2 cells expressed Intercellular adhesion molecule 1 (Icam1) and Dlk1 (Pref1) 
along with several adipocyte-identity genes, including Pparg, Fabp4 and Cd36, 
suggesting that these cells could be “committed preadipocytes” (Figures 2.1.B, 2.2 and 
2.3). Group 3 cells expressed Clec11a, Fmo2, as well as Tissue factor (F3/CD142), 
which is a marker of “adipogenesis-regulatory cells” (Aregs) that were recently reported 
to be non-adipogenic themselves and capable of inhibiting adipogenesis in a paracrine 
manner (Schwalie et al., 2018). Combined these three clusters contained the majority of 
the cells profiled. 
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Figure 2.2: Marker gene expression patterns for the various cell groups identified in 
developing (p12) subcutaneous adipose tissue. 
Single cell tSNE plots from the stromal-vascular fraction of 12 day old pooled male and female 
C57/BL6J mouse pups, highlighting the expression patterns of selected genes from the literature 
(mesenchymal stem cell markers, gray box), and cluster-specific marker genes. 
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Figure 2.3: Marker gene expression profiles for the various cell groups identified in 
developing (p12) subcutaneous adipose tissue. 
Single cell violin plots, showing the mean and variance in expression density across all the single-
cell groups identified in the stromal-vascular fraction of iWAT from 12 day old pooled male and 
female C57/BL6J mouse pups. Selected marker genes for each group and from the literature are 
highlighted. 
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We next examined the smaller clusters of cells and attempted to assign them 
identities based on their gene expression profiles. The two major components of the 
vasculature, smooth muscle cells (group 8) and endothelial cells (group 9) were identified 
based on the expression of alpha-smooth muscle actin (Acta2) and platelet endothelial 
adhesion molecule-1 (Pecam1) respectively (Figures 2.1.B, 2.2, and 2.3) (Woodfin, 
Voisin, & Nourshargh, 2007). Group 10 showed expression of myelinating proteins 
including, myelin protein zero (Mpz), myelin basic protein (Mbp), and proteolipid protein 
1 (Plp1). These were therefore identified as Schwann cells which are responsible for 
myelinating peripheral neurons (Monk, Feltri, & Taveggia, 2015). Adrenergic signaling 
from neurons plays a key role in coordinating the response of adipose tissue to 
environmental conditions (such as fasting and cold exposure) strengthening our 
confidence in identifying group 10 cells as Schwann cells (Grujic et al., 1997; Lafontan 
& Berlan, 1993). Clusters 5 and 6 represent less abundant cell populations whose gene 
expression patterns did not readily reveal their role in the tissue. 
Group 4 was specifically marked by Wnt6 and Sfrp5 expression but did not show 
detectable levels of mesenchymal marker genes such as Pdgfra or Thy1. Group 4 appears 
highly related to group 3 cells based on some overlap in their gene expression patterns 
(notably Vit and Ifitm1). Interestingly, Wnt6 is known to inhibit adipogenesis and 
promote osteogenesis, while Sfrp5 is a member of the secreted frizzled-related protein 
family, which sequesters WNTs to reduce their signaling (Cawthorn et al., 2012; Heller et 
al., 2002). The expression of both inhibitors of adipogenesis and inhibitors of inhibitors 
of adipogenesis suggest that these cells may be working to maintain a specialized niche 
55 
 
within the tissue; this raises the possibility that these cells may represent a pool of stem-
like cells within the tissue. 
 Group 7 (yellow) was classified as “adipocytes” based on their high expression 
levels of mature adipocyte-specific genes (e.g. Adipoq, Plin1, Car3) and lack of 
expression of mesenchymal progenitor markers (ex. Pdgfra). These cells likely represent 
newly formed adipocytes without significant lipid stores, making them denser than water, 
which co-purified with the pelleted stromal cell fraction rather than with the floating 
adipocyte fraction. Notably, these cells do not form an isolated cluster but rather lie 
immediately next to the Group 2 cells suggesting the presence of a relationship between 
these two cell types. 
The SVC compartment of adult adipose tissue from mice housed at 
thermoneutrality (30°C) for their entire lives displays similar cellular diversity, including 
prominent populations of mesenchymal cell groups 1-3 (Figure 2.4.A-C). As anticipated 
populations of smooth muscle cells (group 4), endothelial cells (group 5), and Schwann 
cells (group 10) were all identified based on the markers discussed previously (Figure 
2.4.A). Notably, immune cells were included in this experiment and populations of T-
cells (Cd45+, Cd3d+), B cells (Cd45+, Cd19+), macrophages (Cd45+, Cd68+), and 
dendritic cells (Cd45+, Ccl5+), were all identified based on the expression of commonly 
accepted marker genes (Wetzels et al., 2018). In contrast to the data from the p12 pups, 
where Groups 1-3 were present in roughly equal proportions, in the thermoneutral housed 
adults, Group 1 (Dpp4+) and Group 2 (Icam1+) cells appear to be the major 
mesenchymal populations with Group 3 (Cd142+/Clec11a+) cells less abundant in the 
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tissue. Overall however, the populations, cluster defining genes, and composition of the 
SVF appear remarkably similar in the adult and pup datasets. 
From these data, we formed the hypothesis that Group 2 cells (Icam1+) are 
committed preadipocytes due to their close proximity to adipocytes on the tSNE and 
expression of both adipocyte identity genes and mesenchymal marks. Additionally, we 
hypothesized that Group 1 (Dpp4+) cells may represent a less committed progenitor cell, 
capable of giving rise to the other cell types in the tissue, based on the expression of 
numerous growth factors implicated in niche maintenance (BMPs and WNTs) and the 
presence of mesenchymal marks (Figure 1.3). We sought to examine this hypothesis 
using computational lineage prediction techniques which employ a concept called 
“psuedotime”. These techniques take advantage of the large number of cells in single cell 
data sets and the asynchronous nature of many developmental hierarchies to identify cells 
in (nearly) all states along the continuum from precursor to product (Trapnell et al., 
2014). 
We examined potential precursor-product relationships between the identified 
mesenchymal populations using Monocle 2 to perform in silico cell trajectory analyses on 
the data from the p12 pups (Qiu et al., 2017). Pseudotemporal analysis predicted that 
Group 1 interstitial progenitors have two developmental trajectories: (Cell Fate A) Group 
2 “preadipocytes”, terminating in Group 7 “adipocytes”; and (Cell Fate B) Group 3 and 4 
cells (Figure 2.5.A). Group 3 cells appear to represent an intermediary cell type between 
group 1 interstitial progenitors and Group 4 cells. 
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A split heatmap shows select genes which Monocle 2 identified as defining the 
origin (center genes), endpoints (far right and far left genes), and intermediate states 
which define the course of the cell trajectories (Figure 2.5.B). As expected, this includes 
many of the cluster defining genes identified for each of the cell types. Cells transiting 
from Group 1 stromal progenitors into preadipocytes are marked by the stage-selective 
expression of several genes, including Nrep, Prss12, Ccl7, Gpx3, Ctsh, Ctsb and Cyb1b1 
(Figure 2.5.B). Altogether, these analyses suggest that Group 1 progenitors (Dpp4+) 
provide a source of both Group 2 committed preadipocytes and Group 3 Cd142+ cells. 
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Figure 2.4: Single cell RNA seq reveals similar populations of subcutaneous adipocyte 
progenitors in adults as in pups. 
(A) Unsupervised clustering of 9,652 stromal-vascular cells harvested from the subcutaneous 
iWAT of adult male 129S6/SvEv mice housed at thermoneutrality (mean genes per cell = 1,702). 
The tSNE map depicts 10 distinct cell clusters (relevant marker genes in parenthesis). (B) 
Expression of selected genes from the literature (mesenchymal stem cell markers, gray box), and 
cluster-specific marker genes. (C) Violin plots showing the mean and variance in expression 
density of selected genes across all the groups. 
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Figure 2.5: Monocle cell trajectory analysis predicts lineage hierarchy in adipocyte 
progenitors. 
(A) Pseudotemporal cell ordering of groups 1 to 4 and adipocytes along differentiation 
trajectories by using Monocle. Pseudotime (arbitrary units) is depicted from dark to light blue 
(left). Group identities were overlaid on the pseudotime trajectory map (right). (B) The origin of 
Pseudotime is represented in the center of the heatmap. Genes differentially expressed along ‘Cell 
Fate A’ and ‘Cell Fate B’ trajectory are depicted towards the left and right respectively. 
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Development of a FACS strategy to isolate group 1- 3 cells from mouse subcutaneous 
WAT 
To investigate the function of these cell populations, we developed fluorescence 
activated cell sorting (FACS) strategies for isolation of Group 1-3 cells from murine 
subcutaneous adipose tissue. To develop this strategy, we examined the single cell data 
for marker genes that fit the following criteria: 1) Expressed at the cell surface, 2) Highly 
expressed, 3) Selective (i.e. highly enriched in only one group), 4) Generalizable (i.e. 
compatible with cells from both p12 pups and adult mice). Furthermore, we wanted to 
have at least one positive mark for each cellular population rather than relying solely on 
negative selection to achieve specificity. Since there are well validated FACS strategies 
for depleting immune (CD45+), endothelial (CD31+), and red blood cells (RBC lysis 
and/or Ter119+) cells, we planned to gate these cells away at the beginning of each 
isolation. Therefore, we accepted marker genes that fit our criteria when looking at 
Groups 1-3 but were also expressed on immune, endothelial, or red blood cells.  
Based on these criteria we identified Dpp4 as a selective marker of Group 1 cells, 
Icam1 as a selective marker of Group 2 cells (note: Pref1 is a more selective marker, but 
is only present in pups), and Cd142 as a selective marker of Group 3 cells. We therefore 
developed the FACS strategy in Figure 2.6. First cells are sorted on the basis of size and 
complexity and singlets are isolated using the standard technique of plotting FSC-H vs 
FSC-W. Second, live cells are isolated on the basis of negative DAPI staining and non-
immune/non-endothelial cells are isolated on the basis of negative staining for CD45 and 
CD31 respectively. Fluorophores were chosen such that membrane Tomato labeled cells 
63 
 
could be isolated in the next step, allowing for the isolation and tracking of cells in co-
culture and transplantation experiments. In the final steps, Groups 1-3 were isolated using 
the following marks: Group 1 (DPP4+, CD142 (-)) cells (hereafter DPP4+), Group 2 
(ICAM1+; CD142(-)) (hereafter ICAM1+), and Group 3 (CD142+). 
To validate this purification strategy, we FACS sorted DPP4+, ICAM1+, and 
CD142+ cells and performed bulk RNA Sequencing in triplicate on the isolated cellular 
populations from p12 pups (Figure 2.7.A). Differential expression was determined using 
DESeq2 and group defining genes were defined for each of the DPP4+, ICAM1+, and 
CD142+ populations. A group defining gene was identified as one that is upregulated in 
each of the possible pairwise comparisons (ex. Significantly upregulated in both DPP4+ 
vs ICAM1+ and in DPP4+ vs CD142+). These gene lists were then used to interrogate 
the single cell data from Groups 1-3 to generate the heatmaps presented in Figure 2.7.B. 
These data show strong correlation in the transcriptomes between Group 1 and DPP4+ 
cells, Group 2 and ICAM1+ cells, and Group 3 and CD142+ cells, supporting the validity 
of this isolation strategy (Figure 2.7.B). 
Finally, we compared the abundance of each of these cellular populations — 
DPP4+, ICAM1+, and CD142+ — in SVC preparations from both p12 and adult mice 
(Figure 2.8.A-B). All three populations were readily identified in both pup and adult mice 
and in roughly similar proportions (Figure 2.8.A-B). Indeed, there were no significant 
differences between the proportion of ICAM1+ and CD142+ cells in adults and pups. 
There were significantly more DPP4+ cells in the adult IWAT than in the pup IWAT 
(~30% in adults vs ~20% in pups of live lin(-) cells) (Figure 2.8.C). Overall, the data 
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presented in Figures 2.6-2.8 indicate that the FACS sorting strategy we developed is valid 
for isolating Group 1-3 cells from pup and adult mouse subcutaneous WAT. 
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Figure 2.6: FACS strategy for isolation of cell groups from mice for functional studies.  
FACS gating strategy for isolation of DPP4+, ICAM1+ and CD142+ cells from mouse adipose 
tissue. Debris and most leukocytes were removed by size and doublets were excluded. Live cells 
were selected by the absence of DAPI staining and Lin(-) cells were selected by the absence of 
staining for CD45 and CD31 (APC-Cy7). Unstained control cells were included to define the 
gating strategy (left). CD142+ cells were selected first (CF647), then the remaining CD142(-) 
cells were further gated against DPP4 (FITC) and ICAM1 (PE/Cy7) (right) 
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Figure 2.7: Validation of FACS strategy by bulk RNA sequencing.  
(A) FACS gating strategy that was used to enrich DPP4+, ICAM1+ and CD142+ cells for bulk 
RNA-Seq analysis. Briefly, CD31(-) and CD45(-) cells were stained for DPP4, ICAM1 and 
CD142. Groups were purified as follows: Group 1 (CD142-, DPP4+), Group 2 (CD142-, 
ICAM1+) and Group 3 (CD142+). DP = double positive (DPP4+, ICAM1+, CD142-); DN = 
double negative (DPP4-, ICAM1-, CD142-). (B) Heatmap of the most significant differentially 
expressed genes in freshly isolated DPP4+ (blue), ICAM1+ (red) or CD142+ (green) cells from 
12 day old pooled male and female C57/BL-6J mouse pups analyzed by bulk RNA-Seq (right). 
Heatmap of 12 day old pooled male and female C57/BL-6J mouse pups single-cell RNA-Seq 
(Group 1-3 from Fig 1A) (left). 
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Figure 2.8: DPP4+, ICAM1+ and CD142+ populations are found at comparable abundance 
in p12 pups and adult iWAT.  
(A) FACS plots from representative iWAT SVF from 12 day old pooled male and female 
C57/BL-6J mouse pups (left) and 8-10 week old adult male CD1 or C57/BL-6J mice (right). (B) 
Quantification of relative population abundance from (A) (n = 9 BR). (C) Quantification of 
relative population abundance (n = 9 BR/group) 
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DPP4+ cells are multipotent mesenchymal progenitors 
 We sought to determine the functional properties of these cells in vitro in order to 
better understand their role in vivo. We therefore performed a series of assays to 
determine the adipogenic, proliferative, and alternative-lineage (ex. osteogenic) 
differentiation potentials of each cell type. These were performed with the hypothesis that 
the DPP4+ cells would be the most “stem like” and should have the most alternate 
lineage potential and proliferative activity, while the ICAM1+ cells are the most 
committed to the adipocyte lineage and therefore should show the highest adipogenic 
potential.  
We first examined the morphology of these cells in culture. Cultured DPP4+ cells 
displayed a conspicuous rounded/flattened morphology, whereas ICAM1+ and CD142+ 
cells had a fibroblastic morphology with elongated protruding lamellipodia (Figure 
2.9.A). We next performed a series of differentiation assays with different amounts of 
adipogenic induction in order to precisely determine which of the cell types were the 
most and least adipogenic. For these assays, cells were plated at high confluency and 
treatments were initiated within 48 hours of plating. These conditions were chosen to 
minimize the amount of time cells spent in culture and to attempt to better preserve the in 
vivo properties of these cells. 
 In cultures of cells derived from young mice (p12-30), ICAM1+ cells showed 
rare instances of spontaneous adipogenesis in control media (DMEM/F12 + 10% FBS) 
without the addition of any inducers, implying that these cells are highly committed to 
the adipocyte lineage (Figure 2.9.B). Spontaneous adipogenesis was never observed in 
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DPP4+ or CD142+ cells. Quantification of adipogenesis using an automated image 
analysis algorithm performed on the entirety of each tissue culture well (as described in 
Figure 2.10) supports this observation (Figure 2.9.B), right hand side). 
All three populations underwent robust adipocyte differentiation and activated 
comparably high levels of adipocyte-specific genes when treated with the standard 
complete cocktail of adipogenic inducers (Figure 2.9.C). However, under minimal 
adipogenic conditions, containing only a low concentration of insulin, ICAM1+ and 
CD142+ cells differentiated efficiently into adipocytes (similar to that seen with complete 
cocktail), whereas DPP4+ cells displayed very low adipogenic capacity (Figure 2.9.D). 
ICAM1+ and CD142+ cells expressed adipocyte-specific genes at/near the levels 
observed in primary adipocytes isolated from adipose tissue, while DPP4+ cultures 
displayed little to no induction of these genes (Figure 2.9.E). 
Classical features of mesenchymal progenitor cells include a capacity for 
multilineage differentiation and high proliferative activity. We found that DPP4+ cells 
proliferated at a higher rate than ICAM1+ or CD142+ cells (Figure 2.9.F). Furthermore, 
the DPP4+ cell population displayed an enhanced competence for differentiation into 
osteocytes, with higher induction of osteocyte-specific marker genes (Figure 2.9.G). 
Altogether, these data identify DPP4+ cells as highly proliferative multipotent 
progenitors possessing many properties attributed to mesenchymal stem cells. By 
contrast, ICAM1+ and CD142+ cells are relatively restricted to the adipocyte lineage. 
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Figure2.9: DPP4+ progenitors display enhanced proliferative and multilineage 
differentiation capacity. 
Cells were isolated by using the following FACS strategy: Lin− (CD45−, CD31−) cells were 
stained with anti-DPP4, anti-ICAM1, and anti-CD142. Groups were gated as follows: CD142+ 
cells were selected first, followed by DPP4+ (CD142−, DPP4+) or ICAM1+ (CD142−, ICAM1+) 
cells. (A) Phase contrast imaging of DPP4+, ICAM1+ and CD142+ cells 24 h after isolation. (B) 
Bodipy staining of neutral lipid in adipocytes (Green) from cultures of isolated DPP4+, ICAM1+ 
or CD142+ from p12 BL-6 mice cells following exposure to control media. Quantification of 
adipogenesis (Right) [n = 3-5, independent wells per condition]. (C and D) Bodipy staining of 
adipocytes and quantification of adipogenesis in cell cultures from adult CD1 mice after exposure 
to the complete adipogenic differentiation cocktail (C) or insulin only (min) (D) [n = 3 biological 
replicates (BRs) per condition]. (E) mRNA levels of adipocyte-specific genes in cultures from (C) 
and (D). Primary adipocytes (adipo) purified directly from adipose tissue were included for 
reference. (F) Quantification of cellular growth (representative of 3 BRs). (G) mRNA levels of 
osteocyte-specific genes in cultures exposed to osteogenic differentiation inducers (n = 5 BRs). 
Statistical testing: not significant, P > 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. Dots 
represent BRs unless otherwise indicated, and error bars indicate SEM. Scale bars, 50 mM. 
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Figure 2.10: Adipogenesis quantification strategy.  
Cells were stained for lipid droplets (Bodipy) and Nuclei (Hoechst 33342) and each well was 
imaged in its entirety at 20x generating a 7x7 stitched grid for mouse studies or 10x/5x5 grid for 
human studies. Stitched images were split into component channels. Nuclei (blue channel) were 
quantified by applying Gaussian Blur (3 Sigma), thresholding, watershed segmentation, and 
counting. Lipid accumulation was quantified by applying Gaussian Blur (2 Sigma), thresholding, 
and quantification of total area above threshold. The adipogenic index of each well was assessed 
by dividing total lipid area by total number of nuclei. All calculations were performed on a per 
well basis. 
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TGF-Beta signaling maintains DPP4+ progenitor cell identity 
To identify pathways regulating the divergent activities of DPP4+ and ICAM1+ 
cells, we compared the bulk transcriptomes of freshly sorted DPP4+ cells and ICAM1+ 
cells via RNA sequencing. Gene ontology analysis identified enrichment of the anti-
adipogenic TGFβ and WNT signaling pathways in DPP4+ cells (Figure 2.11.A) (Ignotz 
& Massagut, 1985; Ross et al., 2000). Indeed, numerous WNTs (Wnts 1, 10b, 16), BMPs 
(Bmps 2, 6, 7), and TGFβ components (Tgfbr2, Tgfb2) are very highly enriched in DPP4+ 
cells (Figure 2.11.B).  
To assess the importance of TGFβ signaling on DPP4+ cell activity, we treated 
freshly isolated DPP4+ cells with either recombinant TGFβ or SB431542, a potent and 
specific TGFβ receptor inhibitor (Figure 2.12.A-B). TGFβ-treatment induced the 
expression of many Group 1 marker genes, including Dact2, Wnt10b, and Ptgs2 (Cox2), 
while also suppressing Group 2 and adipogenic marker genes (Figure 2.12.B). 
Conversely, TGFβ receptor inhibition had the opposite effect, including strongly 
inducing Group 2 and adipocyte genes in DPP4+ progenitor cells (Figure 2.12.B). 
At a functional level, TGFβ-treatment augmented the proliferation of DPP4+ 
cells, while TGFβ receptor antagonism suppressed proliferation down to the levels of 
ICAM1+ cells (Figure 2.12.C). TGFβ-treatment inhibited adipocyte differentiation and 
suppressed the induction of adipocyte-specific genes in DPP4+ cells exposed to the 
complete induction cocktail (Figure 2.12.D-E) By contrast, TGFβ only mildly suppressed 
the adipogenic conversion of ICAM1+ cells and exerted an intermediate inhibitory effect 
on CD142+ cells (Figure 2.12.D-E). Reciprocally, inhibition of TGFβ signaling enhanced 
74 
 
adipocyte differentiation of DPP4+ cells exposed to minimal adipogenic conditions but 
had no observable effect on ICAM1+ or CD142+ cells (Figure 2.12.F-G). Thus, TGBβ 
signaling regulates the identity and functional character of DPP4+ cells. Moreover, these 
results show that ICAM1+ cells are especially refractory to the anti-adipogenic effects of 
TGFβ, reinforcing the notion that, amongst the mesenchymal cell populations, ICAM1+ 
cells are the most highly committed to become adipocytes. 
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Figure 2.11: DPP4+ cells display transcriptional upregulation of the TGF-Beta signaling 
pathway. 
(A) RNA-Seq and GO analysis of pathways enriched in FACS purified DPP4+ vs. ICAM1+ cells. 
Combined score = log p-value multiplied by z-score of deviation from expected ranking. (B) 
Volcano plot of statistical significance versus fold change between DPP4+ and ICAM1+ cells 
demonstrating the most differentially expressed genes. 
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Figure 2.12: TGFβ regulates the proliferation and adipogenic differentiation competency of 
multipotent DPP4+ progenitors. 
(A) Model of experimental paradigm for panels B and C. (B) mRNA levels of group 1, group 2, 
and adipocyte (adipo) marker genes in DPP4+ cells treated with vehicle control, TGFb, or the 
TGFb receptor inhibitor SB431542 (n = 4 BRs). (C) Quantification of cell growth in cultures 
treated with TGFb or SB431542 (representative of 3 BRs). (D) Bodipy staining of adipocytes 
(green) differentiated with the complete induction cocktail with or without TGFb treatment. 
Relative adipogenesis is the adipogenic index of TGFb-treated cells relative to that of control 
cells (right) (n = 3 BRs). (E) Fold changes in mRNA levels of adipocyte-specific genes in 
cultures from (D). (F) Bodipy staining of adipocytes (green) and quantification of differentiation 
in the indicated cultures (right) (n = 3 BRs). Relative adipogenesis is the adipogenic index of 
SB431542-treated cells (SB cpd) relative to that of control cells. Min, minimal cocktail (insulin 
only). (G) Adipocyte-specific mRNA levels in cultures from (F), displayed as fold change in 
treated cells relative to control cells. Scale bars, 50 mM. Statistical testing: not significant (ns), P 
> 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. Dots represent BRs, and error bars 
indicate SEM. 
78 
 
DPP4+ progenitors produce ICAM1+ and CD142+ preadipocytes  
To determine the in vivo fate of DPP4+, ICAM1+, and CD142+ cells in adipose 
tissue, we transplanted mTomato-expressing DPP4+, ICAM1+ or CD142+ cells into the 
developing fat pads of wildtype animals (Figure 2.13, Figure 2.14). Flow cytometry 
analyses of stromal cells isolated from recipient animals showed that DPP4+ cells 
acquired ICAM1 and CD142 expression as early as day 7 post-transplant, and a subset of 
the implanted cells downregulated DPP4 expression by day 14 (Figure 2.13.A, Figure 
2.14.A). Transplanted ICAM1+ cells acquired expression of CD142 but did not produce 
significant numbers of DPP4+ cells (Figure 2.13.B, Figure 2.14.B). Transplanted 
CD142+ cells did not acquire DPP4 expression but a subset of these cells downregulated 
CD142 and retained ICAM1 expression (Figure 2.13.C). Histologic examination of the 
transplants after 50 days revealed robust development of mTomato+ mature adipocytes 
from DPP4+, ICAM1+ and CD142+ cells (Figure 2.13.A-C, right panels). These results 
demonstrate that DPP4+ cells act as progenitors for both ICAM1+ and CD142+ cells, 
with these populations further differentiating into mature adipocytes. Moreover, the 
results suggest that CD142+ and ICAM1+/CD142- cells interconvert in vivo. This led to 
the development of the model presented in Figure 2.15. 
 
DPP4+ progenitors reside in the reticular interstitium 
Finally, given the divergent genetic and functional properties of DPP4+ and 
ICAM1+ cells, we examined the anatomic relationship of these populations by 
immunofluorescent staining for DPP4 and PREF1. PREF1 is another marker of Group 2 
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(ICAM1+) cells in developing adipose tissue that was also previously defined as a pre-
adipocyte marker (Figure 2.1) (Smas & Sul, 1993). Histological examination of 
transverse sections of iWAT from 2-day-old pups revealed a striking anatomic 
partitioning of DPP4+ (Group 1) and PREF1+ (Group 2) cells (Figure 2.16). PREF1+ 
cells were intercalated between mature adipocytes, distributed throughout the central 
body of the iWAT. By contrast, DPP4+ cells were localized in the reticular interstitium 
(RI) (Figure 2.16, inset 2), a recently appreciated fluid-filled network of collagen and 
elastin fibers, which encases many organs, including adipose depots (Benias et al., 2018). 
Many cells co-expressing DPP4 and PREF1 were found at the leading edge of p2 iWAT, 
potentially representing DPP4+ cells in the process of transiting to ICAM1+ cells during 
adipogenesis (Figure 2.16, inset 1). At even earlier stages of development, double 
positive cells were more prominent throughout the body of the nascent iWAT depot 
(Figure 2.17). Staining in adult murine adipose tissue for DPP4 along with other Group 1 
markers ANXA3 and CD55 shows a similar localization of these cells in the RI (Figure 
2.18). Previous reports show that preadipocytes and CD142+ cells occupy a perivascular 
niche, an anatomically distinct structure with a similarly collagen-rich extracellular 
matrix (Schwalie et al., 2018; W. Tang et al., 2008; Vishvanath et al., 2016). Notably, 
DPP4+ interstitial progenitors are excluded from the perivascular compartment and lack 
the expression of classic pericyte markers (Figure 2.19). A schematized model of the 
locations of these cell types is presented in Figure 2.20.  
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Figure 2.13: DPP4+ progenitors give rise to ICAM1+, CD142+ cells and mature adipocytes 
in vivo. 
(A) Sort-purified CD142(−), DPP4(+) and (B) CD142(−), ICAM1(+) cells from mTomato(+) 
donor mice were analyzed before transplantation (day 0) (left) into the subcutaneous adipose of 
10-day-old mTomato(−) recipientmice.Seven and 14 days after transplantation,mTomato(+) cells 
were recovered and analyzed for the expression of DPP4, ICAM1, and CD142 (shown is one 
representative transplant from n=4BRs). Fifty days after transplantation, mTomato+ cells were 
visualized by immunofluorescence in recipient iWAT (right) (representative image; n = 3 to 4 
BRs). AF, autofluorescence (525/50 nM) showing host adipocytes. (C) Sort-purified CD142(−) 
cells were analyzed 14 days posttransplant for the expression of DPP4, ICAM1, and CD142 
(shown is one representative transplant from n = 4 BRs).The left FACS plot depicts the CD142-
positive gate, and the right FACS plot shows analysis of cells from the CD142-negative gate. 
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Figure 2.14: Transplant experiment replicates showing DPP4+ progenitor cells give rise to 
ICAM1+ and CD142+ cells in vivo. 
(A) Sort-purified CD142(-);DPP4(+) and (B) CD142(-); ICAM1(+) cells from mTomato(+) 
donor mice were transplanted into the subcutaneous adipose of 10-day-old mTomato(-) recipient 
mice. Seven and 14 days after transplantation, mTomato(+) cells were recovered and analyzed for 
expression of DPP4, ICAM1, three additional biologic replicates are shown for each time point. 
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Figure 2.15: Model of progenitor cell lineage hierarchy in adipose tissue. 
Model depicting the lineage hierarchy relationships of the indicated cell types. DPP4+ cells are 
able to produce both ICAM1+ and CD142+ cells and this process is unidirectional. ICAM1+ and 
CD142+ cells can interconvert. Both ICAM1+ and CD142+ cells can produce adipocytes, though 
it is unclear if this process is direct or requires conversion to one of the cell types first. TGF-beta 
potently suppresses progression of DPP4+ cells toward the ICAM1+ and adipocyte phenotype. 
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Figure 2.16: DPP4+ progenitors reside in the reticular interstitium. 
Full-thickness flank tissue from a 2-day-old mouse pup was crosssectioned. Murine skin and 
adipose were stained with hematoxylin and eosin (H&E) with labels localizing the dermis (D), 
dermal fibroblasts (DF), the panniculus carnosus (PC), the RI, and adipocytes (Ad). Anti-DPP4 
(red), anti-PREF1 (green), and DAPI (blue) were used for immunofluorescence. (Inset 1) 
Magnification of the leading edge of the developing iWAT. (Inset 2) Cross-sectional 
magnification of the body of the iWAT. Arrows show examples of DP (DPP4+, PREF1+) cells. 
The arrowheads point to DPP4+, PREF1(−) cells.  
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Figure 2.17: DPP4+ progenitors reside in a distinct anatomic niche. 
DPP4+ progenitor cells reside in a distinct anatomic niche. (A) Full thickness flank tissue from a 
newborn (p0.5) mouse pup was cross-sectioned at the indicated positions (a and b, upper left). (B) 
H&E staining of murine skin and adipose with labels localizing: Dermis (D), Dermal Fibroblasts 
(DF), panniculus carnosus (PC), reticular interstitium (RI), adipocytes (Ad), lymph node (LN) . 
(C) Immunofluorescence using anti-DPP4 (Red, Group 1), anti-PREF1 (Green, Group 2), DAPI 
(nuclei, blue). Inset 1: magnified view of the leading edge of the developing WAT; inset 2 = 
cross-sectional magnification of the body of the iWAT; inset 3 = magnification through the body 
of the nascent iWAT depot. Arrows show examples of DP (DPP4+; PREF1+) cells, Arrowhead 
points to DPP4+;PREF1(-) cell. 
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Figure 2.18: Group 1 markers (DPP4, ANXA3, and CD55) stain progenitor cells that reside 
in the reticular interstitium of adult mice. 
Full thickness flank tissue (iWAT) from adult C57/BL-6J mice was cross-sectioned. H&E 
staining of murine skin and adipose with labels localizing dermis D, panniculus carnosus PC, 
reticular interstitium RI, adipocytes A (top right panel). Immunofluorescence using anti-DPP4 
(red, top left panel), anti-Anxa3 (green, middle left panel), and anti-CD55 (green, bottom left 
panel). Double-staining using anti-DPP4 plus Anxa3 (middle right panel), and anti-CD55 (bottom 
right panel) depicting co-expression in yellow. Individual gene expression t-SNE plots for each 
gene are provided for reference to the left. Scale bars = 100μM 
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Figure 2.19: DPP4+ interstitial progenitors do not occupy the perivascular space. 
(A) H&E staining of adult murine subcutaneous iWAT. A = artery, V = vein, C = capillary, RI = 
reticular interstitium. (B) Adult murine iWAT stained with anti-DPP4 (red), anti-PECAM1 
endothelial cells (green), antiSMA smooth muscle cells (white), and DAPI nuclei. Yellow 
arrowheads outline the lumen of arterioles reproduced at higher magnification in inset 1 and 2. 
(C) Single cell violin plots, showing the mean and variance in expression density of smooth 
muscle cell and pericyte marker genes across all the single-cell groups identified in p12 SVF. (D) 
Single cell tSNE plots depicting the expression pattern of pericyte markers. 
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Figure 2.20: Model of progenitor cell localization in developing adipose tissue. 
Model depicting the anatomical relationships of the indicated cell types at the leading edge of 
developing adipose tissue. As the tissue expands, progression of DPP4+ cells down the adipocyte 
lineage occurs at the junction of the tissue and the reticular interstitium. Here, DPP4+ cells 
convert to DPP4+/ICAM1+ cells and eventually to ICAM1+ committed preadipocytes which 
subsequently develop into adipocytes. 
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Comparison of our cellular subpopulations to those identified by other groups 
This study identified and functionally assessed three major mesenchymal cell groups 
in murine adipose: Group 1 DPP4+ ‘interstitial progenitor cells’ (IPCs); Group 2 
ICAM1+ ‘preadipocytes’ and Group 3 CD142+/Clec11a+ cells. Recent reports by other 
groups using similar methods have also profiled the progenitor cells residing in tissue 
depots (Burl et al., 2018; Hepler et al., 2018; Schwalie et al., 2018). We therefore sought 
to compare the cellular populations seen in these studies to those identified in this work. 
For each of these three works, we determined: 1) The cellular subpopulations they 
observed and 2) the cluster defining genes for each cellular subpopulation. We then 
mapped these cluster defining genes onto our adult mouse inguinal fat single cell RNA 
sequencing data (Figure 2.4) to determine whether their populations comported with ours. 
Overall, this analysis indicates that each of our studies identified analogous cell groups, 
signifying that these cell populations are present across a wide variety of adipose sources 
from animals of different ages and metabolic status (Figures 2.21, 2.22, 2.23). This high 
overall concordance between studies highlights the robustness of single-cell RNA-Seq 
technology and strengthens the notion that the identified cell groups represent a general 
paradigm for adipose progenitor biology. 
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Figure 2.21: Comparison to Burl et al. 
The top 20+ cluster-defining genes reported by Burl et al. for their ASC1 (top) and ASC2 
(bottom) populations are overlaid on the adult mouse single-cell RNA-Seq data and group 
identities depicted in Fig. 1A. 
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Figure 2.22: Comparison to Hepler et al.  
The top 20 cluster-defining genes reported by Hepler et al for their FIP (top left), APC (top right) 
and Committed Preadipocyte (bottom) populations are overlaid on the adult mouse single-cell 
RNA-Seq and group identities depicted in Fig. 1A  
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Figure 2.23: Comparison to Schwalie et al.  
The top 10-20 cluster-defining genes reported by Schwalie et al. for their P1 (top left), P2 (top 
right) and P3-‘Areg’ (bottom) populations are overlaid on the adult mouse single-cell RNA-Seq 
and group identities depicted in Fig. 1A. 
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2.1 Discussion 
This work defines a developmental hierarchy of adipose progenitors, active during 
early murine adipogenesis, which may be a general paradigm for adipogenesis in both 
mice and humans. In young animals, DPP4+ interstitial progenitors produce CD142+ 
cells and ICAM1+ preadipocytes that are poised to differentiate into adipocytes (Figure 
2.15). We speculate that, in adults, DPP4+ cells undergo adipose lineage commitment in 
response to various stimuli, providing a renewable source of preadipocytes.  
It is also conceivable that other cell populations in adult adipose depots, including 
ICAM1+ or CD142+ cells residing within the perivascular niche, mediate tissue turnover 
and remodeling without further contribution from DPP4+ cells. Future genetic lineage 
tracing studies will ascertain if DPP4+ cells are the major or exclusive progenitor source 
of adipocytes during development and in adult animals. Furthermore, the identification of 
functionally distinct precursor populations will inform the development of more targeted 
approaches to promote metabolically beneficial hyperplastic adipose tissue growth. A 
particularly significant finding from this work is that adipose progenitor cells reside in a 
previously unrecognized anatomic niche (Figure 2.20). The reticular interstitium is a 
large tissue that surrounds many organs, but has not been well studied. Our results raise 
the possibility that the RI, in addition to serving as a reservoir for adipocyte progenitor 
cells in fat depots, plays important roles in the development and regeneration of other 
tissues. 
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CHAPTER 3: The Properties of DPP4+, ICAM1+, and CD142+ Cells in 
Other Adipose Tissue Depots and Under External Stress 
 
The first half of this chapter is adapted from: Merrick, David., Sakers, Alexander., 
Irgebay, Zhazira., Okada, Chihiro., Calvert, Catherine., Morley, Michael P., Percec, 
Ivona., Seale, Patrick. Identification of a mesenchymal progenitor cell hierarchy in 
adipose tissue. Science (80-. ). 364, eaav2501 (2019). (Merrick et al., 2019) 
 
The second half of this chapter, analysis of the response of adipocyte progenitor cells to 
cold exposure, is unpublished and was performed independently. 
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3.1 Abstract 
Adipose tissue is a highly plastic organ that found in multiple locations 
throughout the body. These depots have critical roles in responding to the external 
stressors of overnutrition and of cold exposure which require the generation of new white 
adipocytes and new thermogenic beige adipocytes respectively. Previous work defined a 
lineage hierarchy in subcutaneous adipose tissue in which DPP4+ interstitial progenitor 
cells are the common progenitors to ICAM1+ committed preadipocytes and CD142+ 
group 3 cells. Here, we show that the cell types in this lineage are found throughout the 
major adipose depots in mice, including visceral white fat, subcutaneous white fat, and 
interscapular brown fat. Additionally, we show that during diet induced obesity, there is 
depletion of the DPP4+ progenitors and a reduction of the adipogenic capacity of all 
progenitor cells in visceral adipose tissue. These findings suggest that exhaustion of the 
adipocyte progenitors, specifically DPP4+ cells, may play a role in the pathogenesis of 
obesity induced metabolic disease. Finally, we show that in the subcutaneous fat, a short 
duration of cold exposure is sufficient to upregulate transcriptional signatures of 
adipocyte differentiation in each population. We did not find evidence for a specialized 
committed beige preadipocyte and suggest that all three populations may be part of the 
both the beige and white adipocyte lineage. Taken together this work suggests that the 
lineage hierarchy between DPP4+, ICAM1+, and CD142+ cells is a general feature of 
adipose tissue and suggests a key role for DPP4+ cells in the response to overnutrition. 
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3.2 Introduction 
Adipose tissue is organized into numerous discrete depots distributed throughout 
the body, each of which have distinctive characteristics and specialized roles in normal 
physiology (Jong, Larsson, Cannon, & Nedergaard, 2015). Mammals have three types of 
adipose: white, beige, and brown (Cannon & Nedergaard, 2004). White adipose is the 
most abundant form and serves as a lipid storage and endocrine organ. Brown and beige 
adipocytes are specialized to expend energy in the form of heat (Cannon & Nedergaard, 
2004). Brown adipocytes develop during embryogenesis from a shared lineage with 
muscle (BAT)(Seale et al., 2008, 2007). Beige adipocytes develop in response to cold or 
beta-adrenergic stimulation within white adipose depots (Young et al., 1984). Beige 
adipocytes appear to have the ability to develop both from pre-existing “white” 
adipocytes and from de novo adipogenesis (Roh et al., 2018; Rosenwald et al., 2013; 
Rosenwald & Wolfrum, 2014; Q. A. Wang et al., 2013; W. Wang et al., 2014). 
The major adipose depots in mice include the visceral (gonadal) white fat, the 
interscapular brown fat, and the subcutaneous inguinal and axillary white fat (Jong et al., 
2015). These depots are roughly analogous to the visceral, subcutaneous, and brown 
adipose depots found in humans (Schoettl, Fischer, & Ussar, 2018). The visceral fat 
serves important roles in the contexts of fasting/refeeding and starvation/overnutrition. In 
particular, the behavior of the visceral fat in response to chronic overnutrition is of great 
scientific and public health interest due to the association of visceral obesity with the 
development of type II diabetes and metabolic disease (Fox et al., 2007; N. B. Ruderman 
et al., 1981; N. Ruderman et al., 1998). 
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In mice, the visceral fat responds the most dynamically to fasting. During a fast, 
the visceral adipose depots lose 30-50% of their mass by 24 hours while it takes up to 48 
hours for the subcutaneous depots to do the same (H. Tang et al., 2017). In the setting of 
chronic overnutrition, the visceral (epididymal) fat expands first via hypertrophy of pre-
existing adipocytes and later (after about 5 weeks) via the formation of new adipocytes, 
i.e. hyperplasia (Jeffery et al., 2015; Q. A. Wang et al., 2013). 
 In contrast, the subcutaneous adipose tissue expands primarily through 
hypertrophy, without appreciable de-novo adipogenesis (Jeffery et al., 2015; Q. A. Wang 
et al., 2013). These effects correlate with a burst of proliferation observed in the 
precursor cells of visceral but not of subcutaneous adipose tissue during high fat feeding 
(Jeffery et al., 2015). The differences in the modes of expansion between these two 
depots raises the possibility that their resident precursor cells may be responding to 
overnutrition in fundamentally different ways. 
Chapter 2 showed that the precursor compartment of mouse inguinal adipose 
tissue contains three major, functionally distinct cell types, DPP4+ “interstitial 
progenitors”, ICAM1+ “committed preadipocytes”, and CD142+ “group 3” cells. It is 
therefore important to ascertain whether these cell types represent a general feature of 
adipose tissue or are restricted to just the inguinal subcutaneous fat. Additionally, the 
inguinal fat undergoes significant remodeling during two physiologic scenarios: cold 
exposure and diet induced obesity. In light of the findings of chapter 2, we sought to 
determine how the different precursor subtypes respond to these commonly encountered 
exogenous stressors. 
97 
 
Much work has focused on identifying the origins of beige adipocytes, including 
whether a so-called “beige” preadipocyte exists and whether it is a distinct cell type from 
“white” preadipocytes (D. C. Berry et al., 2016; Rosenwald et al., 2013; Rosenwald & 
Wolfrum, 2014; W. Wang et al., 2014). Such a distinction would imply that there are 
progenitor cells within white adipose tissue depots that are committed to become UCP1+ 
thermogenic beige adipocyte rather than white adipocytes. Alternatively, both white and 
beige adipocytes may arise from the same pool of progenitors. Under this model, 
different signals received post-commitment, i.e. during the course of adipogenesis, would 
be responsible for whether the progenitor develops into a white or a beige adipocyte. We 
sought to test this model in the proceeding chapter. Overall, netter understanding of the 
mechanisms by which the precursor cells function during the generation of metabolically 
beneficial beige adipocytes and how they are altered during adipose tissue expansion may 
yield promising insights into how to treat metabolic disease.  
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3.3 Results 
Analogous populations of DPP4+, ICAM1+, and CD142+ cells are found in all major 
adipose tissue depots 
 Previous work showed that DPP4+, ICAM1+, and CD142+ cells are distinct 
adipogenic precursor subtypes each with unique functional properties found in the 
inguinal adipose tissue. We sought to determine if these precursor subtypes were found 
within the other major adipose tissue depots of the body, namely, the subcutaneous 
axillary WAT (axWAT), the visceral epididymal WAT (eWAT), and the interscapular 
BAT (iBAT) (Figure 3.1). Flow cytometry analysis showed that the three major 
mesenchymal cell populations (DPP4+, ICAM+, CD142+) identified in iWAT were also 
present in subcutaneous axillary WAT, interscapular brown adipose tissue and visceral 
epididymal WAT of adult mice (Figures 3.2, 3.3, and 3.4). Of note, the relative 
proportion of DPP4+ cells was much lower in visceral WAT compared to subcutaneous 
depots (iWAT or axWAT) (Figures 3.2, 3.3, and 3.4). The cell populations isolated from 
axWAT, eWAT, and BAT displayed the same pattern of adipogenic and proliferative 
activity as those from iWAT (Figures 3.2, 3.3, and 3.4). Regardless of their depot of 
origin, ICAM1+ cells had greater adipogenic competence and were more resistant to the 
inhibitory effects of TGFβ when compared to DPP4+ cells (Figures 3.2-3.4and Figure 
2.12). Together, these results suggest that DPP4+, ICAM1+ and CD142+ mesenchymal 
cells have conserved roles in all the major adipose depots. 
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Figure 3.1: Anatomic locations of major mouse adipose depots. 
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Figure 3.2: Relative population abundance and adipogenic capacity of DPP4+, ICAM1+ 
and CD142+ cells isolated from axillary adipose tissue.  
(A) FACS plot of representative subcutaneous axillary white adipose tissue (axWAT) SVF from 
pooled adult CD1 mice (left). Quantification of relative population abundance (right) (n = 3 
BR/group). (B) Quantification of adipogenesis via adipogenic index (from Bodipy and Hoechst 
staining) upon induction with complete adipogenic cocktail (n = 3 BR/group). (C) Quantification 
of relative adipogenesis upon induction with complete cocktail plus TGFβ1 compared to 
complete cocktail treated controls (Right). (n = 2-3 BR/group). (D) Quantification of 
adipogenesis (from Bodipy and Hoechst staining) upon induction with minimal (insulin only) 
adipogenic cocktail (n = 3 BR/group). 
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Figure 3.3: Relative population abundance and adipogenic capacity of DPP4+, ICAM1+ 
and CD142+ cells isolated from visceral adipose tissue. 
(A) FACS plot of representative visceral epididymal white adipose tissue (eWAT) SVF from
adult CD1 mice (left). Quantification of relative population abundance (right) (n = 3 BR/group).
(B) Quantification of adipogenesis via adipogenic index (from Bodipy and Hoechst staining)
upon induction with complete adipogenic cocktail (n = 3 BR/group). (C) Quantification of
relative adipogenesis upon induction with complete cocktail plus TGFβ1 compared to complete
cocktail treated controls (Right). (n = 2-3 BR/group). (D) Quantification of adipogenesis (from
Bodipy and Hoechst staining) upon induction with minimal (insulin only) adipogenic cocktail (n
= 3 BR/group). (E) Quantification of relative adipogenesis upon induction with minimal cocktail
+ SB431542 compared to minimal cocktail treated control (n = 3 BR/group).
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Figure 3.4: Relative population abundance and adipogenic capacity of DPP4+, ICAM1+ 
and CD142+ cells isolated from brown adipose tissue. 
(A) FACS plot of representative interscapular brown adipose tissue (iBAT SVF from adult CD1
mice (left). Quantification of relative population abundance (right) (n = 3 BR). (B) Quantification
of adipogenesis via adipogenic index (from Bodipy and Hoechst staining) upon induction with
complete adipogenic cocktail (n = 3 BR/group). (C) Quantification of relative adipogenesis upon
induction with complete cocktail plus TGFβ1 compared to complete cocktail treated controls
(Right). (n = 2-3 BR/group). (D) Quantification of adipogenesis (from Bodipy and Hoechst
staining) upon induction with minimal (insulin only) adipogenic cocktail (n = 3 BR/group). (E)
Quantification of relative adipogenesis upon induction with minimal cocktail + SB431542
compared to minimal cocktail treated control (n = 3 BR/group).
105 
 
Reduced activity of visceral progenitors during obesity 
We next examined the responses of these cell populations to adverse metabolic 
conditions. DPP4+, ICAM1+ and CD142+ cells were isolated from ~16-week-old diet-
induced obese mice. These mice weighed significantly more than age and strain matched 
chow-fed controls and were glucose-intolerant, making them a good model of human 
obesity with insulin resistance (Figure 3.5.A). The visceral eWAT from obese animals 
had a lower proportion of DPP4+ cells and an increased proportion of CD142+ cells 
when compared to lean controls (Figure 3.5.B). Interestingly, ICAM1+ and CD142+ cells 
from the visceral depot of obese mice were less proliferative and had lower adipogenic 
differentiation capacity than corresponding cells from lean control animals (Figure 
3.5.C,D). Notably, these effects were apparent under minimal adipogenic conditions, 
suggesting that the defects in adipogenesis are mild enough that they can be overcome 
with stronger adipogenic stimulation. 
By contrast, in the subcutaneous WAT there were not significant changes in the 
abundance of each cellular subtype (Figure 3.6.A). Furthermore, ICAM1+ and CD142+ 
cells from the subcutaneous iWAT of obese mice retained high proliferative and 
adipocyte differentiation competency (Figure 3.6.B,C). These results imply that high fat 
feeding and/or obesity depletes the DPP4+ mesenchymal progenitor pool and impairs the 
adipogenic differentiation competency of pre-adipocytes, specifically in visceral WAT. A 
model postulating how selective differentiation of the precursors with the greatest 
adipogenic capacity may explain these findings is presented in Figure 3.7. 
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Figure 3.5: Obesity reduces the adipogenic capacity of visceral WAT ICAM1+ and CD142+ 
cells.  
(A) Glucose tolerance test (GTT) (left) and weight of diet-induced obese (DIO) vs lean control 
mice used in panels B-G (n =4/group lean, n=17/group DIO). (B) Representative FACS plot of 
epididymal white adipose tissue (eWAT) SVC from lean (left) and DIO animals (middle). 
Quantification of population abundance (right) (n =3 BR/group). (C) Quantification of cellular 
growth (representative of 3 BR). (D) Quantification of adipogenesis (Bodipy staining) upon 
induction with complete adipogenic cocktail (left), or with minimal cocktail (right). (n = 3 
BR/group). Statistical Testing: NS p>0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001. 
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Figure 3.6: The adipogenic capacity of subcutaneous WAT ICAM1+ and CD142+ cells is 
augmented in obesity. 
Diet-induced obese (DIO) vs lean control mice used in panels A-C (n =4/group lean, n=17/group 
DIO). Analysis of subcutaneous adipose tissue from the same cohort of mice in figure UE. (A) 
Representative FACS plot of inguinal WAT SVC from lean (left) and DIO animals (middle) (n=3 
BR/group). Quantification of population abundance (right) (n=3 BR/group). (B) Quantification of 
cellular growth (representative of 3 BR). (C) Quantification of adipogenesis upon induction with 
complete (left) or minimal (insulin) adipogenic cocktail (n = 3 BR/group). Statistical Testing: NS 
p>0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001. 
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Figure 3.7: Model of progenitor response to diet induced obesity in visceral and 
subcutaneous WAT.  
In visceral WAT, diet induced obesity induces adipogenesis and high amounts of lineage 
progression going from DPP4+ cells (blue) through ICAM1+ (red) / CD142+ (green) cells and 
finally to adipocytes. The cells that remain after this stimulus are likely to be the most insulin 
resistant and least adipogenic cells. In contrast, in the subcutaneous WAT, diet induced obesity 
induces little adipogenesis or lineage progression. There is no depletion of DPP4+ cells and the 
progenitor compartment displays enhanced competency for in vitro adipogenesis, perhaps 
representing compensation for the depletion of the visceral precursor pool.  
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Cold exposure induces transcriptional features of adipocyte differentiation in all 
precursor subpopulations 
We performed single cell RNA sequencing on the SVCs of adult mice exposed to 
1 day of cold to attempt to identify committed beige preadipocytes. We hypothesized that 
this short period of cold exposure would reveal new adipocyte progenitor cell subtypes 
(potentially including beige preadipocytes) not present in the thermoneutral adult dataset 
(presented in Chapter 2).  
Single cell RNA-Seq of 1 day cold exposed SVCs identified ten groups (Figure 
3.8.A). Consistent with both the thermoneutral adult and p12 pup datasets, there were 
three prominent mesenchymal populations, which we identified as DPP4+, ICAM1+, and 
CD142+ cells (Groups 1-3 respectively) (Figure 3.8.A). These results were nearly 
identical to what was observed in the adult thermoneutral dataset, and similar to what was 
observed in the p12 pup dataset (Figures 2.1 and 2.4). 
Notably, the cold exposed mice showed a greater proportion of group 3 / CD142+ 
cells than the thermoneutral mice (Figure 3.8.A and Figure 2.4.A). As expected, smooth 
muscle cells (group 4), endothelial cells (group 5), and Schwann cells (group 10) were all 
identified based on the markers discussed previously (Figure 3.8.A). As in the 
thermoneutral dataset, immune cells were included in this experiment; populations of T-
cells (Cd45+, Cd3d+), B cells (Cd45+, Cd19+), macrophages (Cd45+, Cd68+), and 
dendritic cells (Cd45+, Ccl5+), were all identified (Wetzels et al., 2018). Overall, the 
identified cellular populations and the genes that define them were highly similar 
between the thermoneutral and cold exposed groups (Figure 3.8.B-C). Importantly, no 
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populations could be identified which expressed Ucp1, the defining gene for beige 
adipocytes. No new cellular groups were identified, refuting our hypothesis that a new 
population of preadipocytes would appear in the cold (Figure 3.8.A-C). 
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Figure 3.8: Single cell sequencing of adult mice exposed to brief cold. 
(A) Single cell tSNE plots of SVF from an adult mouse exposed to 24hrs of cold exposure (6 ◦ 
C). Expression of selected genes from the literature (mesenchymal stem cell markers, gray box, ), 
and from Supplemental Figure 1B (Group 1 genes, blue box; Group 2 genes, red box; Group 3 
genes; smooth muscle, pink box; endothelial cells, green box; Macrophage/Dendritic/T-Cell/B-
cell, purple boxes) are highlighted. (B) Violin plots showing the mean and variance in expression 
density across all the groups identified. Selected marker genes for each group and from the 
literature are highlighted. 
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Given that there were minimal shifts in the composition of the precursor 
compartment upon cold exposure and no new groups were identified we hypothesized 
that beige adipocytes may arise directly from the DPP4+, ICAM1+, or CD142+ cells 
already present in the tissue. We therefore performed bulk RNA sequencing on sorted 
DPP4+, ICAM1+, and CD142+ cells from thermoneutral housed and 1 day cold exposed 
adult mice to analyze more subtle changes in gene expression within these groups. Given 
the unclear role of CD142+ cells in the tissue, we hypothesized that CD142+ cells may 
be primed to become beige adipocytes, while ICAM1+ cells may be primed to become 
white adipocytes. 
FACS analysis indicated no significant shifts in the abundance of each group 
upon cold exposure (Figure 3.9.A). Additionally, cold exposure induced relatively 
modest changes in the gene expression of each of these groups (Figure 3.9.B). In the 
aggregate, the major differentially expressed genes were derived from differences 
between cell types rather than between cold exposed vs thermoneutral mice (Figure 3.9.C 
and Figure 3.10). Previous work defined the major cluster defining gene sets for DPP4+, 
ICAM1+, and CD142+ cells in mice (see Chapter 2). The expected cluster defining genes 
were expressed in each cellular population, indicating that the sorting strategy used to 
generate this dataset was valid (Figure 3.10). Given these relatively modest changes, we 
examined the pairwise comparisons of Cold vs TN within each cell type (Figures 3.11, 
3.12, 3.13). 
In all cell populations, the cold and thermoneutral groups separated when 
examined by principal component analysis (Figures 3.11.A, 3.12.A, 3.13.A). GO analysis 
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of the pairwise comparisons revealed commonalities between DPP4+, ICAM1+, and 
CD142+ cells in their response to cold. GO terms associated with adipocyte 
differentiation such as “PPAR signaling pathway”, “fat digestion and absorption”, and 
“regulation of lipolysis in adipocytes” terms were upregulated in the cold compared to 
the TN cells (Figures 3.11.B, 3.12.B, 3.13.B). Conversely, cells at thermoneutrality 
showed upregulation of extracellular matrix and fibrosis associated terms such as “TNF 
signaling pathway”, “ECM-receptor interactions”, “Protein digestion and absorption”, 
“focal adhesion”, and “HIF-1 signaling” (Figures 3.11.C, 3.12.C, 3.13.C). Notably, 
“steroid hormone biosynthesis” and “thyroid hormone biosynthesis” also appear in these 
comparisons. Where present, these are driven by upregulation of “Sult1e1 and SRD5A1” 
and “Creb3l3 and Creb3l1” respectively. Sult1e1 (estrogen sulfotransferase) catalyzes the 
sulfation of estrogen leading to its inactivation while SRD5A1 (steroid 5 alpha reductase 
1) converts testosterone to the more active dihydrotestosterone (Marra, 2014). Creb3l3 
and Creb3l1 are cAMP responsive binding protein 3- like proteins 1 and 3 respectively; 
there role here is unknown but they are present in multiple tissues and are unlikely to be 
involved in thyroid hormone synthesis.  
Given the apparent commonalities between the genes upregulated in cold vs 
thermoneutral, we further analyzed the data to examine whether cold exposure leads to a 
common response within each cellular subpopulation (Figure 3.14). To do so, we defined 
genes as “upregulated” in a comparison if they had a log2FC >0.5 with and were 
significant (FDR of 10%). We determined which genes were unique to DPP4, ICAM1, or 
CD142 populations and which genes were common to all 3 (Figure 3.14.A). At 
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thermoneutrality there were 108 genes commonly upregulated in all three cellular 
populations. GO analysis on this gene set reveals the same terms as observed in the 
pairwise comparisons, namely “protein digestions and absorption”, “protein processing in 
the ER”, “ECM-receptor interaction”, “focal adhesion”. In the cold, there were 89 genes 
that were commonly upregulated. Consistent with the pairwise comparisons GO analysis 
on this gene set showed upregulation of “lipolysis in adipocytes”. “PPAR signaling 
pathway”, and “Metabolic pathways”. The GO terms circadian entrainment and circadian 
rhythm were driven by upregulation of Per2, Per3, Prkg1 (Figure 3.14.B).  
None of these analyses clearly identified a unique response to cold exposure in 
DPP4+, CD142+, or ICAM1+ cells. We looked at the expression patterns of select 
adipocyte identity genes and thermogenic genes (Figure 3.15). As expected, adipocyte 
identity genes showed lower expression in DPP4+ cells than in ICAM1+ or CD142+ cells 
(Figure 3.15.A). There was strong upregulation of Fabp4, Plin, and Retn with cold 
exposure in ICAM1+ and CD142+ cells. These results are consistent with cold exposure 
inducing adipocyte differentiation of ICAM1+ and CD142+ cells. Examination of the 
thermogenic program genes revealed paradoxically that Ucp1 expression was the highest 
in DPP4 cells at baseline but that CD142+ cells showed the most dynamic upregulation 
(i.e. largest fold change upregulation from warm to cold) (Figure 3.15.B). ICAM1+ cells 
showed only a modest induction. The transcriptional coactivators Ppargc1a and 
Ppargc1b were upregulated in all cold-warm comparisons but showed this pattern most 
strongly in ICAM1+ cells. DPP4+ cells showed high levels of EBF2 and its repressor 
ZFP423, while ICAM1+ and CD142+ cells showed low levels of each (Shao et al., 
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2016). Overall, these results do not clearly identify which precursor subset, if any is fated 
to become beige adipocytes. 
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Figure 3.9: Cold exposure induces minimal changes in DPP4+, ICAM1+, and CD142+ cells. 
(A) Quantification of population abundance via FACS (n=3 BR/group) in cold exposed and 
thermoneutral housed (TN) mice. (B) PCA plot of bulk RNA-sequencing data from FACS sorted 
DPP4+, ICAM1+, and CD142+ cells from 1 day cold exposed and TN mice (n=3 BR/group). (C) 
Heatmap of the most significant differentially expressed genes in freshly isolated DPP4+ (blue), 
ICAM1+ (red) or CD142+ (green) cells from (B). 
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Figure 3.10: Validation of FACS isolation strategy via bulk RNA sequencing. 
Bulk RNA sequencing was performed on freshly FACS sorted DPP4+, ICAM1+, and CD142+ 
cells from cold from thermoneutral (TN) housed and 1 day cold exposed mice. Heatmap of select 
previously defined group identity genes for DPP4+, ICAM1+, and CD142+ (n=3BR/group). 
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Figure 3.11: Response of DPP4+ cells to brief cold exposure. 
Bulk RNA sequencing was performed on freshly FACS sorted DPP4+ cells from thermoneutral 
(TN) housed and 1 day cold exposed mice (n=3 BR/group). (A) PCA plot. (B) KEGG 2016 gene 
ontology of genes upregulated (log2FC>1) by cold exposure. (C) KEGG 2016 gene ontology of 
genes upregulated (log2FC>1) at thermoneutrality.  
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Figure 3.12: Response of ICAM1+ cells to brief cold exposure. 
Bulk RNA sequencing was performed on freshly FACS sorted ICAM1+ cells from thermoneutral 
(TN) housed and 1 day cold exposed mice (n=3 BR/group). (A) PCA plot. (B) KEGG 2016 gene 
ontology of genes upregulated (log2FC>1) by cold exposure. (C) KEGG 2016 gene ontology of 
genes upregulated (log2FC>1) at thermoneutrality.  
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Figure 3.13: Response of CD142+ cells to brief cold exposure. 
Bulk RNA sequencing was performed on freshly FACS sorted CD142+ cells from thermoneutral 
(TN) housed and 1 day cold exposed mice (n=3 BR/group). (A) PCA plot. (B) KEGG 2016 gene 
ontology of genes upregulated (log2FC>1) by cold exposure. (C) KEGG 2016 gene ontology of 
genes upregulated (log2FC>1) at thermoneutrality.  
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Figure 3.14: Common upregulated genes sets at thermoneutrality and cold. 
Bulk RNA sequencing was performed on freshly FACS sorted DPP4+, ICAM1+, and CD142+ 
cells from thermoneutral (TN) housed and 1 day cold exposed mice. Upregulated genes were 
defined as those with log2FC>0.5 within a given cell type when comparing cold to thermoneutral 
conditions (n=3 BR/group). (A) Venn diagrams represent overlaps in upregulated genes at 
thermoneutrality or in cold. (B) KEGG 2016 gene ontology analysis of genes commonly 
upregulated in all 3 cell types at thermoneutrality or cold.  
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3.15: Heatmap of select genes from thermoneutral and cold exposed DPP4+, ICAM1+, and 
CD142+ cells. 
Bulk RNA sequencing was performed on freshly FACS sorted DPP4+, ICAM1+, and CD142+ 
cells from thermoneutral (TN) housed and 1 day cold exposed mice. Heatmap of select previously 
defined genes important for (A) general adipocyte identity or (B) thermogenesis (n=3BR/group). 
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3.4 Discussion 
 The work presented here shows that the progenitor cell subtypes, DPP4+, 
ICAM1+, and CD142+, identified in inguinal white adipose tissue are present in the 
major adipose depots found in mice. Furthermore, in all depots DPP4+ cells were found 
to be more proliferative, less adipogenic, and more TGFβ sensitive than ICAM1+ cells. 
The identification of analogous cellular populations with similar function properties 
indicates that the distinctions between DPP4+, ICAM1+, and CD142+ cells are likely to 
be a general feature of all adipose tissue. Consistent with this, we anticipate that the 
lineage hierarchy identified in chapter 2, in which DPP4+ cells are the common 
progenitor to ICAM1+ and CD142+ cells, is also present within these tissues. Future 
work should include lineage tracing and transplantation studies in these depots to test this 
possibility.  
 The identification of the same types of progenitor cells across multiple locations 
allowed us to ask how these cells behave under the stress of diet induced obesity in 
different adipose depots. The most notable finding was the relative loss of progenitor cell 
functionality in the visceral compartment. In agreement with Schwalie et al, we found 
that there was a higher proportion of CD142+ cells in eWAT relative to iWAT and in 
obese vs. lean adipose tissue (Figures 3.5 and 3.6). Such a finding suggests that 
progenitor cell exhaustion and reduced precursor differentiation may contribute to the 
pathologic remodeling of visceral WAT in obesity, which is linked to metabolic disease 
progression. One possible explanation for these findings is that obesity induces cell 
autonomous changes in precursor cell function. The other possibility is that in the context 
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of the levels of high-adipogenesis in the visceral compartment, selection bias accounts for 
the observed results (Figure 3.7). The model presented in figure 3.7 assumes there is a 
stochastic distribution of adipogenic potential in the precursors before the onset of diet 
induced obesity. In the visceral compartment, where there is high adipogenesis during 
diet induced obesity, only the least adipogenic progenitors remain after prolonged caloric 
excess (Q. A. Wang et al., 2013). In contrast, in the inguinal WAT where there is low 
adipogenesis during diet induced obesity, such a selection process does not occur, and we 
see maintenance of the functional capacity of the tissue resident progenitors. Future work 
should focus on the mechanism by the visceral progenitor pool becomes exhausted and 
less adipogenic in obesity. 
 Finally, we hypothesized that either ICAM1+ or CD142+ cells may be a 
committed beige preadipocyte. Both single cell analysis and bulk RNA sequencing of 
FACS sorted progenitor cells from cold exposed mice indicated that with 1 day of cold 
exposure there are only relatively modest changes in the progenitor cell compartment. 
Using scRNA-Seq no new populations were detected; via bulk RNA sequencing, we 
observed that cold induced upregulation of components of adipocyte differentiation in all 
populations. Examination of the bulk RNA sequencing data for the expression of select 
thermogenic genes yielded a confusing picture. DPP4+ interstitial progenitors, the least 
differentiated cells in the lineage hierarchy, paradoxically had the highest expression of 
Ucp1, Ebf2, and Zfp423. CD142+ cells showed the greatest dynamic upregulation of 
Ucp1. ICAM1+ cells showed the highest levels of Pparpgc1a and Pparpgc1b. Thus, the 
transcriptional components of the thermogenic program do not appear to be dynamically 
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regulated in a specific population. Given the short duration of cold exposure, it is possible 
that these analyses were performed too early in the process of cold-induced tissue 
remodeling. Therefore, future work should employ similar techniques to those used here 
to determine the precise time course and nature of the cold response in these progenitor 
cells.  
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CHAPTER 4: Adipocyte Progenitor Cells in Human Adipose Tissue 
 
Adapted from: Merrick, David., Sakers, Alexander., Irgebay, Zhazira., Okada, 
Chihiro., Calvert, Catherine., Morley, Michael P., Percec, Ivona., Seale, Patrick. 
Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science (80-. 
). 364, eaav2501 (2019). (Merrick et al., 2019) 
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4.1 Abstract 
Adipose tissue plays a central role in coordinating systemic metabolism. In the 
context of overnutrition, the capacity for fat to expand to store excess calories protects 
the body from inappropriate lipid deposition in other organs. The identities of the 
progenitor cells responsible for the formation of new adipocytes in human fat remained 
unknown. Previous work showed that the progenitor cells in mouse adipose tissue are 
organized into a lineage hierarchy containing DPP4+ interstitial progenitors which are the 
common precursor to ICAM1+ committed preadipocytes and CD142+ cells. We 
therefore examined whether human adipose tissue is similarly organized. We developed a 
FACS based strategy for isolating these cells from humans and found similar populations 
of DPP4+, ICAM1+, and CD142+ cells. Functional assays and single cell RNA 
sequencing demonstrated that DPP4+ and ICAM1+ cells from human exhibited similar 
properties and gene expression patterns to those from mice. However, unlike in mice, 
CD142+ cells are not a distinct population. Overall this work suggests the progenitors in 
human adipose tissue is organized into a two-component linear hierarchy containing 
DPP4+ interstitial progenitors and ICAM1+ committed preadipocytes. These findings lay 
the groundwork for future studies examining how these different progenitor populations 
may be targeted to treat metabolic disease.  
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4.2 Introduction 
 The previous chapters have demonstrated that the progenitor cells in murine 
adipose tissue are organized into a lineage hierarchy in which DPP4+ interstitial 
progenitors are the common precursor to ICAM1+ committed preadipocytes and to 
CD142+ cells. These cells are found throughout all major mouse adipose tissue depots, 
but it remained unknown if analogous populations were present in human adipose tissue.  
Human and mouse adipose tissue have important similarities which makes 
studying the properties of mouse adipose tissue relevant to human biology (Sharp et al., 
2012). For example, many of the same cell surface proteins used to isolate progenitors 
from mouse adipose tissue are effective for the isolation of human progenitors (Hepler, 
Vishvanath, et al., 2017; Jong et al., 2015; Raajendiran et al., 2019; Shao, Sun, et al., 
2018). However, important differences remain, especially: 1) Human adipose turns over 
at a rate of about 8% per year while mouse tissue turns over faster, 2) mice have much 
shorter lifespans (shorter than the lifespan of the average human adipocyte), and 3) 
human subcutaneous adipose tissue forms a continuous subdermal sheet rather than 
forming discrete depots (Spalding et al., 2008). Given these key differences, we sought to 
examine whether the progenitor compartment of human adipose tissue is also organized 
into analogous groups of DPP4+, ICAM1+, and CD142+ cells. 
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4.3 Results 
Human adipose contains analogous stromal populations to mice 
An important question is whether analogous populations of adipose stromal cells 
are present in humans when compared to mice. Chapter 2 identified DPP4+, ICAM1+, 
and CD142+ populations as distinct groups of progenitors found in murine adipose tissue. 
We therefore adapted the FACS sorting strategy employed previously to identify similar 
populations in the adipose tissue from human donors.  
Subcutaneous fat tissue was procured from eight healthy human donors 
undergoing elective cosmetic surgery procedures (Figure 4.1). Compared to mouse 
adipose tissue, human adipose contains many fewer progenitor cells per gram; to ensure 
enough cells for downstream analysis, we procured fat from abdominoplasty (tummy-
tuck) and back lift procedures. In these procedures, over 1kg of skin and subcutaneous fat 
are removed en-bloc with minimal disruption of the tissue. In contrast to progenitors 
isolated from liposuction procedures, which involves extensive shearing and cell death, 
progenitors isolated from abdominoplasty procedures show high viability. Seven out of 
the eight donors were female, and all were overweight or obese (Figure 4.1). These 
statistics reflect the demographics of the predominantly female population who elects to 
undergo these procedures. All donors were non-diabetic and had healthy kidney function. 
Seven out of eight procedures yielded abdominal subcutaneous fat while one yielded 
flank and back subcutaneous fat. Since the abdominal, flank, and back subcutaneous fat 
depots are continuous in humans, these samples were considered equivalent. 
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We used FACS to identify and purify DPP4+, ICAM1+ and CD142+ cells from 
fresh subcutaneous adipose tissue of human subjects undergoing cosmetic plastic surgery 
(Figure 4.2.A). In comparison to mouse, human adipose contained proportionally fewer 
DPP4+ cells (Figure 4.2.B). Human DPP4+ cells, like their mouse counterparts, 
displayed higher proliferative activity (Figure 4.2.C) and reduced potential to 
differentiate into adipocytes relative to both ICAM1+ and CD142+ cells, especially under 
conditions of minimal adipogenic stimulation (Figure 4.2.D-E). Activation of TGFβ 
signaling profoundly inhibited adipocyte differentiation in human DPP4+ cells, while 
having relatively less effect on ICAM1+ and CD142+ cells (Figure 4.3.A-B). Similarly, 
treatment with TGFβ specifically augmented the proliferation of DPP4+ cells but not of 
CD142+ or ICAM1+ cells (Figure 4.3.C-D).  
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Figure 4.1: Demographics of human adipose tissue donors. 
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Figure 4.2 Human adipose contains analogous populations of DPP4+ progenitors and 
ICAM1+ preadipocytes.  
(A) FACS isolation of cell populations from human adipose tissue (representative of eight 
individual donors). Populations were purified as follows: Lin− (CD45−, CD31−) cells were 
stained with anti-DPP4, anti-ICAM1, and anti-CD142. CD142+ cells were selected first, followed 
by DPP4+ (CD142−, DPP4+) and ICAM1+ (CD142−, ICAM1+) cells. DP, double positive 
(DPP4+, ICAM1+); DN, double negative (DPP4−, ICAM1−); FSC, forward scatter; k, thousand. 
(B) Quantification of relative progenitor abundance from n = 8 human tissue donors. (C) Relative 
proliferation rates of human cells (n = 5 donors). (D) Bodipy staining of adipocytes (green) in 
cultures treated with complete (top) or minimal (insulin plus rosiglitazone) (bottom) induction 
cocktail. (E) Quantification of adipogenic differentiation from cells shown in (D) (n = 6 donors). 
Statistical testing: ns, P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. Dots 
represent BRs, and error bars indicate SEM.  
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Figure 4.3 Human DPP4+ and ICAM1+ cells display similar TGFβ responsiveness as the 
analogous populations in mice.  
(A) Bodipy staining of lipids (green) and Nuclei (Hoechst) in human cells treated with complete 
human adipocyte differentiation medium +/- recombinant TGFβ1. (B) Quantification of 
adipogenic differentiation from (A) (n = 6 BR/group). (C) Cellular growth of equal starting 
numbers of human cells treated with recombinant TGFβ1 (One individual, representative of 5 
BR). (D) Relative proliferation rates of human cells (n=5 human donors). 
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CD142+ cells are not a distinct subpopulation in human subcutaneous adipose 
In mice, ICAM1+ and CD142+ cells are similarly adipogenic but differ markedly 
in their response to TGFβ; mouse ICAM1+ cells are resistant to the anti-adipogenic 
effects of TGFβ while mouse CD142+ cells are sensitive (Figure 2.12). The lack of such 
differences in humans led us to hypothesize CD142 was not identifying a distinct 
population of cells in humans. Therefore, to investigate the heterogeneity of human 
adipose stromal cells in an unbiased manner, we performed single cell expression 
profiling of CD45-depleted SVCs from human abdominal subcutaneous WAT. 
Clustering analysis of gene expression profiles identified 5 cell populations, 
including 2 main groups of cells (Groups 1-2) that expressed mesenchymal markers 
PDGFRa, PDGFRb and SCA1 (Figure 4.4.A-B). Group 1 cells selectively expressed 
DPP4, CD55 and WNT2, analogous to murine Group 1 cells (Figures 4.4.A-B and 4.5). 
Group 2 cells expressed ICAM1, PPARg and GGT5, comparable with mouse Group 2 
cells. However, murine Group 3 markers CD142, CLEC11A and FMO2 were broadly 
expressed across human groups 1 and 2 (Figures 4.4.A-B and 4.5). These data suggest 
that human subcutaneous adipose tissue does not contain a distinct population of CD142+ 
cells. This conclusion concurs with the lack of functional differences between sorted 
human ICAM1+ and CD142+ cells in our assays (Figures 4.2 and 4.3). Altogether, we 
conclude that human and murine WAT contain comparable DPP4+ and ICAM1+ cell 
populations with similar functional attributes. 
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Figure 4.4: Human adipose tissue contains analogous populations of interstitial progenitors 
and committed pre-adipocytes but not CD142+ cells. 
(A) Unsupervised clustering of 11,338 cells (mean number of genes per cell = 1253) from the 
abdominal subcutaneous adipose tissue of a 31-year-old female donor (body mass index, 31.6) 
reveals five distinct cell groups represented on a tSNE map (relevant marker genes are in 
parentheses). (B) Individual gene tSNE and violin plots showing the expression levels and 
distribution of representative marker genes. The y axis is the log-scale normalized read count. 
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Figure 4.5: Marker gene expression patterns across human adipose cell groups.  
(A) Single cell tSNE plots of the stromal-vascular fraction from abdominal subcutaneous adipose 
tissue of a 31-year-old female donor (BMI 31.6), highlighting the expression patterns of selected 
genes from the literature (mesenchymal stem cell markers, gray box), and cluster-specific marker 
genes. (B) Single cell violin plots, showing the mean and variance in expression density across all 
the single-cell groups. 
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4.4 Discussion 
Chapter 2 defined the developmental trajectory for making an adipocyte and 
showed that the progenitor cells within adipose tissue are organized into a lineage 
hierarchy. The core components of this hierarchy were DPP4+ interstitial progenitors, 
ICAM1+ committed preadipocytes, and CD142+/group 3 cells. The work presented here 
suggests that human adipose tissue follows similar lineage dynamics, with some 
important differences. 
We show that populations of DPP4+, ICAM1+, and CD142+ cells can be 
identified by FACS in human subcutaneous adipose tissue. However, functional assays 
and single cell RNA sequencing fail to define CD142+ cells as a distinct group. Indeed, 
in assays of adipogenic capacity, proliferation, and TGFβ sensitivity, human CD142+ and 
ICAM1+ cells behaved identically (Figures 4.2 and 4.3). This is in stark contrast to what 
was observed in mice, where CD142+ cells were highly adipogenic but also highly 
susceptible to the anti-adipogenic effects of TGFβ signaling (Figure 2.12). Single cell 
sequencing of human subcutaneous adipose tissue provided an explanation for these 
results. CD142 does not identify a separate population of cells and instead is found on 
both ICAM1+ and DPP4+ cells. Since there are more ICAM1+ cells in the tissue, using 
CD142 as a FACS marker appears to have yielded a mixture containing mostly ICAM1+ 
and a few DPP4+ cells. 
Based on these data, we conclude that the progenitor cells in human subcutaneous 
adipose tissue are organized into two subtypes: DPP4+ interstitial progenitors and 
ICAM1+ committed preadipocytes. These conclusions are based on similar patterns of in 
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vitro functionality and gene expression between the groups identified in humans and 
those seen in mice. Future work should employ transplantation studies to determine 
whether, as in mice, human DPP4+ cells are capable of generating ICAM1+ cells and 
adipocytes in vivo. Additional studies should also extend these findings to determine 
whether other human adipose tissue depots, including the visceral WAT and 
supraclavicular BAT, are similarly organized. Overall, this work strongly suggests that 
the progenitor cells in human and mouse adipose tissue are organized into comparable 
lineage schemas and lays the groundwork for future studies exploring the function and 
dysfunction of adipocyte progenitors during metabolic disease. 
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Chapter 5: Discussion and Future Directions 
Portions of the text of this chapter are adapated from : Merrick, David., Sakers, 
Alexander., Irgebay, Zhazira., Okada, Chihiro., Calvert, Catherine., Morley, Michael P., Percec, 
Ivona., Seale, Patrick. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. 
Science (80-. ). 364, eaav2501 (2019).(Merrick et al., 2019) 
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5.1 Summary 
The work presented here aimed to address several outstanding questions in the 
field of adipose tissue biology. First, we sought to determine the biologically meaningful 
subdivisions of adipocyte progenitor cells present within adipose tissue. In Chapter 2, we 
employed single cell RNA sequencing of subcutaneous adipose tissue from developing 
and adult mice and found three major populations of progenitor cells: Dipeptidyl 
peptidase–4–expressing (DPP4) Interstitial Progenitors, Intercellular adhesion molecule–
1–expressing (ICAM1) committed preadipocytes, and CD142+/Clec11a+ “group 3” 
cells. Computational cell trajectory analyses identified these cell types as components of 
a mesenchymal lineage hierarchy active in adipose tissue. 
DPP4+ cells are highly proliferative and multipotent progenitors that are 
relatively resistant to differentiation into adipocytes. ICAM1+ cells are committed 
preadipocytes that express Pparg and are poised to differentiate into mature adipocytes 
with minimal stimulation. CD142+/Clec11a+ cells represent a distinct adipogenic 
population in murine subcutaneous adipose that share many properties with ICAM1+ 
preadipocytes. In vivo cell transplantation studies confirmed our in silico lineage 
predictions and showed that DPP4+ progenitors give rise to both ICAM1+ and CD142+ 
preadipocytes before eventual differentiation into mature adipocytes. 
DPP4+ cells depend on transforming growth factor–β (TGFβ) signaling to 
maintain their progenitor identity, whereas ICAM1+ preadipocytes are refractory to the 
proliferative and anti-adipogenic actions of the TGFβ pathway. Histological examination 
of murine subcutaneous adipose tissue showed that ICAM1+ preadipocytes are 
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intercalated between mature adipocytes, potentially occupying a perivascular niche. The 
DPP4+ progenitor cells are located in an anatomically distinct niche surrounding the 
adipose depot, which we term the reticular interstitium.  
 Second, we examined how these progenitor cells respond to common adipogenic 
stimuli such as diet induced obesity. In Chapter 3, we showed that acute onset of diet 
induced obesity in mice led to a depletion of DPP4+ mesenchymal progenitors and a 
reduction in the adipogenic differentiation competency of preadipocytes, specifically in 
visceral white adipose tissue. 
 Third, we examined whether we could identify a preadipocyte committed to the 
thermogenic beige adipocyte lineage rather than to the white adipocyte lineage. We 
employed a novel model of cold naïve (thermoneutral) mice to ensure that we were 
capturing mice who had never had a stimulus for beige adipogenesis. Unbiased single cell 
RNA sequencing of whole SVF failed to find any new stromal cell populations induced 
by 1 day of cold exposure. Deep sequencing of DPP4+, ICAM1+, and CD142+ cells 
from thermoneutral and 1 day cold exposed mice revealed that cold exposure upregulated 
a common set of genes in all groups corresponding to a general signature of adipogenesis. 
We did not find evidence for the existence of a committed beige preadipocyte but note 
that the duration of cold exposure may have been too short. 
Finally, in Chapter 4, we extended these results by examining human tissue. 
Single cell analysis of human subcutaneous adipose tissue revealed distinct DPP4+ and 
ICAM1+ populations but failed to find evidence of a distinct CD142+ population. The 
DPP4+ and ICAM1+ populations in human tissue displayed functional similarities to 
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their analogous mouse counterparts in vitro. Specifically, human DPP4+ progenitors have 
high proliferative potential, are relatively resistant to adipocyte differentiation, and are 
sensitive to the effects of TGFβ signaling. In contrast, human ICAM1+ cells are highly 
adipogenic and are resistant to the anti-adipogenic effects of TGFβ.  
 
5.2  Comparison of Our Cellular Populations to Previous Literature 
Comparison of our results to recent scRNA-Seq based publications 
Burl et al. performed single cell RNAseq on SVC from adult mouse iWAT and 
eWAT and identified populations similar to those we found in 12-day old pups (Burl et 
al., 2018). Specifically: the group-defining genes for ASC2 (DPP4+/Pi16+) overlap 
extensively with genes expressed in our Group 1 (DPP4+) population, and ASC1 
(ICAM1+/Col4a2+) is similar to our Group 2 (ICAM1+) cells (Figure 2.21).  
Notably, Burl et al. did not describe a third group that is equivalent to our 
CD142+/Clec11a cells. We speculate that this discrepancy is due to two features of their 
analysis. First, they did not regress cell cycle genes when performing their clustering. 
Second, when analyzing the same tissue, they chose to employ fewer clusters than we did 
(7 vs 10). When analyzing our single cell data with fewer clusters, we find that the Group 
2 (ICAM1+) and Group 3 (CD142+) cells combine into a single group, which Burl et al. 
identified as ASC1. 
Hepler et al. defined two main subtypes of Pdgfrb expressing (mural) cells in murine 
eWAT: fibro-inflammatory precursors (FIPs) that express many overlapping markers 
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with our Group 1 DPP4+ cells; and adipocyte precursor cells (APCs) that are similar to 
our Group 2 ICAM1+ cells (Figure 2.22) (Hepler et al., 2018). Interestingly, FIPs from 
visceral adipose have low adipogenic differentiation capacity. However, the authors 
noted that their FACS strategy used to isolate FIPs from eWAT (PDGFRβ+, LY6a+, 
CD9+) did not identify an analogous population in subcutaneous adipose. Indeed, the 
three markers used to purify FIPs are not specifically enriched in Group 1 DPP4+ cells 
(Figure 2.22, top three genes), though many other FIP-defining markers are highly 
concordant between the populations. Therefore, FIPs may represent a subset of DPP4+ 
cells that are uniquely present in the visceral eWAT depot. 
Schwalie et al. identified three cell clusters that largely coincide with the groups that 
we studied (Figure 2.23) (Schwalie et al., 2018). Schwalie population 1 (P1) expresses a 
similar gene signature as our Group 1 (DPP4+) cells; P2 corresponds to our Group 2 
(ICAM1+) cells; and P3 corresponds to our Group 3 (CD142+/Clec11a+) cells. However, 
a notable discrepancy concerns the functional properties of CD142+ Group 3/P3 cells. 
Schwalie et al. show that mouse and human P3 (CD142)+ cells, which they named 
Adipogenesis-regulatory (Areg) cells, have low adipogenic potential and are also capable 
of inhibiting the differentiation of preadipocytes. In contrast, our study indicates that 
these cells are highly adipogenic both in vitro and upon transplantation in vivo. This 
divergence likely stems from key differences in our respective FACS strategies for cell 
purification. For many of their mouse studies, Schwalie et al. used ABCG1 in addition to 
CD142 to enrich for the P3 population. Examination of the expression pattern of Abcg1 
in our single cell data shows almost no mRNA detectable in Groups 1-3 (Figure 2.23). 
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We performed extensive validation of our flow sorting strategy by bulk RNAseq analyses 
and showed that the CD142+ cells we isolated were highly enriched for expression of the 
corresponding group 3-defining genes (Figure 2.7). Taken together, these results 
demonstrate that Group 3 cells are an adipogenic population, related to ICAM1+ group 2 
cells, in the adipose lineage. We speculate that the anti-adipogenic activity attributed to 
P3 CD142+ cells by Schwalie et al. resides in a different cell type captured in their flow 
sorting strategy. 
Comparison to the broader literature 
 At the outset of this project, we aimed to find the most biologically meaningful 
subdivisions of adipocyte progenitor cells present in the stromal vascular fraction of 
adipose tissue. To do so, we avoided introducing bias by 1) analyzing the whole SVF via 
scRNA-seq rather than a subset of cells as is common in other reports (Burl et al., 2018; 
Hepler et al., 2018), 2) performing unbiased clustering to identify transcriptionally 
distinct progenitor cell populations, and 3) developing FACS sorting strategies to isolate 
clusters identified on scRNA-seq with high fidelity. Importantly, we did this without 
attempting to fit our observed data to previous reports in the literature. We therefore 
believe that our strategy for categorizing adipocyte progenitors captures the most 
biologically relevant subdivisions.  
In Chapters 2 and 4, we identified three populations of adipocyte progenitors in 
mice (DPP4+, ICAM1+, and CD142+ cells) and two in humans (DPP4+ and ICAM1+). 
Consistent with the model proposed in Figure 1.3 we find evidence for a division of the 
progenitor cell compartment of adipose tissue into two major types: A) cells that are more 
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committed to the adipocyte lineage (ICAM1+ and CD142+ cells in mice, ICAM1+ cells 
in humans) and B) precursors to committed preadipocytes, which have more multilineage 
potential (DPP4+ cells in both humans and mice).  
A brief comparison to the literature suggests that DPP4+ cells are roughly 
analogous to the following two populations in previous reports: Lin-
:CD29+:CD34+:Sca1+:CD24+ cells (Rodeheffer, 2008) and CD34high:CD38- cells 
(Carrière et al., 2017). ICAM1+ and CD142+ cells are roughly analogous to the 
following populations reported in the literature: CD34Low:CD38+ cells (Carrière et al., 
2017), PDGFRβ+/Pparg+ cells (W. Tang et al., 2008; Vishvanath et al., 2016), Pref1+ 
cells (Hudak et al., 2014a). The less selective markers PDGFRα and PDGFRβ were 
broadly expressed on all three cell groups, consistent with their roles as general 
mesenchymal markers (Figure 2.1-2.4). The following sections will explore these 
comparisons in more detail.  
Comparison to Lin-:CD29+:CD34+:Sca1+:CD24+ cells 
Our classification of adipocyte progenitor cells into two major functional groups 
is conceptually similar to work done by the Rodeheffer lab (R. Berry & Rodeheffer, 
2013; Jeffery et al., 2015, 2016; Rodeheffer, 2008). Their work divides the SVF into two 
populations: Lin-:CD29+:CD34+:Sca1+:CD24+ (hereafter CD24+ cells) and Lin-
:CD29+:CD34+:Sca1+:CD24- (hereafter CD24- cells). CD24+ cells are reported to be 
the progenitors to CD24- cells which subsequently make adipocytes (R. Berry & 
Rodeheffer, 2013). Our single cell and functional studies largely agree with this body of 
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work but suggest that CD24 does not optimally subdivide the various adipogenic cell 
populations. 
Our single cell data reveal that Cd29, Cd34, and Sca1 are expressed among all 
Lin- cells (on Dpp4+, Icam1+ and, Cd142+ cells) and thus serve as general mesenchymal 
markers (Figures 2.1-2.4). It is therefore likely that our respective FACS strategies are 
yielding similar groups of cells. Importantly, our single cell data reveal that Cd24 is 
expressed in a small subset of Dpp4+ cells and that all Icam1+ and Cd142+ cells are 
Cd24 negative (Figures 2.1-2.4).  
While CD24 enriches for DPP4+ cells, we speculate that it is inferior as a marker 
for two reasons. First, analysis of our single cell data suggests that the CD24 negative 
group isolated by the Rodeheffer lab is a heterogenous mixture containing DPP4+, 
ICAM1+, and CD142+ cells. Our work clearly shows that these three populations have 
distinct functional properties and should be considered separately. 
 Second, CD24 is likely unnecessarily restrictive as a marker, as our single cell 
data suggest that it is only expressed on a subset of DPP4+ cells. Notably, the Cd24+ 
cells do not cluster as a distinct group. Dropout of less highly expressed transcripts may 
explain this pattern. Nonetheless, DPP4+ appears to mark a similar set of cells with more 
specificity and is therefore a better marker. 
Functional studies indicate that DPP4+ cells behave analogously to CD24+ cells; 
both populations have enhanced proliferative and multilineage potential and can produce 
committed preadipocytes (ICAM1+ and CD142+, or CD24-) cells after transplantation in 
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vivo. Notably, histology showing the anatomic location of CD24+ cells has never been 
reported in the literature. Overall, our analysis indicates that DPP4 is a more appropriate 
marker than CD24 for subdividing the progenitor pool.  
Comparison to CD34Low:CD38+ versus CD34High:CD38- 
 A single report has described CD34Low:CD38+ cells as having similar gene 
expression patterns and in vitro adipogenic potential as our ICAM1+ cells (Carrière et al., 
2017). This classification strategy is conceptually similar to the CD24 based strategy 
above and suffers from the same limitations. Specifically, CD38 is only expressed on a 
subset of ICAM1+ and CD142+ cells and this strategy fails to distinguish between 
ICAM1+ and CD142+ cells.  
Comparison to Pref1 cells 
 In developing (p12) mice, our single cell transcriptomic data reveal that there is 
nearly complete overlap between cells expressing Pref1 and cells that are 
Icam1+/Cd142- (Figure 2.1). This allowed us to use PREF1 as a histological marker for 
ICAM1+ cells (Figures 2.16 and 2.17). Based on these data, we conclude that FACS 
isolated PREF1+ and ICAM1+ cells are likely equivalent populations. Characterization 
of PREF1+ cells during the course of embryonic adipogenesis and early post-natal has 
been reported in the literature and is probably applicable to ICAM1+ cells (Gulyaeva, 
Nguyen, Sambeat, Heydari, & Sul, 2018; Hudak et al., 2014b).  
Notably, Pref1 expression is not observed in the adult mouse or human single cell 
data, suggesting a developmentally restricted pattern of gene expression. PREF1 has a 
well-studied role in inhibiting adipogenesis (Hudak & Sul, 2013). The lack of detectable 
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Pref1 expression in adult ICAM1+ cells suggests that these adult cells may have 
important differences from their counterparts in pups. Thus, future experiments should 
examine how adipocyte progenitor cells change from the early post-natal period to 
adulthood. 
Comparison to PDGFRα+ and PDGFRβ+ cells 
 Both Pdgfra and Pdgfrb were broadly expressed among Dpp4, Icam1, and Cd142 
expressing cells in our single cell studies performed in mice and humans (Figures 2.1-2.4, 
4.5). Pdgfrb showed slight enrichment on Icam1 and Cd142 expressing cells, consistent 
with reports describing PDGFRβ/Pparg+ cells in the literature (Figures 2.1-2.4). Overall, 
neither Pdgfrb nor Pdgfra emerged as a selective marker of a transcriptionally distinct 
population of cells. There are well described differences between PDGFRα+ and 
PDGFRβ+ cells in the literature, including different anatomic localizations and levels of 
contribution to cold and high fat diet induced adipogenesis (Y. Lee et al., 2012; 
Vishvanath et al., 2016). Therefore, future work should examine if expression of 
PDGFRα+ or PDGFRβ+ can be used to further subclassify DPP4+, ICAM1+, and 
CD142+ cells. 
5.3 Adipogenesis In Vivo 
Our transplantation studies show that all cellular populations have the capacity to 
make adipocytes in vivo (Figure 2.13). They also demonstrate that DPP4+, ICAM1+, and 
CD142+ cells are constituents of a lineage hierarchy. Specifically, DPP4+ cells have the 
capacity to generate both ICAM1+ and CD142+ cells; ICAM1+ and CD142+ cells can 
interconvert, but neither population generates appreciable numbers of DPP4+ cells after 
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transplantation. We have high confidence in our transplantation studies, as we detected 
integration of the transplanted cells into the architecture of the native tissue (Figure 2.13). 
While these transplantation studies were high quality and informative, they have several 
limitations and numerous questions remain. 
Lineage tracing models: which cells contribute and which are required 
First, transplantation studies show the capacity for transplanted cells to 
differentiate in vivo, but they do not prove that the endogenous population of cells 
behaves similarly in their native context. The gold standard for answering such a question 
is lineage tracing (Kretzschmar & Watt, 2012). Our lab is currently generating a 
Dpp4CreERT2/+ Rosa26mTmG mouse model which will be used to lineage trace DPP4+ 
interstitial progenitors during normal development and under adipogenic conditions such 
as cold exposure and diet induced obesity. This genetic model will prove whether DPP4+ 
cells do indeed make ICAM1+ cells, CD142+ cells, and adipocytes in vivo. 
Second, the immediate precursor to adipocytes remains unknown. Specifically, 
ICAM1+ and CD142+ cells each generated both adipocytes and the reciprocal cellular 
population upon transplantation (Figures 2.13-2.14). It is unclear whether CD142+ cells 
generate adipocytes directly or by first transitioning into an ICAM1+ cell. Similarly, it is 
unknown whether ICAM1+ cells can generate adipocytes directly, or if they must first 
transition into CD142+ cells. A third possibility is that both ICAM1+ and CD142+ cells 
can generate adipocytes directly. 
151 
 
Our data suggest that the ICAM1+ population is the most likely immediate 
precursor to adipocytes. Single cell transcriptomic data indicate that ICAM1+ cells have 
the highest expression of key adipocyte identity genes such as Pparg and Fabp4. 
Furthermore, ICAM1+ cells have the highest adipogenic capacity in vivo and are resistant 
to anti adipogenic signaling via TGFβ. Lastly, an equivalent population of ICAM1+ cells 
but not CD142+ cells is present in humans, suggesting that, at least in humans, the 
immediate precursors to adipocytes are ICAM1+ cells. 
The question of whether ICAM1+ or CD142+ cells are the immediate precursors 
to adipocytes cannot be answered with current lineage tracing technology, since the two 
cell types can readily interconvert. A more tractable question is to ask the relative 
contribution of ICAM1+ and CD142+ cells to the adipocyte lineage using lineage tracing 
models. We are currently in the process of generating a reporter mouse for CD142+ cells 
based on their high expression of Clec11a (Clec11aCreERT2 Rosa26mTmG). Furthermore, we 
are working to determine a suitable Cre driver specific to ICAM1+ cells in vivo. 
Published work using a Pref1 (Pref1rtTA-TRE-Cre) suggests that it may be a useful marker 
for ICAM1+ cells during embryogenesis and early development, but not during 
adulthood (Gulyaeva et al., 2018; Hudak et al., 2014b). Thus, the search for a specific 
Cre driver for ICAM1+ cells is ongoing. 
 Third, what are the required cell types for adipogenesis in vivo during postnatal 
development and during adulthood? Throughout our work, we largely considered 
adipocyte progenitor cells to be equivalently organized in mice from a wide range of ages 
(from as young as p12 in the transplantation studies to as old as 16 weeks in the diet 
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induced obesity studies). This assumption was made based on scRNA-Seq and flow 
cytometry data showing similar populations of DPP4+, ICAM1+, and CD142+ cells 
across multiple ages. Some evidence in the literature suggests that adipogenesis from p0-
p30 is dependent upon different pools of precursors than from p30 onward (Hudak et al., 
2014a; Jiang et al., 2014). One report showed that genetic deletion of Pparg in Pparg 
expressing cells (PpargtTA-TRE-Cre/fl) at E10.5 leads to a late onset lipodystrophy but 
normal adipose tissue at birth. Such a result suggests that the cells responsible for adult 
adipogenesis are 1) specified at E10.5 and 2) express high enough levels of Pparg to 
induce deletion. Our work suggests that DPP4+ cells, which do not express Pparg, are 
responsible for maintaining the adult adipose tissue. To resolve this apparent 
inconsistency, we should test the requirement for DPP4+, ICAM1+, and CD142+ cells in 
adipogenesis at different developmental stages. 
 These experiments can be performed in genetic lineage tracing models in which 
Pparg is deleted under the control of an inducible cell type specific Cre (ex. Dpp4CreERT2 
Ppargfl/fl Rosa26mTmG). Deletion of Pparg will prevent adipogenesis in the affected 
population (Cristancho & Lazar, 2011). The lineage tracing construct will allow us to 
track the fate of the affected cells. We hypothesize that DPP4+ cells are required for 
adipogenesis during the immediate post-natal period based upon our transplantation 
studies and histology showing many DPP4+/ICAM1+ double positive cells at the leading 
edge of developing inguinal WAT in p0.5 and p2 mice (Figures 2.16 and 2.17). Deletion 
of Pparg early in development in DPP4+ cells should therefore lead to a profound 
lipodystrophy. It is unclear however whether DPP4+ cells are required for adipogenesis 
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once the mouse has reached adulthood. Therefore, these experiments will be essential for 
rigorously proving the necessary components of the adipocyte progenitor cell lineage 
hierarchy identified here in vivo.  
 Model of adipogenesis: vascular invasion into the reticular interstitium 
 The model of adipogenesis presented in this thesis conflicts with the prevailing 
model regarding the location of adipocyte progenitors (Figures 1.2, 2.15, 2.20). We 
suggest here that adipocyte progenitors reside in the reticular interstitium (RI), a layer of 
tissue that surrounds and courses through the adipose tissue in the form of fibrous bands 
(Figure 2.20). The predominant model posits that adipocyte progenitors reside in a 
perivascular location (R. Berry et al., 2013; W. Tang et al., 2008). In contrast, our work 
shows that DPP4+ cells are seemingly excluded from the perivascular niche (Figure 
2.19). 
 How can these two models be reconciled? First, we suggest that most of the 
adipocyte progenitors identified in the literature to date are equivalent to the ICAM1+ 
population rather than to the DPP4+ population (see the section above on comparisons to 
the literature). Therefore, DPP4+ cells represent an upstream population to the one 
occupying the perivascular niche.  
Second, we posit that angiogenesis into the RI is a key initiating event in the 
progression of DPP4+ cells into ICAM1+ committed preadipocytes. Under this model, as 
blood vessels grow into the RI, DPP4+ cells respond to signals from the perivascular 
niche and mature into ICAM1+ cells, which now occupy the perivascular space. 
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Furthermore, this model would be consistent with the recognized importance of 
angiogenesis in the hyperplastic growth of adipose tissue (Corvera & Gealekman, 2014; 
Hong et al., 2015). One test of this vascular invasion model would be to examine the 
effects of angiogenic recruitment into the RI by knocking out or overexpressing Vegf 
under the control of a DPP4+ cell specific Cre driver.  
What signals restrain and promote adipogenesis in vivo? 
 A major effort in the field is to determine the signals that promote and restrain 
adipogenesis in vivo. Adipogenesis is generally divided into two stages: commitment and 
terminal differentiation (Cristancho & Lazar, 2011). Historically, it has been difficult to 
study the process of commitment due to a lack of markers for discerning which cells are 
committed to the adipocyte lineage and which are not. Our work aides in this effort by 
defining the in vivo identities of uncommitted cells in the adipocyte lineage (DPP4+) and 
of committed cells (ICAM1+). Using these markers, it is possible to disentangle 
questions about adipocyte commitment (which should be performed on DPP4+ cells) 
from questions about induction of differentiation (which should be performed on 
ICAM1+ cells).  
 Numerous signals have been reported to inhibit adipogenesis, including WNTs, 
TGFβ, and hedgehog signaling (Cawthorn et al., 2012; Ignotz & Massagut, 1985; Suh et 
al., 2006). Many of these signals are reported to inhibit adipocyte terminal differentiation. 
In Chapter 2, we suggest a role for TGFβ signaling in regulating adipogenic commitment 
by modulating the position of adipocyte progenitor cells along the DPP4+ cell to 
ICAM1+ cell lineage trajectory (Figures 2.12). Notably, ICAM1+ cells were still able to 
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undergo efficient adipogenesis even in the presence of TGFβ signaling. We therefore 
conclude that TGFβ inhibits adipogenesis not by restraining committed preadipocytes but 
by promoting the maintenance of DPP4+ cell identity and preventing lineage progression.  
Future studies should examine the role of TGFβ signaling on DPP4+ cells in vivo 
and specifically test its requirement for the maintenance of in vivo DPP4+ cell identity. 
Two genetic models with lineage tracing reporters will be necessary for these 
experiments: 1) Overexpression of TGFβ in DPP4+ cells (Dpp4CreERT2 Lox-Stop-Lox Tgfb 
Rosa26 mTmG) and 2) knockout of one or more of the TGFβ receptors in DPP4 cells 
(Dpp4CreERT2 Tgfbr1fl/fl Tgfbr2fl/fl Rosa26 mTmG). We hypothesize that acute knockout of 
TGFβ signaling will promote rapid lineage progression into ICAM1+ cells and into 
adipocytes while overexpression will have the opposite effect.  
Finally, the work presented here provides a paradigm for studying factors which 
affect lineage commitment in vitro. Future work should use similar techniques to those 
employed in Chapter 2 to examine how factors like WNTs, BMPs, ECM stiffness, and 
Hedgehog signaling affect the identity maintenance and lineage progression of DPP4+ 
cells.  
5.4 The Role of DPP4 and DPP4+ Cells in Adipose and Other Tissues 
 DPP4 is an amino peptidase which cleaves a dipeptide off of the N-terminus of its 
targets (Deacon, 2019). DPP4 exists in two forms: as an integral membrane protein and in 
a soluble form (generated by proteolytic cleavage) that circulates in the plasma and is 
present in extracellular fluid. DPP4 is produced by a wide variety of tissues including the 
intestinal brush border, vascular endothelium, liver, pancreas, and numerous immune 
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cells (Deacon, 2019). DPP4 has many substrates but has been most widely studied for its 
role in inactivating the incretin hormone glucagon like peptide 1 (GLP1). DPP4 also has 
many functions that are not dependent on its proteolytic activity, including interacting 
with components of the ECM and acting as a ligand or receptor for numerous molecules 
(Klemann & Wagner, 2016). Given the broad expression pattern and manifold roles of 
DPP4, it is useful as a cell type specific marker only when used in combination with 
other markers or phenotypic characteristics. In this work, we report that DPP4+ cells 
within the adipose tissue are an anatomically and functionally distinct subset of adipocyte 
progenitors. Numerous questions about these cells remain, including: 1) how the DPP4+ 
cells identified here relate to fibroblast populations in other tissues, and 2) the function of 
DPP4 in these cells. 
Several groups have reported the presence of similar populations of DPP4+ 
fibroblasts in other tissues, most notably in the skin and breast tissue (Borrelli et al., 
2019; Rinkevich et al., 2015; Soare et al., 2019). In both the skin and breast, DPP4+ cells 
are reported to be enriched in the setting of tissue fibrosis (systemic sclerosis and keloids 
in the skin, radiation induced fibrosis in the breasts) (Borrelli et al., 2019; Soare et al., 
2019; Xin et al., 2017). We have shown that DPP4+ cells reside within a niche composed 
of fibrous tissue, which we termed the reticular interstitium (Figure 2.16). We speculate 
that DPP4+ cells are active in generating and maintaining this ECM; in the pathological 
setting, DPP4+ cells may be responsible for adipose tissue fibrosis. Given the description 
of pro-fibrotic DPP4+ cells in the skin and breast, future work should examine whether 
excessive numbers or activity of DPP4+ fibroblasts is a general feature of tissue fibrosis 
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throughout the body. The related question of how DPP4+ fibroblasts in different tissues 
compare to those in adipose, during normal physiology and fibrotic disease, should also 
be explored.  
 Consistent with a role for DPP4+ fibroblasts cells in driving tissue fibrosis, 
several studies have shown that DPP4 inhibitors can reduce hypertrophic scarring in skin 
wounds (Leavitt et al., 2016; M. Long et al., 2018; Mah et al., 2017; Schu et al., 2012). 
Furthermore, DPP4 inhibition has been shown to reduce skin fibrosis and proliferation of 
DPP4+ fibroblasts in a murine model of systemic sclerosis (Soare et al., 2019). However, 
the mechanism by which DPP4 inhibition is mediating these effects is unknown. We 
speculate that DPP4 is playing a functional role in the DPP4+ interstitial progenitor cells 
found in adipose tissue. Therefore, further studies should be done to examine 1) the role 
of DPP4 in DPP4+ interstitial progenitors and 2) whether DPP4 inhibition can reduce age 
and obesity induced adipose tissue fibrosis (Divoux et al., 2010a). 
 
5.5 Progenitor Cell Responses to Obesity and Cold Exposure 
DPP4+, ICAM1+, and CD142+ cells are found in all major adipose tissue depots 
In Chapter 3, we identified analogous groups of DPP4+, ICAM1+, and CD142+ 
cells with similar functional properties in visceral, subcutaneous, and brown fat. We 
therefore speculate that the lineage hierarchy identified in Chapter 2, in which DPP4+ 
cells are the common progenitor to ICAM1+ and CD142+ cells, is also present within 
these tissues. Future work should include lineage tracing studies, as described above, in 
all adipose tissue depots to test this possibility.  
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Depot specific responses of progenitor cells to diet induced obesity 
We asked how DPP4+, ICAM1+, and CD142+ cells behave under diet induced 
stress. The most striking finding from these studies was a depletion of DPP4+ cells in the 
visceral adipose tissue induced by high fat diet. A secondary finding was the profound 
loss of proliferative and adipogenic function in all subsets of progenitor cells of the 
visceral depot. Notably, the subcutaneous inguinal adipose tissue was seemingly 
protected from these effects. These results are consistent with work by other groups 
showing depot specific responses and a reduction in total adipocyte progenitor number in 
the visceral adipose upon high fat feeding (Jeffery et al., 2015; Macotela et al., 2012; Q. 
A. Wang et al., 2013). Our work adds nuance to these results by showing that HFD 
induces a specific depletion of DPP4+ interstitial progenitors. Overall, these findings 
suggest that progenitor cell exhaustion and reduced precursor differentiation may 
contribute to the failure of hyperplastic expansion and to the pathological remodeling of 
visceral WAT in obesity.  
We hypothesize that obesity may induce cell autonomous changes in progenitor 
cell function, perhaps due to the damaging effects of an inflammatory microenvironment 
specific to the visceral adipose tissue (Quail & Dannenberg, 2019). Alternatively, the 
high adipogenesis environment of the visceral adipose tissue may account for the 
observed results (Figure 3.7). In the visceral compartment, where there is high 
adipogenesis during diet induced obesity, only the least adipogenic progenitors remain 
after prolonged caloric excess (Q. A. Wang et al., 2013). In contrast, in the inguinal 
WAT, where there is low adipogenesis during diet induced obesity, such a selection 
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process does not occur, and we see maintenance of the functional capacity of the tissue 
resident progenitors. 
 Future work should focus on the mechanism by which the visceral progenitor 
pool becomes exhausted and less adipogenic in obesity. It should also examine the time 
course of these changes in progenitor cells, as human obesity is not characterized by a 
loss of adipocyte progenitors (Jules Hirsch & Batchelor, 1976). It is possible that acute 
episodes of weight gain induce progenitor cell exhaustion, followed by eventual rebound. 
Responses of progenitor cells to cold exposure 
We hypothesized that a short episode of cold exposure in cold naïve mice would 
reveal a new population of differentiating or committed beige preadipocytes. We failed to 
find evidence for such a cell type but conclude that our analysis is probably limited by an 
inadequate duration of cold exposure. 
To attempt to identify committed beige preadipocytes, we designed our 
experimental paradigm with two considerations in mind. First, the mice were housed at 
thermoneutrality from birth and therefore should have never received signals to undergo 
beige adipogenesis. This scheme should serve to limit the amount of re-activation of 
“whitenened” beige adipocytes that has been reported in the literature (Roh et al., 2018; 
Rosenwald et al., 2013). Second, few new adipocytes form within one day of cold 
exposure; therefore, we anticipated that many of the cold induced changes should occur 
in the precursor compartment, before the cells have the time to become mature adipocytes 
(Q. A. Wang et al., 2013). Unfortunately, single cell analysis identified no novel groups 
of cells that were present in cold exposed mice but not in thermoneutral mice. 
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Similarly, our analysis of the bulk transcriptomes of sorted DPP4+, ICAM1+, and 
CD142+ cells from cold naïve and 1 day cold exposed mice failed to clearly identify 
which precursor subset, if any, is fated to become beige adipocytes. These experiments 
were characterized by relatively modest gene expression changes and no clear pattern of 
thermogenic gene expression (Figures 3.9 and 3.15). The one discernable trend was that 
cold exposure upregulated genes associated with adipocyte differentiation and identity 
(Figure 3.14). 
Combined, these analyses are consistent with the hypothesis that all progenitor 
cells in the inguinal white adipose tissue have the capacity to generate beige adipocytes. 
However, due to the short duration of cold exposure, it is likely that our analyses were 
performed too early in the process of cold-induced tissue remodeling. Therefore, future 
work should first determine the appropriate timeline for observing such changes. 
Subsequent experiments can then more adequately test the nature of the cold response in 
adipocyte progenitor cells.  
 
Adipogenesis assays: commentary on best practices 
 Throughout the course of this work, we relied heavily on the use of in vitro 
adipogenesis assays and image-based quantification techniques to discern the relative 
adipogenic potential of DPP4+, ICAM1+, and CD142+ cells isolated from mice and 
humans. While adipogenesis assays are employed broadly, there is considerable 
variability in how they are executed. Therefore, below is a discussion of best practices. 
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 The most common incorrect variant is to plate different cellular populations at 
low density and grow them to confluence for several days before initiating adipogenic 
differentiation. This method is often employed due to the low yield of adipocyte 
progenitor cells, especially when using FACS to isolate distinct populations. Importantly, 
this method does not directly assay adipogenic potential but rather measures the ability to 
undergo adipogenesis, after many rounds of cell divison. A second common error is to 
quantify the total amount of lipid without accounting for total cell number. Wells with 
more cells can have much lower per-cell rates of adipogenesis but similar overall lipid 
accumulation. The conflation of in vitro adipogenic and proliferative potential may be 
responsible for seemingly inconsistent reports in the literature and future work should be 
careful to avoid this pitfall. 
 
5.6 Conclusion 
 
Overall, these studies define a developmental hierarchy of adipose progenitors 
consisting of DPP4+ interstitial progenitors that give rise to committed ICAM1+ and 
CD142+ preadipocytes, which are poised to differentiate into mature adipocytes. The 
careful dissection of the lineage relationships between adipocyte progenitor cells 
presented here represents an important advance in our understanding of adipose tissue 
biology. We speculate that targeting one or more of these cell populations may be 
beneficial for promoting adaptive hyperplastic adipose growth to ameliorate metabolic 
disease. A key finding from this work is that adipose progenitor cells reside in the 
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reticular interstitium, a recently appreciated network of collagen and elastin fibers that 
encases many organs, including adipose depots. Our results raise the possibility that 
DPP4+ cells, in addition to serving as progenitor cells for adipocytes in fat depots, may 
play important roles in the functioning of other tissues. 
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Materials and Methods 
 
Human Adipose Tissue Samples 
All human adipose tissue samples were obtained from living donors undergoing cosmetic 
surgery. Tissue samples consisted of 1-10 kg intact blocks of discarded tissue, including 
skin and subcutaneous adipose, from procedures to remove excess skin and adipose tissue 
from the abdomen and flanks. Collection of tissue and processing was initiated within 1-3 
hours of removal from the patient. This work was performed under the approval of IRB 
#812150 and IRB #824825. Human subject demographics are outlined in Fig. S22. 
Isolation of Stromal Vascular Cells from Human Subcutaneous Adipose 
The skin and cauterized edges of human tissue samples were removed to yield an intact 
block of subcutaneous fat which was unmanipulated by the surgical procedure. 300-500g 
of tissue was manually minced and digested with Collagenase D (0.75 unit/mL; Roche) 
and Dispase II (1.2 units/ml Roche) in DMEM/F12 containing 0.4% fatty acid free 
bovine serum albumin (Sigma) at 37˚C with agitation for 45 min and shaking for 10 sec 
at 15 min intervals. Digestion was performed at a ratio of 1g of tissue to 1mL of digestion 
medium. The digestion was quenched with DMEM containing 10% FBS and the 
dissociated cells were filtered twice through a single layer of gauze to remove large 
undigested particles followed by centrifugation at 400 x g for 5 minutes at RT. The 
resulting supernatant containing mature adipocytes was aspirated and the pellet, 
consisting of stromal vascular cells, was resuspended and passed through a 100uM filter 
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followed by centrifugation at 400 x g for 5 minutes at RT. Cells were re-suspended in red 
blood cell lysis buffer (Biolegend) for 5 minutes at room temperature then quenched in 
DMEM containing 10% FBS. Cells were then passed through a 40 μM filter and 
collected by centrifugation at 400 x g for 5 minutes. Cells were recovered in FACS buffer 
(HBSS containing 3% FBS, Fisher) and kept on ice for the duration of processing.  
Animals 
C57BL/6J WT (Stock #000664), and C57BL/6J:ROSAmT/mG (Stock #007676) mouse 
lines were obtained from Jackson Laboratories. CD1 WT (Stock #022) were obtained 
from Charles River. 129SVE (Stock #129S6/SvEvTac) mice were obtained from 
Taconic. Diet-induced obese C57BL/6J mice (Stock #380050) and control animals (Stock 
#380056) were obtained from Jackson Laboratories and maintained on their respective 
diets until harvest. All animal procedures were performed under the guidance of the 
University of Pennsylvania Institutional Animal Care and Use Committee. 
Isolation of Stromal Vascular Cells from Mouse Adipose  
Inguinal and axillary subcutaneous white adipose depots were surgically removed from 
wild type mice and processed for stromal vascular cell enrichment. Briefly, adipose 
tissues were manually minced and digested with Collagenase D (1.5 unit/mL; Roche) and 
Dispase II (2.4 units/ml Roche) in DMEM/F12 containing 0.8% fatty acid free bovine 
serum albumin (Sigma) at 37˚C with agitation for 45 min and vortexing for 10 sec at 15 
min intervals. The digestion was quenched with DMEM/F12 containing 10% FBS and 
the dissociated cells were passed through a 100 μM filter, followed by centrifugation at 
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400 x g for 5 minutes. The resulting supernatant containing mature adipocytes was 
aspirated and the pellet, consisting of stromal vascular cells, was re-suspended in red 
blood cell lysis buffer (Biolegend) for 5 minutes at room temperature then quenched in 
DMEM/F12 containing 10% FBS. Cells were then passed through a 40 μM filter and 
collected by centrifugation at 400 x g for 5 minutes. Cells were recovered in FACS buffer 
(HBSS containing 3% FBS, Fisher).  
Fluorescence-Activated Cell Sorting (FACS) 
Mouse: Stromal vascular cells from the subcutaneous adipose of ~20-30 mice (age p10-
p20) or 10-20 mice (age 8 weeks or older) were pooled and re-suspended in FACS buffer 
for incubation with the following antibodies for 30min at 4˚C: CD26(DPP4)-FITC 
(Biolegend, San Diego, CA, cat#137806 1:200); anti-mouse ICAM1-PE/Cy7 (Biolegend 
cat#116122 1:100), anti-mouse CD45-APC/Cy7 (Biolegend; cat#103116 1:1000), anti-
mouse CD31-APC-Fire (Biolegend cat#102528 1:1000), anti-mouse CD142 1:100 (Sino 
Biological cat#50413-R001), pre-conjugated with Biotium Mix-n-Stain CF647 (Sigma 
cat#MX647S100). DAPI (Roche cat#10236276001 1:10000) was added for the final 5 
minutes. The cells were washed three times with FACS buffer to remove unbound 
antibodies. The cells were sorted using a BD FACS Aria cell sorter (BD Biosciences) 
equipped with a 100 micron nozzle and the following lasers-filters: DAPI: 405-450/50; 
FITC: 488-515/20; mTomato: 532-610/20; PE/Cy7: 532-780/60; CF647: 640-660/20; 
APC/Cy7 and APC-Fire 640-780/60. All compensation was performed at the time of 
acquisition in Diva software using compensation beads (BioLegend cat# A10497) for 
single color staining and SVCs for negative staining and fluorescence (DAPI, mTomato). 
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Human: Stromal vascular cells were re-suspended in FACS buffer for incubation with the 
following antibodies for 60min at 4˚C: CD26(DPP4)-FITC (Biolegend, San Diego, CA, 
cat# 302704 1:100); anti-mouse ICAM1-PE/Cy7 (Biolegend cat# 353116 1:100), anti-
mouse CD45-APC/Cy7 (Biolegend; cat# 368516 1:100), anti-mouse CD31-APC/Cy7 
(Biolegend cat#303120 1:100), anti-mouse CD142-APC (Biolegend cat# 365206 1:100). 
DAPI (Roche cat#10236276001 1:10000) was added for the final 5 minutes. The cells 
were washed three times with FACS buffer to remove unbound antibodies. The cells 
were sorted using a BD FACS Aria cell sorter (BD Biosciences) equipped with a 100 
micron nozzle and the following lasers-filters: DAPI: 405-450/50; FITC: 488-515/20; 
PE/Cy7: 532-780/40; APC: 640-660/20; APC/Cy7 640-780/60. All compensation was 
performed at the time of acquisition in Diva software using compensation beads 
(BioLegend cat# A10497) for single color staining and SVCs for negative staining and 
fluorescence (DAPI).  
Single-Cell RNA-sequencing using 10x Genomics Chromium Platform: 
For both mouse and human studies stromal vascular cells were isolated and flow sorted 
with gating to isolate single cells away from debris, doublets, and dead cells. For the p12 
pups (pooled male and female C57BL/6) and human single cell study, the cells were 
further gated against CD45 to exclude leukocytes. For the adult mouse thermoneutral 
(pooled male 129S6/SvEvTac) sample CD45 cells were segregated and remixed with the 
SVC cells at a ratio of approximately 20% of the total cells. The sorted cells were loaded 
onto a GemCode instrument (10x Genomics, Pleasanton, CA, USA) to generate single-
cell barcoded droplets (GEMs) according to the manufacture’s protocol using the 10x 
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Single Cell 3’ v2 chemistry. The resulting libraries were sequenced on an Illumina 
HiSeq2500 instrument with the HiSeq Rapid SBS kit. The resulting reads were aligned 
and gene level unique molecular identifier (UMI) counts obtain using the Cell Ranger 
(Pipeline).  
The Cell Ranger Single Cell Software Suite v.2.0.1 (mouse studies) or v.3.0.1 
(human studies) was used to perform sample de-multiplexing, alignment, filtering, and 
UMI counting (https://support.10xgenomics.com/single-cell-gene-
expression/software/pipelines/latest/what-is-cell-ranger). Clustering and gene expression 
were visualized with the Seurat package (version 3.0, https://satijalab.org/seurat/) on R 
Studio (https://www.rstudio.com). Cells were first filtered to have > 500 detected genes 
and less than 5% of total UMIs mapping to the mitochondrial genome. Clusters with very 
few cells were filtered before downstream analysis. Data was scaled to mitigate the 
effects of the following variables number of genes detected per cell, percent 
mitochondrial reads and cell cycle phase. Dimensionality reduction was performed using 
the T-stochastic Neighboring Embedding method (t-SNE) using Seurat. Differential gene 
expression analysis between clusters was performed using the Seurat function 
FindMarkers using the wilcox test. Violin plots, heatmap and individual tSNE plots for 
the given genes were generated using the Seurat toolkit ‘VlnPlot’, ‘DoHeatmap’ and 
‘FeaturePlot’ functions respectively. 
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Pseudotime Analysis 
Pseudotemporal analysis was performed on a filtered subset of clusters (Groups #1-4 and 
Adipocytes) from the p12 pups subcutaneous SVF using the Monocle R package 
(http://cole-trapnell-lab.github.io/monocle-release/). Ordering genes were selected using 
a cutoff of expression in at least 10 cells and a combination of inter-cluster differential 
expression and dispersion with q-value cutoff of <1e-10, which produced list of 1027 
genes. A split heatmap was generated from selected genes showing significant change 
through pseudotime, high differential expression, or known biologic identity using the 
Monocle function ‘plot_genes_branched_heatmap’ at ‘branch_point’ 1. 
RNA-Seq Library Preparation and Analysis 
Subcutaneous SVCs from pooled C57BL/6 male and femalep10-16 pups were sorted as 
described above into DPP4+ and ICAM1+ populations (Figure 2, GO analysis) or 
DPP4+, ICAM1+, and CD142+ (Figure S10) and collected in TRIzol (Invitrogen). Total 
RNA was isolated using the RNeasy Micro Kit (Qiagen). Three independent biologic 
replicates were collected for each population. RNA concentration and quality were 
assessed using Nanodrop2000, Qbit, and Bioanalyzer RNA 2100 (Agilent; Santa Clara, 
CA). All samples had RNA integrity number (RIN) greater than 7. Library preparation 
and cDNA sequencing was performed by Novogene using paired-end 150bp reads (20 
million reads per sample). FASTQ files were aligned using STAR and differential gene 
expression was analyzed using the R package DESeq2. 
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Cell Culture and Differentiation 
Mouse Studies: DPP4+, ICAM1+ and CD142+ populations were FACS-purified and 
plated on Corning CellBind 384, 96, 48, or 24 well plates (Sigma-Aldrich) and cultured 
in DMEM/F12 containing 10% FBS and 50 ng/mL Primocin (Invivogen, cat# ant-pm-1). 
The cells were incubated for 24-48 hours to facilitate attachment prior to induction of 
either adipogenic or osteogenic differentiation. For adipogenic differentiation cells were 
plated at near confluence after sorting to ensure the same number of cells per well for 
each cell type at the start of adipogenic induction. Adipogenic differentiation was carried 
out in DMEM/F12 + 10% FBS and 50 ng/mL Primocin with the addition of either A) full 
adipogenic cocktail induction (20 nM insulin, 1 nM T3, 1 M Dexamethasone (Sigma, 
cat# D4902), 0.5uM Isobutylmethylxanthine (Sigma, I7018), 125 nM Indomethacin) for 
2 days followed by transfer to adipogenic maintenance media (20 nM Insulin, 1 nM T3) 
or B) minimal adipogenic cocktail (20 nM Insulin). Media changes were performed every 
2 days and cells were analyzed for all experiments within 4-6 days of induction of 
differentiation. Osteogenic differentiation was performed using the MesenCult 
Osteogenic Stimulatory Kit (Stem Cell Technologies, cat#05504). Medium was changed 
every 2 days and the cells were analyzed after 8 days of differentiation.  
 
Human Studies: DPP4+, ICAM1+ and CD142+ populations were FACS-purified and 
plated on Corning CellBind 384, 96, or 48 well plates (Sigma-Aldrich) and first cultured 
in PM-1 media (Zenbio, cat# PM-1) supplemented with recombinant 1 nM FGF2 
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(Invitrogen, PHG0261) and 50 ng/mL Primocin. Cells were plated at near confluence and 
incubated for 48-72 hours to facilitate attachment prior to induction of adipogenic 
differentiation. Adipogenic differentiation was carried out in DM-1 media (Zenbio, cat# 
DM-1) + 3% FBS and 50 ng/mL Primocin with the addition of either A) full adipogenic 
cocktail induction (20 nM insulin, 1 nM T3, 1 M Dexamethasone (Sigma, cat# D4902), 
0.5uM Isobutylmethylxanthine (Sigma, I7018), 1nM Rosiglitazone maleate (Alexis 
Biochemicals, 350-103-G001) for 7 days followed by transfer to adipogenic maintenance 
media (20 nM Insulin, 1 nM T3) or B) minimal adipogenic cocktail (20 nM Insulin, 1nM 
Rosiglitazone) throughout. Medium was changed every 7 days and the cells were 
analyzed after 14-18 days of differentiation. 
Mouse and Human: In some experiments, cultures were treated with 10 ng/mL of 
recombinant TGFβ1 (R&D Systems, cat#240-B-002) or the TGFβ inhibitor (10 μM) 
SB431552 (R&D, cat#1614) throughout differentiation. TGFβ was added at the same 
time as adipogenic induction occurred while SB431552 was added to cells within 24 
hours of plating. The cells were incubated in a humidified incubator at 37˚C and 5% 
CO2. 
Histology 
Tissues were fixed with 2-4% paraformaldehyde via transcardiac perfusion, followed by 
overnight fixation of dissected adipose pads. The tissues were subsequently dehydrated 
through a series of ethanol washes then embedded in paraffin for thin sectioning. For 
cross-sectional imaging of the inguinal adipose depots, a full-thickness section of the 
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mouse flank (including the skin and adipose pad) were fixed and embedded in paraffin, 
then rotated and sectioned in the cross-sectional orientation. Immunohistochemistry was 
performed following heat antigen retrieval methods and stained with the following 
antibodies: anti-RFP (rabbit, Rockland 1:500), anti-DPP4 (goat, R&D 1:250), anti-Pref1 
(rabbit R&D), anti-Anxa3 (rabbit, Biorbyt), anti-Pi16 (rabbit, mybiosource). 
Transplantation 
DPP4+, ICAM1+ and CD142+ populations were purified by FACS from the 
subcutaneous adipose of pooled male and female p10-p16 ROSAmT/mG pups (donor cells). 
mTomato+ donor cells were washed with FACS buffer twice, then concentrated by 
centrifugation. ~50,000 cells were mixed 1:1 with Matrigel (Phenol Free & Growth 
Factor Reduced (GFR), Corning) on ice. Wild type C57BL/6 mouse pups age 8-12 days 
were anesthetized using an isoflurane nosecone, abdominal hair was chemically removed 
prior to creation of an approximately 5 mm midline Y-shaped cutaneous incision to 
expose the bilateral inguinal adipose pads. Donor cell/Matrigel slurry was injected along 
the edge of the inguinal fat pad in several depots. The recipient animals were closed with 
6-0 polypropylene suture and placed back with their litter. After the indicated time, donor 
cells were harvested from the recipient animals by dissection of the entire inguinal 
adipose pad, followed by the FACS procedures as described above. Biological replicates 
here mean separate pools of donor cells transplanted into separate individual recipient 
mice. 
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Quantification of adipocyte differentiation and cell proliferation 
Adipogenesis was assessed by Biodipy 493/503 (Invitrogen, cat#D3922) staining for 
lipid droplet accumulation and Hoechst 33342 (Thermo Fisher, cat#62249) staining for 
nuclei number at 4-6 days post induction (mouse) and 14-18 days post induction (human) 
in individual wells of a 384 well plate (Sigma-Aldrich, cat# CLS3770). The cells were 
imaged on a Keyence inverted fluorescent microscope (BZX-710) using DAPI (Ex 
360/40, Em 460/50, Keyence, OP-87762) and GFP (Ex 470/40, Em 525/50, Keyence, 
OP-87763) filters. Individual wells were imaged in their entirety at 20x to capture a 7x7 
tiled/stitched grid (mouse studies) or at 10x to capture a 5x5 tiled/stitched grid (human 
studies).  
Image Calculations: Tiling and stitching was performed with Keyence BZ-X 
Viewer Software. Image quantification was performed in ImageJ as shown in Fig. S23. 
Images were split into component channels. Nuclei (blue channel) were quantified by 
applying Gaussian Blur (3 Sigma), thresholding, watershed calculation for segmentation, 
and counting. Lipid accumulation was quantified by applying Gaussian Blur (2 Sigma), 
thresholding, and quantification of total area above threshold. The level of adipogenesis, 
called Adipogenic Index, was assessed by dividing total lipid area by total number of 
nuclei and represents a number with arbitrary units for comparing absolute levels of 
adipogenesis. Relative adipogenesis was calculated as the ratio of the adipogenic index in 
treatment/control samples; here the control is the untreated sample from the same cell 
type and biological replicate (e.x. ICAM1+ TGFβ Biological Replicate A / ICAM1+ 
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Control Biological Replicate A). This represents a number with arbitrary units for 
comparing fold induction or suppression compared to baseline.  
Statistics: All image calculations were first performed on a per well basis with the 
same thresholds applied to all wells within a single experiment. Once thresholds were 
determined, calculations were performed on all images in an automated manner. The 
adipogenic index for biological replicates was calculated by averaging the results from 
multiple technical replicates (2-8 wells per cell type, per treatment, per biological 
replicate). Here independent wells (i.e. derived from the same biological and FACS pool 
but plated into separate wells of the same plate) are considered technical replicates. 
Statistical testing was performed on biological replicates. 
Cellular proliferation was assessed by plating FACS isolated DPP4+, ICAM1+ or 
CD142+ cells into a 96-well plate. For mouse studies cells were plated at 3600 cells/well 
(Figure 2D), or 2000 cells/well (Figure 2H) in DMEM/F12 + 10% FBS and Primocin. 
For human studies cells were plated at 5,000 cells/well in PM-1 media (Zenbio, cat# PM-
1) supplemented with recombinant 1 nM FGF2 (Invitrogen, PHG0261) and 50 ng/mL 
Primocin. For both human and mouse studies: total nuclear content was measured for 
each well using CyQuant Direct Cell Proliferation Assay (Thermo Fisher cat#C35011). 
Where indicated, TGFβ1 (10ng/mL) and SB431542 (10uM) treatment were initiated after 
measuring the first timepoint. Proliferation data is displayed either as a curve showing 
data from independent wells from a single representative biological replicate (2D, 2H, 
S15C) or as a bar graph from multiple biological replicates showing relative proliferation 
rates. Relative proliferation rates were calculated for the human data in order to provide a 
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comparable baseline as follows: 1) the mean slope of DPP4, ICAM1, and CD142 cells 
was determined and called the “Patient Baseline”. 2) data are displayed as Cell Type 
Slope/Patient Baseline. Ex (DPP4 cells Slope Patient 1) / (Average Slope of DPP4, 
ICAM1, and CD142 from Patient 1). 
RT- qPCR 
Total RNA was isolated using the RNeasy Micro Kit (Qiagen) and quantified using a 
NanoDrop. Five-hundred nanograms to 1 µg of RNA was reverse-transcribed using the 
high-capacity cDNA synthesis kit (Applied Biosystems) followed by real-time PCR with 
SYBR Green master mix (Applied Biosystems) on a 7900 HT machine (Applied 
Biosystems). Tata-binding protein (Tbp) was used as an internal normalization control. 
Data are presented as fold change relative to control. For 2 For figures 2J and 2L, data are 
calculated as treatment/control where the control is the untreated sample from the same 
cell type and biological replicate (e.x. ICAM1+TGFβ Biological Replicate A / ICAM1+ 
Control Biological Replicate A). Data were analyzed using ANOVA followed by 
multiple comparisons unless otherwise indicated.  
Statistical Methods 
Statistical methods were not used to predetermine sample size. The experiments 
were not randomized and investigators were not blinded in experiments. All p values 
are reported with adjustment for multiple comparisons. Most statistical tests were 
performed comparing DPP4+, ICAM1+, and CD142+ cells and therefore used an 
ANOVA followed by multiple comparisons. Pairwise comparisons were determined a 
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priori, were two sided, and were performed only if the ANOVA was significant, using 
either the Holm-Sidak or Tukey HSD. Samples (from each human donor or pool of mice) 
generates cells from all three populations (DPP4+, ICAM1+, and CD142+). Therefore, 2 
Way ANOVA or Repeated Measures ANOVA were employed to account for the 
matched nature of these data. For all parametric tests, QQ and residual plots were 
generated to test for deviation from the ANOVA assumptions of normally distributed 
residuals with equal variance. In cases with unequal variance between samples the 
Brown-Forsythe correction (One Way ANOVA) or Geisser-Greenhouse correction 
(Repeated Measures ANOVA) was used. Where ANOVA would be the appropriate 
statistical test but the data were unbalanced, the Mixed Effects Model for statistical 
testing was used instead. For Figure S14 multiple t-tests followed by Holm correction 
was performed instead of ANOVA. 
Where indicated, biological replicates represent independent samples; i.e. cells 
derived from different human donors or from separate pools of mice. For proliferation 
assays, cells from one human donor or pool of mice were plated into multiple wells, and 
this was repeated across multiple individuals or pools of mice.  
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